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ABSTRACT 
Understanding the Alternative Splicing-regulated Transcriptomic 
Changes During Mouse Retinal Development and Disease Through 
Global and Gene-centric Approaches 
   Devi Krishna Priya Karunakaran, Ph.D 
        University of Connecticut, 2015 
Alternative splicing (AS) is an important layer of gene regulation and has been shown to 
control various cellular processes including splicing, mRNA export, translation and cell 
cycle. Mis-regulation in AS has been implicated in many diseases. But, the role of AS in 
the retinal development and diseases remains unexplored. To this end, I employed a two-
pronged approach, (i.e), gene-centric approach and an en-mass transcriptome analysis 
approach to address this question. For the first approach, I studied the role of an 
alternative splicing factor, Sfrs10 and a kinase, Citron Kinase (CitK) and its spliced 
isoforms in murine retinal development and diseases.   Expression analysis of Sfrs10 in 
mouse and human retinae showed that unlike mouse, it was not expressed in normal 
human retina but was observed only in AMD retina, suggesting a specific role in response 
to oxidative stress.  In parallel, I showed that the loss of CitK affected the cell division of 
a subset of retinal progenitor cells which in turn affected the late neurogenesis, 
specifically that of the Islet1+ bipolar neurons. In the second approach, global analyses 
were performed by employing RNA deep sequencing on cytoplasmic and nuclear 
fractions of developing retinal tissue. We investigated if the nuclear transcriptome would 
be ahead of that of the cytoplasm where it simultaneously executes the current molecular 
program whilst preparing for the next program i.e., de novo transcription. Also, I employed 
a custom bioinformatics pipeline to reverse-engineer the order in which the molecular 
programs are set up as the retinal tissue develops. Further, I extended the study to Nrl 
ii 
 
gene knockout to identify the perturbation of molecular pathways in the absence of the 
gene. Here, our bioinformatics strategy could predict the perturbed molecular programs 
well before its histological manifestation. We also compared our methodology with the 
existing methods of data analysis and show that our pipeline could give information on 
transcription kinetics of genes segregated into each bin. Thus, this pipeline was employed 
in the temporal comparison of a triple microRNA cluster knockout and its wild type 
counterpart across different stages of development. 
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Chapter 1: Retinal development 
“The development of an organism may be considered as the execution of a 
‘developmental program’ present in the fertilized egg. A central task of developmental 
biology is to discover the underlying algorithm from the course of development.”  
– Aristid Lindenmeyer 
 As a developmental biologist, I acknowledge the words of Lindenmeyer, which has 
aptly captured the essence of every developmental biologist’s goal i.e., to understand the 
course of the dynamic process of development and intricate regulatory networks that 
dictate various decisions taken at every step during development. Thus, the focus of my 
research was to understand the role of RNA processing, specifically that of alternative 
splicing and how it regulates the transcriptome in the developing mouse retina. To this 
end, I employed a two-pronged approach – a gene-centric approach using i) an 
alternative splicing factor called Serine-arginine rich splicing factor 10 (Sfrs10), where I 
studied its role in mouse retinal development and disease and ii) a kinase called Citron 
Kinase, where I studied the role of its spliced isoforms in retinal progenitor cells in the 
developing rat retina and iii) en-masse approach using deep RNA sequencing. 
In this chapter, I will discuss the model system used in this study, which is the mouse 
retina. First, I will discuss the history of the retinal research and why retina has been a 
preferred model system to many neurobiologists. This is followed by the architecture of 
the vertebrate retina and how the visual information flows from the input neurons in the 
retina to the brain. Then, I will explain how retina develops from the diencephalon, various 
models proposed to understand the cell fate of retinal progenitor cells and birth order of 
retinal cells. Lastly, I will discuss the transcription factors that are known to regulate the 
production of each retinal type.  
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1.1 Retina as a model system 
 The eye, as an organ, has been long studied and the history dates back to fourth 
century B.C. when Plato mentioned in his writings that the light from the eye captured 
objects with its rays. Later, in 1604, Johannes Kepler was the first to give the ‘theory of 
retinal image’ explaining that vision occurs through a picture of visible things on the white, 
concave surface of the retina[1]. Since then, retina and the image formation in the eye 
have always been of great interest to many neuroscientists. An important breakthrough 
in the retinal field happened in 1887, when Roman y Cajal started working with the avian 
retina as he considered retina to be the most suitable system to study the basic 
organization of the nervous system [2]. In 1893, he published his findings on the retinal 
biology and mentioned how retina is an advantageous structure for neurobiologists 
because of its accessibility, its stereotypic architecture with cell bodies and synapses, and 
the linear flow of visual information. The studies made on the retinal circuitry paved way 
for his ‘neuron doctrine’ [2]. Thereafter, cell fate of retinal progenitor cells, ‘competence 
model’ of the retinal progenitor cells were studied [3]. In 1996, birth order of the retinal 
neurons was characterized by Cepko and her group, who uses retina as the model system 
to explore central nervous system development as its size and location lends itself to 
experiments both in vivo and in vitro [3, 4]. Recent advancements in technology along 
with plethora of literature on expression kinetics of many genes playing vital role in various 
key processes during its development have bettered our understanding of the retinal 
development. Thus, the aforementioned advantages of retina along with exhaustive 
literature in the field has made it a great system to investigate the role of RNA processing, 
specifically alternative splicing during its development and in retinal diseases. 
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1.2 Structure of the vertebrate retina 
The retina is a thin layer of neural tissue that lines the inner part of the eye. It converts 
the electrical light signal into a chemical signal which is then relayed to the brain via the 
optic nerve. The retina is comprised of three nuclear layers and two synaptic layers [3, 
5](Fig 1.1). The retinal pigmented epithelium (RPE) forms a single layer of cells attached 
to the choroid and outer segments of photoreceptors. This layer provides nutrients and 
removes wastes from the photoreceptor cells. Closer to the RPE is the outer nuclear layer 
(ONL). This layer contains the nuclei of the light-detecting photoreceptor cells rod 
photoreceptors and cone photoreceptors. Rod photoreceptor cells are more numerous 
than cones (Fig 1.1) and are significantly more sensitive, being able to be activated by 
individual photons of light [6]. Three types of cone photoreceptors exist in the retina: red, 
green, and blue, each of which are activated by red light, green light and blue light, 
respectively [7]. In murines, there are only red/green and blue cone photoreceptors and 
they constitute about 3% of the cells in the ONL and are much less sensitive than rods 
but allow for color vision [8]. The inner nuclear layer (INL) contains the nuclei of 
interneurons and one glia, namely the Muller glia. These interneurons include horizontal 
cells, bipolar cells, and amacrine cells (Fig 1.1). The outer plexiform layer (OPL) is the 
synaptic layer where photoreceptor cell axons synapse with bipolar cell and horizontal 
cell dendrites. The layer closest to the vitreous is known as the ganglion cell layer (GCL) 
(Fig 1.1), which contains the main output neurons of the retina, namely the ganglion cells 
[3]. The long ganglion cell axons comprise the optic nerve, which terminates in the lateral 
geniculate nucleus in the brain from which the information is relayed to the visual cortex. 
The inner limiting membrane is the most proximal to the vitreous and separates the first 
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layer of the retina from the vitreous humor and contains the end-feet of the Muller glia 
(Fig 1.1). The inner plexiform layer (IPL) contains synapses between bipolar cells, 
amacrine cells and ganglion cell dendrites [3].   
During phototransduction, light interacts with the photoreceptor outer segments and 
rhodopsin in rods and cone-opsins in cones undergo a conformational change and 
become activated [9]. This results in the photoreceptors decreasing the release of 
neurotransmitters to the interneurons of the INL. Photoreceptor interaction with bipolar 
cells varies based on the type of bipolar cell but this interaction relays the information to 
the ganglion cells [9] (Fig 1.1). Lateral modulation of signal by horizontal cells and 
amacrine cells allows cells from one region of the retina to influence cells of another 
region. Horizontal cells receive input from photoreceptors and provide a feedback 
mechanism to other photoreceptor cells. This in-turn helps to regulate and coordinate the 
input from multiple photoreceptor cells [9]. Amacrine cells modulate the interaction 
between bipolar cells and ganglion cells. They receive input from bipolar cells and also 
serve as a feedback mechanism for those cells [9]. Once light reaches the ganglion cells, 
it is transmitted to the brain. Muller glia processes extend from the vitreous humor side to 
the photoreceptors acting like a ‘photoptic tube’ through which light can easily pass. This 
direct passage of light is facilitated by the fact that the glia contain very few organelles, 
which, if present, would scatter much of the light that would pass through [10]. 
1.3 Development of the mouse retina 
In mouse, the eye begins to develop when optic vesicles evaginate from the 
diencephalic region of the neural tube around E9.5 [11]. After the evagination of the optic 
vesicles from the diencephalon, each optic vesicle invaginates to form an optic cup 
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around E10.5 (Fig 1.2). The inner lining of the optic cup gives rise to the neural retina 
while the outer lining results in the formation of the RPE [11] (Fig 1.2). 
Retina is a very good model system with a stereotypic architecture as well as the birth 
order of its cell types are well characterized.  Ganglion cells are born first at E11.5, 
followed by cone photoreceptors, horizontal cells and amacrine cells (Fig 1.3). Amacrine 
cells are produced postnatally too. Muller glia and bipolar cells are produced postnatally 
while rod photoreceptor cells are produced throughout retinal development with its peak 
production at birth [3] (Fig 1.3). In 1996, Cepko et al., proposed the ‘Competence model’ 
where it was shown that progenitor cells in early embryonic development are capable of 
producing more than one neuronal cell type, which was mainly determined by intrinsic 
signals rather than environmental cues [3]. While, the progenitor cells later in the 
development were restricted to giving rise to only one type of neuron [3]. Thus, although 
a retinal progenitor cell is considered multipotent, at any given time during development, 
the given progenitor cell will be restricted in its ability to produce certain cell types [12]. 
For example, progenitor cells fated to produce bipolar cells do not have the 
competence/ability to produce neurons born embryonically, even when placed in an 
embryonic milieu [12]. The reverse of this experiment also was performed where 
progenitors fated to produce embryonically born neuronal types could not produce them 
when placed in the postnatal environment [12]. This substantiated the view that progenitor 
cells had the ability to produce all retinal neurons, but their competence was restricted by 
the developmental time period in which they were isolated. Thus, cell-fate of retinal 
neurons is determined by both intrinsic factors inherent to the progenitor cells, which 
determine their competence to produce subsets of neurons, as well as by extrinsic signals 
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which influenced the specific type of a neuron that will eventually be produced in a given 
competence state [12]. 
1.4  Gene regulation in the developing mouse retina 
Identification of gene regulatory networks connecting various pathways during retinal 
development have led to a better understanding of not only the retinal development but 
also, mechanisms that regulate these processes. The role of one of the master regulatory 
genes, Pax6, has been well-established in Drosophila, where ectopic expression of the 
gene was shown to induce eye formation with normal morphology [13]. Pax6 has been 
shown to play a crucial role in maintaining the multipotency of the retinal progenitor cells 
[14]. It acts upstream of β helix-loop-helix (bHLH) family of transcription factors, many of 
which are key players in retinal development. One of the members of bHLH family, Math5 
has been shown to positively regulate the formation of ganglion cells while it is negatively 
regulated by the Notch-Delta pathway [15]. Key transcriptional factors in photoreceptor 
formation include Nrl and Trβ2, which compete to keep the rod and cone photoreceptor 
cell production in balance [16]. In the absence of Nrl, all rod photoreceptors become cone-
like. Nrl along with its target, Nr2e3 is essential for the rod photoreceptor production [17]. 
Nrl and another factor Crx (Cone- rod homeobox) are together required for the 
maintenance of rod and cone photoreceptors [18-20]. A few factors crucial for bipolar cell 
production and maintenance include bhlhb4, and Otx2, where bhlhb4 has been shown to 
be essential for rod bipolar cell maturation [21], while Otx2 has been shown to be crucial 
for both photoreceptors and bipolar cells [22]. Other bHLH factors such as Mash1 and 
Math3 are also needed for proper bipolar cell production [23]. While the homeobox gene, 
Chx10 is primarily present in retinal progenitor cells during early retinal development, later 
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it is expressed in the bipolar cells and Muller glia and is required for their production [21, 
24]. Another factor, Sox2 has been shown to play a vital role in the embryonic and adult 
neural progenitors and is expressed in Muller glia [25]. Thus, transcriptional regulation 
controlling the production of various retinal cell types is well established. But, the 
underlying layer of isoform regulation of most of these genes still remain unexplored. This 
understanding of isoform-level regulation can help greatly in therapeutic strategies when 
a particular isoform can either be knocked down or upregulated without altering the 
expression at the gene level. To this end, in the next chapter, I discuss the importance of 
Alternative splicing (AS) and how this layer of regulation has diverse roles including in 
central nervous system development. 
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Figures: 
Figure 1.1 
 
Fig 1.1: Stereotypic architecture of the retina: Hematoxylin and eosin stain of an 
adult mouse retinal section superimposed with schematic representation of retinal cell 
types.  OS=outer segements of photoreceptors; IS=inner segments of photoreceptors; 
ONL=outer nuclear layer; OPL=outer plexiform layer; INL=inner nuclear layer; IPL=inner 
plexiform layer; GCL=ganglion cell layer; RP=rod photoreceptor; CP=cone 
photoreceptor; RBP=rod bipolar; CBP=cone bipolar; AC=amacrine cell; GC=ganglion 
cell; MG-Mϋller glia 
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Figure 1.2 
 
Fig 1.2. Development of the retina from neural ectoderm: Retinal development 
begins around embryonic day (E) 8.5 with the evagination of the diencephalon to form the 
optic vesicle followed by the formation of lens placode with signals from optic vesicle at 
E9. Inductive signals between lens placode and optic vesicle results in the formation of 
optic cup and les vesicle at E10. At E10.5, lens is formed and the bilayered optic cup 
forms the outer non-neural retinal pigmented epithelial (RPE) layer and the neural retinal 
layer. Adopted and modified from Colozza G. et al [26]. 
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Figure 1.3 
 
Fig 1.3. Birth order of retinal cell types: The black arrow indicates the time-line starting 
with E11.5 to postnatal day (P) 14 and P0 is the day of birth.  The first cell type sto be 
born is the output neuron, ganglion cells (green), followed by cone photoreceptors (red), 
interneurons horizontal cells (dark blue), amacrine cells (mustard yellow), bipolar cells 
(fuchsia), and Muller glia (orange).  The rod photoreceptor (white) production occurs 
across development with a peak at P0. Adopted and modified from Cepko et al [3]. 
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Chapter 2: Alternative Splicing 
This chapter focuses mainly on RNA processing, specifically the alternative splicing 
(AS). My research focus is to combine the retinal development and AS to understand the 
role of AS in the developing mouse retina. To this end, this chapter describes the 
processes of transcription and splicing followed by alternative splicing process and the 
diverse roles played by AS in cell cycle, metabolism, disease, and CNS development as 
well as the factors that aid this process called alternative splicing factors.  
2.1 Transcription and Splicing 
Development of an organism is a tightly-controlled dynamic process, which 
involves the regulation of various genes at multiple levels of complexity. At the cellular 
level, numerous decisions are made including proliferation, division, differentiation and 
determination. For all these processes, expression of various genes at different phases 
are required. Therefore, their expression should be tightly regulated at every phase. The 
development of central nervous system follows the same paradigm. A neural progenitor 
cell is capable of undergoing an asymmetric (a progenitor cell and a neuron) or symmetric 
cell division, which could be into two neurons or two progenitor cell. For each of these 
decisions to be executed, various cell cycle regulating genes and fate determining genes 
are involved. Spatio – temporal expression of these genes are often regulated at the 
transcriptional levels and at post-transcriptional levels. The transcriptional level of 
regulation refers to the transcriptome changes that occur in a tissue-specific and time-
specific manner.  
Regulation of gene expression can be done at the DNA level, with the usage of an 
alternative transcription start site and polyadenylation sites or total silencing of a particular 
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gene or a set of genes by regulating the levels of a transcription factor. Often, the gene 
expression regulation occurs at the post transcriptional level, where different isoforms for 
a gene are generated, thereby allowing for diversity at the proteome level as well as in 
mRNA localization, transport, and turnover. Certain sequences in mRNA such as its 3’ 
untranslated region (3’UTR), exon-exon junction also determine the patterns of its 
turnover, transport, subcellular localization and its translation [27]. The exon-junction 
complex (EJC) plays an important role in the post-transcriptional regulation of mRNA, 
where it is recruited during splicing and remains associated with the mRNA and allows 
the export of the transcript to the cytoplasm [28]. 
Although the central dogma (information from DNA flows through a temporary 
messenger RNA in the nucleus, which is then exported to cytoplasm and is translated 
into proteins that carry out all major structural and functional activities in a cell) has 
pointed RNA to be an intermediate, there is another layer of regulation at the post-
transcription level that ultimately decides the type of protein synthesized. RNA processing 
or regulation of RNA gained importance in late 1970s, when “one gene one protein” 
hypothesis was questioned as there was a discordance in the number of protein coding 
genes to the number of protein products in the higher mammals. The first step in RNA 
processing is the production of mature RNA by the process called splicing.  
Splicing: Splicing is co-transcriptional and is carried out by a complex, which is made of 
five small nuclear RNAs and a large number of accessory proteins, called spliceosome 
[29, 30]. This splicing machinery is required for the recognition of splice sites and to 
catalyze the two esterification steps. The primary RNA transcript (pre-mRNA), which is 
the identical copy of DNA has the exon and intron boundary (AG/GT), marked by a 
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5’Splice site (SS) (discovered in 1978 [31]) and a 3’Splice site, which is marked by AG/G 
(intron-exon boundary) [32] and a branch point [33, 34]  (Fig 2.1). The machinery gets 
assembled at these splice sites, which begins with the recognition of the 5’SS by the 
snRNP U1 and binding of the splicing factor 1 (SF1) to the branch point and of the U2 
auxiliary factor (U2AF) to the polypyrimidine tract [35] (Fig 2.1). This step results in the 
formation of E-complex, which then becomes energy-dependent, pre-spliceosomal ‘A’ 
complex after SF1 is replaced by U2 snRNP at the branch point [35] (Fig 2.1). Further, 
U4/U5-U6 tri-snRNP complex gets recruited leading to the formation of ‘B’ complex (Fig 
2.1), which is then converted to the catalytically active ‘C’ complex after conformation 
changes [35]. This remodeling of the complex leads to the excision of intron as a ‘lariat’ 
structure and fusion of exons to form the mature transcript (Fig 2.1). 
The decision to include or exclude an exon is decided by another level of regulation 
called Alternative splicing (AS) (Fig 2.2). The process of AS is aided by certain cis- and 
trans-acting factors called RNA-binding proteins, which play an important role in various 
aspects of posttranscriptional regulation of both nuclear and cytoplasmic mRNA including 
alternative splicing, localization, export and translational regulation, besides playing a vital 
role in constitutive splicing [36].   
2.2 Alternative Splicing 
Alternative splicing (AS) has long been thought be occurring at the initial step of 
splicing during the SS recognition and early spliceosome assembly [37]. Although that is 
mostly the case, recent evidences have shown that this decision could be made during 
different stages of splicing including later stages of spliceosome assembly via the 
interaction between cis-acting and trans-acting factors that either promote or repress the 
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recognition of SS or during either of the two esterification steps (Fig 2.2). AS is one of the 
mechanisms that contribute to proteome diversity as well as to tissue-specificity of many 
genes, thereby regulating gene expression in a spatio-temporal manner. Indeed, recent 
high-throughput sequencing studies on various human tissues have shown that 50% or 
more of alternatively spliced isoforms are differentially expressed among the examined 
tissues. The concept of AS was first introduced in 1977 with the discovery of exons and 
introns in the adenovirus hexon gene [38, 39]. Walter Gilbert predicted that different 
combinations of exons of could be spliced together to give the diversity in the mRNA 
isoforms [40]. Thus, AS can be seen as an important mechanism to create protein 
diversity in response to various developmental, environmental and metabolic cues [41-
43]. 
  AS gained impetus due to the realization that there are fewer human protein 
coding genes (PCGs) compared to the number of proteins in humans. Due to the advent 
of technologies such as splicing-sensitive microarrays and high-throughput RNA 
sequencing (HTS), importance and the occurrence of AS in various tissues have gained 
limelight. Datasets obtained from these technologies have facilitated the understanding 
of AS regulated events in contexts of development or differentiated tissues or normal 
versus diseased states. In humans, about 90% of multi-exonic genes in various tissues 
employ alternative splicing [44, 45]. While, some AS events are species-specific, it is 
mostly an evolutionarily conserved process, which highlights the importance of AS very 
early in evolution. An example of a species-specific AS event is that of the transient 
receptor potential cation channel V1 (Trpv1) gene. A trigeminal ganglion-specific isoform 
of this gene is expressed in vampire bats but not in fruit-feeding bats. This isoform has a 
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lower temperature threshold, thereby enabling the vampire bats to sense warm-blooded 
animals [46].  
2.2.1 Types of Alternative Splicing 
 Alternative splicing can occur in multiple ways to produce different combinations 
of exons to yield various isoforms. Some of the frequently occurring types of AS events 
include, i) inclusion of the alternate exon ii) exclusion of the alternate exon iii) alternative 
5’ SS selection iv) alternative 3’ SS selection v) intron retention, where an entire intron or 
a part of it can be retained along with exons. Alternative splice sites are often termed 
‘cryptic donor’ or ‘cryptic acceptor’ [47, 48] (Fig 2.3). There are also other less-frequent 
complex events such as mutually exclusive AS event, alternative transcription start site, 
usage of different polyadenylation signals. The frequency of these events vary among 
invertebrates and vertebrates. It has been shown that in higher vertebrates including 
mouse and humans, most frequently occurring AS event is exon skipping (almost 40% of 
AS events), while in drosophila, exon skipping, alternate acceptor and donor and intron 
retention events are observed at equal frequency with about 20% of exon skipping event 
[48]. 
 Difference in the type of AS events are also seen in the different regions of mRNA, 
i.e., coding region versus untranslated region (UTR). It has been shown that exon 
skipping event is more frequent in the coding region while the intron retention event is 
more frequent in the 5’UTR. Also, more cryptic acceptors are found in the coding 
sequence compared to that in the UTRs. The less-frequent complex events mostly occur 
in the coding region [48]. 
2.2.2 Factors influencing alternative splicing 
16 
 
Various factors such as secondary structure, splice site selection, cis-acting 
elements can influence the AS event. The secondary structure can affect AS events by 
sometimes masking the splice sites or binding sites for splicing factors. For example, a 
stem and loop secondary structure has been shown to sequester alternative exon 6B of 
the chicken β-tropomyosin pre-mRNA, leading to its exclusion [49]. Another example is 
that of the Ras gene, where the IDX exon of Ras pre-mRNA can form a secondary 
structure with an ISS, preventing the binding of hnRNP H [50]. The helicase P68 exposes 
this binding site resulting in the binding. Some small nucleolar RNAs (snoRNAs) have 
also been implicated in AS regulation. For example, snoRNA HBII 52 has been shown to 
regulate the AS of Htr2c pre-mRNA by binding to an ESS in exon V b to aid its inclusion 
[51]. 
The selection of splice site is also partially influenced by secondary structures in 
the pre-mRNA. An example is that observed in Dscam pre-mRNA in Drosophila. The exon 
6 cluster of this pre-mRNA contains 48 mutually exclusive exons and various 
combinations of these exons have been shown to produce 38,016 isoforms [52]. 
Combination of a conserved sequence downstream of exon 5 (docking site) and another 
conserved sequence, a variant of which is upstream of each of exon 6 variants (selector 
sequence) allows for the inclusion of only one exon 6 variant. The other variants are 
excluded by the binding of hrp36, a Drosophila homolog of hnRNP A, to the selector 
sequence [53]. 
Alternative exons are shorter than constitutive exons and are flanked by longer 
introns but they are more conserved than the constitutive exons, especially the exon-
intron boundary and these extend to 80 – 100 nucleotides in to the intron, where cis-
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regulatory elements are embedded. The nature of cis-acting elements and their target 
binding proteins depend on their position relative to regulated exons. Proteins such as 
Nova1, Nova2, Fox1, Fox2, hnRNP L, hnRNP F, hnRNP H have been shown to act as 
either activators or repressors depending on the location of their binding site. For 
example, Nova1 binds to an intron splicing enhancer (ISE) in Gabrg2 (GABA A receptor, 
γ2) pre-mRNA and enhances the inclusion of exon 9, while it binds to the exon splicing 
suppressor (ESS) in the exon 4 of its own pre-mRNA and prevents its inclusion [54]. 
hnRNP L can either activate or repress depending on the location of its binding site 
relative to the regulated 5’ SS [55]. Similarly, hnRNP H can promote or repress the 
spliceosomal assembly based on the location of G-rich sequences whether it is 
downstream of the 5’SS or in the exon [55]. Sometimes, these factors can work in 
combination to activate or inhibit the splicing process. For example, Nova1 and Nova2 
can bind to an ESS and inhibit the formation of the ‘E’ complex by altering the composition 
before hnRNPs bind, ultimately inhibiting the binding of U1 snRNP. On the contrary, if 
Nova1 and Nova2 bind to an ISE downstream of the alternative exon, they promote the 
formation of ‘A’, ‘B’ and “C’ complex during splicing [56].  
2.2.3 Role in diseases 
AS plays an important role in diseases as one can imagine the effects of disrupted 
splicing, such as cancer, metabolic disorders such as obesity, gene mutation etc. [57-59].  
A well-known example of disrupted RNA processing and AS events is observed in 
a class of disorders called ‘microsatellite expansion disorders’. Microsatellites are very 
short sequence (~ 1 to 10) repeats, which are variable in number between individuals and 
are capable of causing a disease when the number expands beyond the threshold. This 
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expansion can cause either loss of protein function or gain of aberrant protein function in 
the open reading frame or gain of function of the RNA that contains this expansion [60]. 
A few examples of diseases that are caused by RNA gain of function is myotonic 
dystrophy types 1 and 2 (DM1 & DM2) [61, 62], fragile X-associated tremor ataxia 
syndrome (FXTAS) and spinocerebellar ataxia 8 (SCA8) [63]. In DM1, CUG repeat 
located in the 3’UTR of Dmpk mRNA expands beyond its normal range of 5 – 38 repeats 
to about 50 - > 2500 repeats [64], while DM2 is caused by expanded CCTG repeats in 
intron 1 of the Znf9 gene [65] and the clinical symptoms of DM1 and DM2 are quite similar 
except that DM2 is less severe and does not present in the congenital form [62, 64]. 
The flexibility offered by AS to offer proteome diversity is used well in various types 
of cancer. Since there is a thin line of separation between normal cell cycle and cancerous 
growth, most AS events that are known to occur involve reverting of some of the isoforms 
expressed during cell cycle in the adult stage, thereby leading to the cancerous growth. 
AS regulates several genes that play important roles in promoting invasive behavior. In 
addition, a process that often plays a role in the acquisition of invasive behavior in cancer 
cells, the epithelial-to-mesenchymal transition (EMT), is accompanied by a 
reprogramming of AS [66]. Also, once the cells become cancerous, they suppress the 
apoptotic pathway. Therefore, genes involved in apoptosis pathway, which are 
alternatively spliced, express their anti-apoptotic isoforms thereby aiding the growth [67]. 
Some of the apoptotic genes that are alternative spliced include Bcl-x, Caspase2 and 
Fas. AS events in exon 2 of Bcl-x create two isoforms – Bcl-x(L), which has anti-apoptotic 
effects and Bcl-x(s), a pro-apoptotic isoform [68].  
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Casp2 mRNA is alternatively spliced to produce two most important isoforms – 
Caspase-2L, which is a full-length coding isoform with pro-apoptotic properties, while the 
other isoform, Caspase-2s, is an isoform with additional 61-nucleotide exon. This exon 
inclusion results in the frameshift leading to a premature stop codon, thus creating a short-
lived nonsense-mediated decay substrate. This isoform was shown to protect against cell 
death [69, 70].  
Another example is Fas pre-mRNA, where the full-length protein coding isoform 
(Fas-L) is pro-apoptotic. While, it also produces a shorter isoform, which excludes a 63 
nucleotide-long exon 6. This event results in the deletion of transmembrane domain 
leading to the soluble form of Fas, which is capable of inhibiting FasL-mediated cell death 
[71].  
2.2.4 Role in central nervous system development 
AS plays an important role in defining tissue-specificity. This, in part, could be 
explained by tissue-specific expression of the splicing factors and their target mRNA 
expression. Among all human tissues, brain has been shown to employ the highest 
degree of AS. Many brain-specific AS regulators have been identified, such as, nPTB, 
NOVA1, NOVA2, Hu/elav proteins, to name a few. In addition, more than 300 RNA 
binding proteins have been identified in proliferating and post-mitotic brain cells with a 
region and cell specific expression. For example, PTB is highly expressed in progenitors 
while downregulated in differentiated neurons, where another isoform, nPTB is 
upregulated. Recently, it has been shown that switch from PTB to nPTB is an important 
post-transcriptional regulatory step in neuronal differentiation [72].  
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Another brain-specific factor, Nova proteins, are also involved in programming of 
different types of neuronal cells. Nova1 and Nova2 are differentially expressed in 
postnatal mouse brain, with Nova2 being highly expressed in the neocortex and 
hippocampus and Nova1 being expressed in the hindbrain and spinal cord [73]. 
Conditional knockout analysis of Nova2 has shown that Nova2 regulates ~7% of brain-
specific splicing in the neocortex and that Nova2- dependent AS regulates the expression 
of mRNA transcripts that encode synaptic functions [73]. 
2.2.5 Role in cell cycle regulation 
During normal development and differentiation, dynamic changes in the 
expression and activity of the splicing machinery are coordinately regulated to modulate 
the alternative splicing events in a spatio-temporal fashion and according to the 
physiological needs of the cell. Cell cycle is a key process during development allowing 
for the proliferation of progenitor cells and for the simultaneous execution of decisions 
such as determination, differentiation into a particular lineage once cells exit the cell cycle. 
Therefore, numerous intricate networks work in a well-coordinated manner to execute 
these cellular processes. Perturbations caused by mutations, which alters the expression 
or activity of a splicing factor can lead to an array of human diseases. Cell cycle regulation 
is also a tightly- controlled process, which keeps the cell under check and prevents it from 
becoming cancerous. Any deviation in the expression of genes that are ‘check points’ in 
cell cycle can lead to uncontrolled growth of cells leading to cancer. Therefore, alternative 
splicing plays an important role in cell cycle regulation by regulating the isoforms of 
various important genes involved in cell cycle. 
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 There are many genes that are employed at various phases of cell cycle including 
cyclin D1a, CD44, Rac1, Ras etc. Cyclin D1a, is the more common full-length isoform 
containing five exons. Another variant isoform is known as cyclin D1b, which is 
polyadenylated in exon 4 at a particular site [74]. Although both isoforms can associate 
with CDK4 and regulate the activity of CDK similarly [75], D1a can shuttle between the 
nucleus and cytoplasm in a cell-cycle dependent manner due to the presence of a 
phosphorylation site present at its C-terminus, while D1b remains nuclear due to the 
absence of this phosphorylation site [75, 76]. Cyclin D1b remains nuclear and is known 
to be upregulated in breast and prostate cancers [77] and mutations in D1a at the 
phosphorylation site can also mimic D1b and increased nuclear levels of the protein could 
be more oncogenic [78].  
Another key player of cell cycle that is highly regulated by AS is CD44. Gunther et al., 
has shown that CD44 contains variant exons 4 -7 and isoform containing variant exons 
6-7 were expressed specifically in a metastasizing pancreatic carcinoma cell line [79]. 
Various combinations of ten variant exons in CD44 leads to numerous isoforms of CD44 
[80]. An isoform containing variant exon 6 was seen to be expressed in B and T 
lymphocytes after lymphocyte activation [81]. Normal expression of CD44 is that of the 
isoform containing the variant exons 8-10, which is seen in epithelial cells [82].  
A member of Ras superfamily of GTPases, Rac1 has two variant isoforms. Like Ras, 
Rac1 shuttle between an active form when it is bound to GTP and an inactive GDP-bound 
form. Rac1 activates transcription by NFkB and AKT kinase, members of important 
pathways implicated in various cancers [83, 84]. An isoform of Rac1 called Rac1b, which 
contains a 57-nucleotide exon 3b, has been shown to be expressed in colorectal cancer. 
22 
 
Another important gene involved in the cytokinesis step of cell cycle regulation is 
Citron Kinase (CitK). It belongs to Rho family of GTPases and is found to be expressed 
in the proliferative cells of the developing brain. There are two known isoforms of this 
gene – full length protein-coding isoform called citron kinase and a shorter isoform without 
the kinase domain coding region. This gene was employed to study the role of alternative 
splicing in retinal progenitor cells in the developing rat retina and the function of other 
newly identified isoforms of CitK. Background on this gene is discussed in the next section 
and the results obtained in the study is discussed in chapter 4. 
2.2.6 Alternative Splicing factors 
Trans-acting factors that facilitate the process of AS are called alterative splicing 
factors (ASFs). These factors can either repress or promote the inclusion of an exon in 
the final transcript. Accordingly, there are two large family of ASFs namely serine-arginine 
rich (SR) proteins and heterogeneous nuclear ribonuclear protein (hnRNPs). While SR 
proteins usually are splicing enhancers and that they promote the inclusion of the 
alternative exon, members of hnRNP family suppress the inclusion of an exon. SR 
proteins typically contain one or two RNA –recognition motif (RRM) and one or two RS 
dipeptide containing domain. The RS domain of these proteins interact with other splicing 
factors and facilitate the recruitment of the spliceosomal components such as snRNP U1 
to the 5’ SS or U2AF65, the largest subunit of U2AF to the 3’SS (SR proteins are 
discussed in detail in chapter 3) [85]. hnRNPs contain RRM-type and hnRNPK homology 
(KH) domain-type RNA binding domains and play a key role in splicing of pre-mRNA and 
mRNA metabolism. They act as repressors by affecting the formation of the E and A 
complexes during the spliceosome assembly. Other repressors include Polypyrimidine-
23 
 
tract binding proteins (PTB or hnRNP I), which blocks the binding of U2AF, hnRNP A1, 
which binds to intronic splicing suppressors (ISS) located upstream of exon 3 in HIV Tat 
pre-mRNA and prevents the binding of U2 snRNP [86]. Also, tissue-specific factors, Fox1 
and Fox2 inhibit the formation of the E’ complex by binding to intronic sequences to 
prevent SF1 binding to the Calca pre-mRNA [87]. In addition to repressing, splicing 
inhibitors also block the binding of activators to enhancers. Hu/ELAV family of proteins 
inhibit U1 snRNP binding by competing with the binding of TIA1 to an AU-rich sequence 
downstream of the 5’ SS of exon 23a of neurofibromatosis type 1 pre-mRNA [88]. Another 
example is hnRNP A1 binding to an ESS upstream of the Tra2b-dependent exon splicing 
enhancer in exon 7 in the SMN2 pre-mRNA, inhibiting the formation or stabilization of U2 
snRNP complex [89]. 
Thus, the final decision of whether or not an alternative exon is included in the 
transcript is determined by concentration or activity and the combination of activators and 
repressors. For example, SR protein 9G8 (SFRS7) and hnRNP F and H regulate the 
splicing of exon 2 of α-tropomyosin by competing for the same binding site [90]. Similar 
regulation exists in β-tropomyosin exon 6B, where there is an antagonistic regulation 
between hnRNP A1 and SR proteins, ASF/SF2 (SFRS1) and SC35 [91]. PTB and CELF 
(CUGBP- and ETR-3 like factor) protein family and CUGBP1 act antagonistically to 
regulate the inclusion of exon 5 of troponin T type 2 pre-mRNA [92].  
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Figures 
Figure 2.1 
 
Fig 2.1 Steps in the splicing process. Basic splicing mechanism begins with the 
recognition of 5’ splice site and branch point by U1snRNP and U2AF (‘E’ complex). This 
leads to the recruitment of U2 snRNP, resulting in the formation of ‘A’ complex, which 
results in first trans-esterification step. Recruitment of the tri-snRNP complex (U4-U6-
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U5) to the pre-mRNA leads to the second trans-esterification step. Finally, the intron is 
excised as a ‘lariat’ and the exons are fused to form the mature RNA. 
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Figure 2.2 
 
Fig 2.2 Mechanism of alternative splicing. A. Presence of splicing enhancers, such as 
SR proteins (shown in ‘blue’) on the pre-mRNA facilitates the recruitment of the splicing 
machinery, leading to the inclusion of the alternate exon. B) Presence of splicing 
repressors, such as hnRNPs (shown in ‘magenta’) on the pre-mRNA prevents the 
recruitment of the splicing machinery, leading to the exclusion of the alternate exon. 
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Figure 2.3 
 
Fig 2.3. Types of Alternative Splicing. A – E. – Various types of alternative splicing 
events include A) exon splicing B) Mutually exclusive event C) Alternative 5’ splice site 
D) Alternative 3’ splice site E) intron retention. 
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Chapter 3: Role of the alternative splicing factor, Sfrs10 in mouse 
retinal development 
This chapter approaches the question of role of alternative splicing (AS) specifically 
through an alternative splicing factor, Serine-arginine rich alternative splicing factor 10 
(Sfrs10) in mouse retinal development and disease. This approach to understanding the 
role of AS, follows the same paradigm of understanding the process of transcription 
through transcription factors. First, expression analysis of this gene, both at the mRNA 
and protein level, is discussed followed by the investigation of its role as a stress-
response gene in age-related macular degenerating retinae.  
3.1 SR proteins 
Serine/arginine (SR) family of proteins are a highly conserved family of splicing 
regulators. The discovery of SR proteins dates back to studies in Drosophila, when 
genetic screening identified SWAP (suppressor-of-white-apricot), Tra and Tra2 as 
splicing factors [93, 94]. Characterization of their sequences led to the identification of the 
RS domain. Identification of factors ASF/SF2 and SC35 from human cell lines extended 
their structural characterization to reveal the presence of atleast one RNA recognition 
motif (RRM) and another region that is not an exact match to RRM but partially matched 
the consensus sequences and was referred to as RRM homolog (RRMH). These proteins 
are called “SR proteins” and was described by Roth and his colleagues based on five 
criteria [95]: 1. All members have a phosphoepitope recognized commonly by the 
antibody, mAb104 2. They co-purify in a two-step salt precipitation procedure 3.  They 
contain one or two RRMs at the N-terminus and an arginine-serine (RS) dipeptide 
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containing domain at the C-terminus. Sizes of these proteins are conserved from 
Drosophila to humans on a SDS-PAGE. These proteins can complement splicing 
deficient S100b extracts [95]. SR proteins, besides, acting as exon-splicing enhancers 
(ESE), have also been implicated in mRNA export, localization, nonsense-mediated 
decay (NMD) and translation [85, 96-98].  When they act as ESEs, they recruit the splicing 
machinery to the pre-mRNA via their RS-domain-protein interactions, to the splice site 
[99-101]. Kinetic analyses have shown that the relative activity of SR proteins determines 
the magnitude of splicing efficiency [85]. This activity depended on the SR protein number 
and the distance between the ESE and the intron. Also, the activation of splicing was 
proportional to the number of RS repeats within the RS domain [102].  
Location: SR proteins are usually enriched in nuclear compartments termed 
‘speckles’, which occur throughout the nucleus [85, 103]. Speckles can be of two types – 
Inter-chromatin granule clusters (IGCs), which are about 20-25nm in diameter, and 
perichromatin fibrils, which are about 5nm in diameter. IGCs are usually the 
storage/assembly sites for pre-mRNA splicing factors while the fibrils are sites of actively 
transcribing genes and splicing [104, 105]. Biochemical analyses have shown that RS 
domains are responsible for bringing the SR proteins to these speckles. RS domain, RRM 
and their phosphorylation status are required for the recruitment of SR proteins to 
perichromatin fibrils from IGCs.  
Phosphorylation and concentration of SR proteins: Phosphorylation of SR 
proteins is vital for their activity in both constitutive and alternative splicing and for their 
localization. Serines in the RS domain get phosphorylated and this activity determines 
their activity [85]. Regulation of SR protein activity by phosphorylation has been 
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implicated in cancers and other diseases. Phosphorylation is required for efficient SS 
recognition. A number of SR protein kinases have been identified that specifically 
phosphorylate the serine residues in the RS domain. They include SR protein kinase 
(Srpk), Clk/Sty kinase, cyclin-dependent kinases (Cdk), and topoisomerases [106, 107]. 
Also, SR proteins function in a concentration-dependent manner. SRp38 has been shown 
to facilitate inclusion of the Flip exon of the Gria2 (Glutamate receptor, ionotropic, 
AMPA2) pre-mRNA, whereas the mutually exclusive Flop exon is included in its absence. 
Interestingly, both of these exons contain SRp38-binding sites and it was shown that 
intracellular concentrations of SRp38 and differential binding to exons influenced whether 
Flip or Flop exon was included [108]. 
SR proteins as repressors: There is a balance between activation and repression, 
which regulates the inclusion/exclusion of an exon in the primary transcript [86, 109]. 
Although, there are several members in the SR protein family, some of the members have 
distinct binding sites endogenously, for example, SRSF3 and SRSF4 do not have any 
overlap in the binding sites of their targets [110, 111]. There are a few SR proteins which 
cooperatively operate with overlap in their binding sites, such as SRSF1 and SRSF2, 
which can compensate for one another in exon inclusion/exclusion [112]. Sometimes, SR 
proteins bind to intronic regions and function as negative regulators. An example is that 
of SF2/ASF, which during adenovirus infection, binds to an intronic repressor element 
located upstream of the 3’ SS at the branch point sequence in the adenovirus pre-mRNA 
[113]. The binding prevents the recruitment of U2AF and so the splicing process.  
Role of SR proteins in mRNA export: SR proteins are known to shuttle between 
cytoplasm and nucleus depending on their phosphorylation status. SF2/ASF, SRp20 and 
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9G8 have been shown to shuttle between the two compartments. It has been shown that 
SR proteins, 9G8 and SRp20 promote nuclear export of the intronless histone H2A mRNA 
by binding to 22-nucleotide sequence within H2A mRNA in mammals and frog. These SR 
proteins have also been shown to handover mRNA to the nuclear export factor, Tip-
associated protein (Tap) [114, 115]. Another SR protein, Npl3p, a yeast protein has been 
shown to assist mRNA export in yeast, where the phosphorylation of its RS domain 
regulates the efficiency of its export function [116]. 
Role of SR proteins in translation: SR proteins have been shown to play diverse roles 
in RNA processing including translation of mRNA. They can either directly or indirectly 
influence translation. For example, SF2/ASF influences the AS of the kinase that 
regulates translation initiation, Mnk2 pre-mRNA [58]. Directly, SF2/ASF has been shown 
to influence translation by associating with polyribosomes and mediating the recruitment 
of components of mammalian target of rapamycin (mTOR) pathway, which releases the 
inhibitor of the cap-dependent translation, thereby promoting translation [117]. Also, 
SRp20 has been shown to promote translation of a viral RNA initiated at the internal 
ribosome entry site [118]. 
3.2 Serine-Arginine rich alternative splicing factor 10 (Sfrs10) 
SFRS10 (Tra2beta) belongs to SR-protein family. Sfrs10 is a mammalian homolog 
of Drosophila Tra2beta, which regulates the AS of genes involved in sex determination of 
the fly [119, 120] and causes sex reversal in Drosophila due to the altered splicing of 
doublesex (dsx) transcripts [121]. Sfrs10 contains a RRM and two RS domain, one at the 
N-terminus and the other at the C-terminus. Sfrs10 has been shown to activate splicing 
of some targets via (A)GAA binding motifs in its RRM [122], while for some targets, it can 
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activate through its N-terminal RS domain (RS1), which has been shown to be vital and 
highly conserved between vertebrates and non-vertebrates. Sfrs10 protein lacking RS1 
domain has been shown to play the role of a splicing repressor suggesting a dual role of 
an enhancer and repressor during splicing [123]. 
3.2.1 Role in development and metabolism 
 In higher vertebrates, loss of Sfrs10 results in mouse embryonic lethality around 
embryonic day (E) 7.5-8.5 [124].  Brain specific knockout of Sfrs10 has shown to result in 
perinatal death where pups die by P1 and show malformed brain [122].  The role of Sfrs10 
in various tissues such as testis, intestinal and vascular smooth muscle has been studied. 
SFRS10 has been shown to be involved in the regulation of splicing of the clathrin light 
chain B (Cltb) at the vesicles, which is involved in receptor-mediated endocytosis [125, 
126], and in splicing of Mypt,  which is involved in vascular smooth muscle diversification 
(splicing of MYPT) [127]. SFRS10 has been shown to alter splicing of lpin1 [128], which 
is a key regulator of lipid metabolism, thereby leading to increased lipogenesis and VLDL 
secretion in mice [129-131]. It has been shown that Sfrs10 plays a crucial role in neuronal 
development and survival through its targets such as Sgol2 and Tubd1 [125]. Additionally, 
knockdown of Tra2b has been shown to perturb p21-mediated cell cycle inhibition, 
thereby resulting in apoptosis [125]. 
3.2.2 Role in diseases and in stress-response 
Sfrs10 was originally identified as a stress response gene called RA301 that was 
strongly induced in cultured astrocytes during reoxygenation following hypoxia and in 
ischemic rat brain [132].  The same group showed that knockdown of Sfrs10 in astrocyte 
subjected to hypoxia/reoxygenation stress had 3-fold reduction in the release of a 
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neuroprotective interleukin-6 (IL6).  This was the first report of an ASF linked to active 
stress-response mechanism. Other evidence of stress induced upregulation of Sfrs10 
was shown by Tsukamoto et al [133]  where it was observed that middle carotid artery 
occlusion caused upregulation of Sfrs10 in vascular smooth cells. In gastric cell lines 
exposed to arsenite led to changes in splice patterns of Sfrs10 itself and it was 
translocated to the cytoplasm in part due to the change in its phosphorylation status [134].  
In the same study, knockdown of Sfrs10 altered inclusion of exons responsible for the 
central variable region of CD44, which led to suppression of cell growth.  Also, carotid 
artery occlusion induced ischemia in the brain showed hyperphosphorylation and 
translocation of Sfrs10 into the cytoplasm of the affected neurons [70].  This shift in Sfrs10 
was concomitant with changes in the splice site usage in the known initiator caspase, 
ICH-1/caspase2 gene. Over expression of Sfrs10 has been shown to upregulate p53 
levels [135]. Reduced levels of Tra2b have been observed in various diseases including 
stroke, breast cancer [136] and neurodegenerative diseases like spinal muscular atrophy 
(splicing of SMN) [137-139] and in tauopathies like Alzheimer’s disease and fronto-
temporal dementia with Parkinsonism (FTDP) [136, 140]. The gene, microtubule 
associated protein tau (MAPT) undergoes AS to produce six brain-specific protein-coding 
isoforms. The ratio of these isoforms is perturbed due to mutations in the splicing 
elements in the gene, which leads to the production of irregular ratios of Mapt transcripts 
observed in patients affected with FTDP. It was also shown that mutations in Mapt 
produced abnormal Tau proteins causing neurodegeneration. Sfrs10 regulates the 
splicing event of exon 10 inclusion in Tau pre-mRNA. Inclusion or exclusion of exon 10 
leads to the generation of three- or four- microtubule repeats and the ratio under normal 
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conditions equals one and is essential for proper neuronal function. Imbalance created in 
the ratio leads to neurodegenerative diseases such as Alzheimer’s disease [141, 142]. 
3.3 Rationale 
 The alternative splicing factor, Sfrs10, has been shown to play an 
important role in brain development.  I wanted to explore the function of Sfrs10 in the 
developing mouse retina. To this end, I first characterized the gene and its protein 
across mouse retinal development. The expression of alternative splicing factor, Sfrs10 
was examined across various species as the Sfrs10 protein is 100% conserved 
between all mammals including mouse and humans. This led to the analysis of Sfrs10 
protein by immunohistochemistry on sections of retinae obtained from normal humans. 
Surprisingly, Sfrs10 protein was not expressed in normal humans, unlike in mouse, 
where it had an ubiquitous expression by adulthood. Since Sfrs10 is a well-known 
stress- response gene, I investigated retinal sections obtained from patients with age-
related macular degeneration (AMD). Further, I also tried to explore the function of this 
gene under hypoxic stress in cell culture system, which was eventually shown by 
Kuwano et al [143] that Sfrs10 plays a protective role by promoting the formation of anti-
apoptotic isoform of Bcl2 (Bcl2α) under stress. 
Following sections include contents of two my publications [144, 145] titled “The 
expression analysis of Sfrs10 and Celf4 during mouse retinal development” and 
“Expression Analysis of an Evolutionarily Conserved Alternative Splicing Factor, 
Sfrs10, in Age-related Macular Degeneration”. 
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3.4 Background 
Age-related Macular degeneration (AMD) is the leading cause of blindness in the 
aging population in the developed world. According to National Eye Institute, in 2010, 
approximately 2 million people were affected with AMD in the US and the number is 
estimated to go up to 3.6 million by 2030 (http://www.nei.nih.gov/eyedata/amd.asp). AMD 
affects the macula, the region in the retina that is responsible for sharp, central vision. 
AMD can be of two distinct forms: dry AMD (non-exudative or atrophic) or wet AMD 
(exudative or neo-vascular) of which dry AMD is the most common. AMD is a multifactorial 
disease that includes genetic, environmental and physiological components. The 
underlying cause of AMD is thought to be the hypoxic condition experienced by the 
photoreceptors leading to their degeneration [146-152].  
Rod photoreceptors consume more O2 per gram of tissue weight than any other 
cell in the body [6]. This constant high energy demand makes the photoreceptors more 
susceptible to hypoxic stress. Factors such as oxidative stress, accumulation of 
autoxidative lipofuscin in the lysosomes of retinal pigmented epithelial (RPE) cells [153-
158] and accumulation of drusen in between Bruch’s membrane [159, 160] and the 
epithelial layer affect the RPE which results in the senescence of these cells. RPE not 
only plays a vital role in supplying nutrients and oxygen from choroidal vasculature to the 
photoreceptor cells, but also in removing the metabolic wastes from the photoreceptors. 
Since the outer segments of the photoreceptors interact with RPE, senescence of the 
latter affects the normal functioning of the former [161, 162].   
Genome wide association studies have shown SNPs in genes including VegfA, 
VegfR2, Arms2, Htra1, and CFH to have significant association with AMD [163-169].  
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However, the role of alternative splicing in the pathogenesis of AMD is not well 
understood. Members of SR protein family such as SFRS1 have been shown to play a 
role in the pathogenesis of AMD. Phosphorylated SFRS1 was shown to promote proximal 
site selection in exon 8 of VEGF to generate the angiogenic isoform, VEGF (165) in AMD 
[170, 171]. We investigated the role of SFRS10 in AMD. 
3.5 Results 
3.5.1 Sfrs10 is expressed across mouse retinal development 
To determine whether Sfrs10 was expressed during mouse retinal development, RT-PCR 
was performed across retinal development.  The position of the primers used to amplify 
the coding sequence of Sfrs10 is shown in Fig 3.1A.  Expression was observed across 
retinal development with two distinct isoforms at postnatal day (P)4, P10 and P14 (Fig 
3.1B).  Sequence analysis of both these isoforms revealed that the isoform at 1234 bp 
was the canonical isoform encoding a full-length Sfrs10 protein.  The higher MW isoform 
at 1511 bp was similar to the previously reported exon 2a containing isoform.  Inclusion 
of exon 2a introduces a premature stop codon, which results in non-sense mediated 
decay of this transcript.  Gapdh was used as a control (Fig 3.1B’).  5’ rapid amplification 
of cDNA ends (5’RACE) was performed to investigate whether alternate transcription start 
sites were being employed for Sfrs10 across retinal development.  For this, PCR was 
employed on 5’-RACE ready cDNA library from retinae at different developmental time 
points.  While the forward nested primers were in the 5’ linker sequence, the reverse 
primer was in exon 4 of Sfrs10.  The PCR product was then purified and subjected to 
restriction digestion with EcoNI, which yielded two bands as predicted to be of 380 bp 
and 130 bp, respectively (Fig 3.1C).  There was no change in the transcription start site 
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across retinal development.  Similar investigation across different developmental time 
points was carried out to check the alternate polyA signal usage in Sfrs10 (NM_009186.4) 
as it contains three putative polyA signals (1672 bp, 1762 bp, 2247 bp). 3’ rapid 
amplification of cDNA ends (3’RACE) was employed with forward primers designed 
upstream of each polyA signal and a reverse primer in the linker sequence followed by 
restriction digestion with BsrI, which yielded two bands as predicted 407 bp and 230 bp.  
Again, the second PolyA signal at 1762 bp was utilized for Sfrs10 transcript across retinal 
development (Fig 3.1D).   
3.5.2 Sfrs10 is expressed in differentiating retinal cells 
Next, we employed IHC with AB#1 on mouse retinal section across postnatal 
development to ascertain the cell types expressing Sfrs10.  At P0, Sfrs10 was observed 
in the nuclei in the ganglion cell layer (GCL) (Fig 3.2A).  At P4, it was observed at the 
bottom of the outer neuroblastic layer (ONBL), besides the GCL (Fig 3.2B).  Sporadic 
Sfrs10+ cells were also observed in the middle of the ONBL of the P4 retina.  Next, Sfrs10 
was costained with syntaxin, which was localized to the cytoplasm of the Sfrs10+ nuclei.  
At P8, Sfrs10 was observed in all of the cell types in the INL including, Müller glia, 
horizontal cells, bipolar cells, and amacrine cells and the GCL (Fig 3.2D).  In addition, in 
the newly formed ONL at P8, a few Sfrs10+ cells were observed.  Similar pattern was 
observed in the ONL of P10 and P14 retinal sections (Fig 3.2E, F).   
3.5.3 Sfrs10 marks red/green cone photoreceptors between P8-P14 
The sporadic Sfrs10+ cells in the ONL at P8, P10 and P14 could either be rod 
photoreceptors or cone photoreceptors.  To distinguish between these two possibilities, 
P8 and P10 retinal sections were stained for expression of Sfrs10 and red/green opsin. 
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Three independent antibodies for Sfrs10 (AB#1, AB#2, and AB#3) were employed to 
confirm the specificity of the antibody (Fig 3.3A).  Since the primary antibodies to detect 
both Sfrs10 and red/green opsin were raised in rabbit, they could not be detected 
simultaneously.  Instead, serial IHC was performed, first with Sfrs10 followed by red/green 
opsin.  Since Sfrs10 and red/green opsin are segregated into separate cellular 
compartments, i.e. nucleus and cytoplasm, respectively, we were able to employ serial 
IHC.  Here, it was observed that Sfrs10+ nuclei were enveloped by red/green opsin 
staining thereby confirming the identity of these cells to be red/green opsin cone 
photoreceptors (Fig 3.3B-D”).  All three Sfrs10 antibodies showed similar pattern, thereby 
confirming the specific enrichment of Sfrs10 in red/green cone photoreceptors. Further, 
we performed immunoblot analysis on P0 retinal extracts with the two antibodies (AB#1 
& AB#2), which again showed a single immunoreactive band at the expected molecular 
weight of Sfrs10 (Fig 3.3G, H). 
3.5.4 Sfrs10 is peri-nuclear in mouse rod photoreceptors 
Analysis of Sfrs10 expression across postnatal development ending at P14 showed that 
the rod photoreceptors did not express Sfrs10.  However, it is known that rod 
photoreceptors undergo rapid outer segment genesis between P13 and P17 and terminal 
differentiation including synapse formation is thought to be complete by P21 [161, 172].  
To test whether Sfrs10 is expressed in rod photoreceptors during their terminal 
differentiation, IHC was performed for Sfrs10 on P22 retinal sections, which showed 
Sfrs10 expression in rod photoreceptors, albeit in a different pattern (Fig 3.4A).  Unlike 
cone photoreceptors, where Sfrs10 was found in a diffused nuclear pattern, in rod 
photoreceptors it was localized in a peri-nuclear ring-like structure. Since photoreceptors 
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do not have a large cytoplasmic space around the nucleus, it was not clear if Sfrs10 was 
in the cytoplasm or the nucleus.  To further delineate the localization of Sfrs10, 6 μm 
retinal sections were costained with Sfrs10 and LaminB2 antibody, which marks the inner 
membrane of the nuclear envelope [173].  Here Sfrs10 was found on the DAPI stained 
region, but did not overlap completely with LaminB2 thereby confirming its localization on 
the nuclear side of the nuclear envelope (Fig 3.4A-A’’). 
 To investigate the role of Sfrs10 in mouse retinal development, we wanted to use 
a retina-specific conditional knockout of Sfrs10. While I waited for the chimeras to arrive 
from the KOMP facility at the University of California, Davis, I simultaneously started 
addressing the question through en-masse transcriptomic analysis using RNA 
sequencing, which I will discuss in Chapter 5. 
3.5.5 Sfrs10 is 100% conserved in mammals 
Sfrs10 has three functional domains namely, N-terminal RS1 domain (31-113 
amino acids (AA)), C-terminal RS2 domain (231-287 AA) and RNA recognition motif (118-
196 AA) (Fig 3.5A). AA sequences corresponding to these functional domains were 
compared across different vertebrate species to assess the percentage of conservation 
of Sfrs10. The selected species were Danio rerio (zebrafish), Xenopus tropicalis (frog), 
Gallus gallus (chicken), Pan tronglodytes (chimp), Bos taurus (cow), Canis lupus 
familiaris (dog), Homo sapiens (humans), Sus scrofa (pig), Mus musculus (mouse), 
Rattus rattus (rat) and Delphis delphis (dolphin). The selection was based on the 
availability of the entire AA sequence in each class.  
 The entire RS1 domain was conserved 100% between chicken and all the 
mammalian species (yellow background, Fig 3.5B) while only the RS dipeptide region 
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showed 100% conservation in all species (Fig 3.5B). RS2 domain was similar to RS1 
domain in that there was 100% conservation in the RS dipeptide region among all the 
species (yellow background, Fig 3.5B’’) with the entire domain conserved 100% among 
the mammals (Fig 3.5B’’). Within the RRM of SR proteins there are two motifs called 
ribonucleoprotein 1 (RNP1), an octamer, and ribonucleoprotein 2 (RNP2), a hexamer, 
which are highly conserved [174-177]. In Sfrs10, RNP1 sequence is RGFAFVYF (159-
166 AA) and RNP2 sequence is LGVFGL (125-130 AA). Comparison of RNP1 motif 
across the species showed 100% conservation except for zebrafish and frog, which had 
one AA change (phenylalanine to leucine in zebrafish, alanine to serine in frog) (red box, 
Fig 3.5B’). Similarly, comparison of RNP2 motif showed 100% conservation across all the 
species (blue box, Fig 3.5B’). Interestingly, the entire Sfrs10 AA sequence showed 100% 
conservation in mammals including the linker regions between the functional domains.  
3.5.6 Sfrs10 expression is conserved in mouse, rat and chicken retinae 
Given that Sfrs10 is highly conserved at the protein level across different species, 
we wanted to investigate whether its conservation was reflected in its expression.  We 
chose mouse, rat, chicken, and zebrafish as these are widely used model organisms for 
retinal research. We employed immunoblot analysis using an antibody that recognizes 
the conserved N-terminal of the protein (black box, Fig 3.6A). A single band at the 
predicted (39 kDa) size was observed in mouse, rat, and chicken retinal extract (Fig 3.6B). 
This band was at the same molecular weight (MW) as the positive control, which was the 
protein extract prepared from HEK-293t cells transfected with a construct expressing full 
length Sfrs10 protein. Notably, no immunoreactivity was observed in the lane with 
zebrafish retinal extract (Fig 3.6B).  
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3.5.7 Sfrs10 expression is pan-retinal in mouse, rat and chicken 
To ascertain the cell type specific expression of Sfrs10, retinal sections from adult mouse, 
rat and chicken retina were subjected to IHC with the same antibody used for immunoblot 
analysis (black box, Fig 3.6A). In mouse, Sfrs10 was robustly expressed in all the cell 
types of the retina including, ganglion cells, amacrine cells, Müller glia, bipolar cells, 
horizontal cells and in both cone and rod photoreceptors.  The expression pattern in 
photoreceptors was different with Sfrs10 expressed diffusely across the nucleus in cone 
photoreceptors, while the expression was peri-nuclear in rod photoreceptors (Fig 3.7A). 
In rat, Sfrs10 expression was similar to that of mouse and was observed in all cell types 
of the retina (Fig 3.7B). Similarly, in chicken, Sfrs10 was expressed in both the ganglion 
cell layer and in the inner nuclear layer, but in the photoreceptor layer there was a minor 
difference in the expression pattern.  Sfrs10 expression was not observed in a subset of 
cells, which by the staining pattern was deduced to be rod photoreceptors (Fig 3.7C). 
3.5.8 SFRS10 is not expressed in normal human retinae but is upregulated in AMD 
retinae  
Given that Sfrs10 is a known stress response gene that is 100% conserved 
between mouse and human, we sought to investigate its expression in normal and AMD 
human retinae. For this, three independent normal retinal sections were subjected to IHC 
with anti-Sfrs10 antibody (Table 3.1).  
Sample #1 showed no Sfrs10 expression in any of the retinal layers (Fig 3.8A). 
Similarly, sample #2 showed no SFRS10 expression (Fig 3.8B). Again, sample #3 
showed no SFRS10 expression, except for low levels in a few cells in the ganglion cell 
layer (Fig 3.8C).  
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Table 3.1: Case history of specimens analyzed 
 
Sourc
e 
Sampl
e No. 
Ag
e 
Se
x 
Categor
y 
hours 
post 
morte
m fix 
Cause of 
Death Medical History 
Abca
m 1 50 M Normal 
 
unknow
n unknown 
unknown 
NDRI 2 74 F Normal 4 COPD no history available 
NDRI 3 74 F Normal 5 Cancer 
Lung cancer, 
Pneumonia, 
Congestive heart 
failure 
NDRI 4 88 F AMD 7.8 
Respiratory 
failure 
Endometro cancer, 
osteoporosis, 
hypertension, 
glaucoma, macular 
degeneration, 
Hemangioma, 
aortic stenosis, 
insomnia 
NDRI 5 86 F AMD 7.4 Abcess 
Macular 
degeneration, 
Diabetes, Cataract 
surgery, 
hemicholoectomy, 
hypertension, 
hypercholesterole
mia 
NDRI 6 89 M AMD 6.5 CVA 
Macular 
Degeneration, 
pneumonia, 
hypoxic respiratory 
failure, dementia 
UCHC 7 76 F 
unknow
n 
4.0 - 
5.0  
Acute 
cardiac 
arrest Unknown 
Abbreviations: CVA – Cerebro Vascular Accident (Stroke); COPD – Chronic Obstructive 
Pulmonary Disease; NDRI – National Disease Research Interchange; UCHC – University 
of Connecticut Health Center. 
 
Next, we wanted to investigate the expression in AMD, so we obtained three 
independent AMD samples from NDRI (Table 1). Here, the level of degeneration in the 
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three samples was determined by the localization of L/M opsins in the cone 
photoreceptors by IHC. Under normal conditions, opsins are restricted to the membrane 
of the outer segments (OS) [178] as shown in normal sample #3 (Fig 3.9A). However, in 
case of the AMD retinae, L/M opsins were observed in the entire cone photoreceptor 
membrane (Fig 3.9B-D). This is in agreement with previous reports indicating that opsins 
in a degenerating retina relocalize to the entire photoreceptor membrane due to aberrant 
opsin trafficking [178]. Notably in Sample #4, vertical alignment of OS was lost and the 
thickness of the outer nuclear layer (ONL) was reduced compared to other two AMD 
retinae,  indicating that this retina had a higher degree of degeneration (Fig 3.9B). 
Subsequently, all of these retinal sections were subjected to IHC with anti-Sfrs10 
antibody. Sample #4 showed a distinct upregulation of SFRS10 in a speckled pattern (Fig 
3.10A). Similar upregulation was seen in a few cells in all three nuclear layers in sample 
#5, where the layers were comparable to that in a normal retina (Fig 3.10B).  The 
expression in sample #6 was similar to previous two samples with upregulation seen as 
distinct speckles in ganglion cells as well as in some cells in the INL and the ONL (Fig 
3.10C). In addition, we analyzed the foveal/parafoveal regions from sample #7 by serial 
IHC. Again, the staining for red/green opsin showed that the opsin is redistributed 
throughout the membrane of the photoreceptor, indicating that the sample was 
undergoing degeneration (Fig 3.10D). In case of SFRS10, the staining in red and green 
cone photoreceptors (encapsulated by red/green opsin) was diffused throughout the 
nucleus (solid white arrows in the inset, Fig 3.10D), while, a speckled expression was 
observed in rod photoreceptors (open white arrow in the inset, Fig 3.10D).  
3.5.9 Human Sfrs10 promoter is different from that of rodents 
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  The lack of expression in normal human retina could be due to the difference in 
the transcriptional regulation of mouse and human Sfrs10.  To investigate the Sfrs10 
promoter region, multiple sequence alignment was performed on the 400 bp region 
upstream of transcription start site in human, mouse and rat (Fig 3.12A).  The homology 
between mouse and rat was 80% (Fig 3.12A), but the homology between mouse and 
human promoter was 34% (Fig 3.12A’), and between rat and human promoter was 32% 
(Fig 3.12A”).  Moreover, promoter in all three organisms did not have a conventional TATA 
sequence (Fig 3.12A). Since the mouse and rat promoters were highly similar and they 
both showed pan-retinal expression, we sought to investigate whether their promoters 
contained hallmarks of promoters associated with ubiquitously expressed genes.  For 
this, the presence of GC-rich regions or CpG islands was investigated, as they are usually 
associated with “active” chromatin structures like those of house-keeping genes [179, 
180].  Using CpG island detection tools such as CpG Island Searcher and CpGPlot, it 
was found that mouse and rat Sfrs10 promoter region had CpG islands (Fig 3.11A, B). 
These CpG islands had average GC content of 60-70% and observed/expected CpG ratio 
>60%. However, the human Sfrs10 promoter did not have CpG islands (Fig 3.11C).   
3.5.10 Sfrs10 forms stress-related speckles 
Besides the upregulation of Sfrs10 in AMD retinae, it also showed a speckled pattern of 
expression. This pattern has been described for other SR proteins such as SC35 [181, 
182].  In addition, Sfrs10 has been shown to colocalize with SC35 in human 
neuroblastoma cell lines [183]. Thus, human retinal sections were co-stained with  Sfrs10 
and SC-35, which showed that SFRS10+ speckles did not overlap with SC35+ speckles 
(Fig 3.13A-B’’). This led us to investigate whether SFRS10+ speckles were indeed stress 
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granules. HSF1 is known to form stress granules under various kinds of stress [184]. Also, 
HSF1 was shown to colocalize with SFRS10 in human colon cancer cell lines [185]. 
Therefore, AMD retinal sections were co-stained with Sfrs10 and HSF1, which showed 
that SFRS10+ speckles did not overlap with HSF1+ stress granules. Nonetheless, the 
presence of HSF1+ granules confirmed that this retina is under stress and that SFRS10+ 
speckles are distinct and stress induced (Fig 3.13C-D’’).  
3.5.11 Sfrs10 role in hypoxic stress 
To test the role of Sfrs10 under hypoxic stress, whether it plays a pro-apoptotic or 
anti-apoptotic role, I employed cell culture system to mimic human AMD conditions. I used 
three different cell lines, namely human embryonic kidney (HEK) cells, HeLa cells and 
retinal cells derived from retinae by Dr. Kamla Dutt. I had planned to induce hypoxic stress 
by administering1) cobalt chloride 2) Arsenite and 3) hypoxic chamber in these cells. 
While my preliminary tests to check if Sfrs10 was expressed in these cell lines showed 
that it was expressed under normal conditions in these cells, another group published the 
finding on the same question, and showed that Sfrs10 acts as an anti-apoptotic gene by 
competing with miR-204 and promoting the expression of Bcl2α isoform, which is a 
protective isoform of Bcl2 [143]. 
3.6 Discussion 
Sfrs10 as a nuclear marker for red/green cone photoreceptors 
 ASFs are known to auto-regulate their levels.  Indeed, Sfrs10 is one of the 
seven RNA-splicing associated genes that contain “exonic” class of “ultraconserved 
elements” [186].  This class of RNA-binding proteins is shown to auto-regulate their levels 
by the inclusion of a stop codon containing exon, which is highly conserved in the 
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vertebrate genome.  This auto regulation is thought to be critical for the maintenance of 
cellular homeostasis of various classes of RNA-binding proteins.  This is concordant with 
the expression pattern of Sfrs10 observed across the retinal development.  The higher 
MW isoform contains exon 2a, which introduces premature stop codon, rendering the 
transcript to NMD pathway and regulating the levels of the lower MW canonical isoform.  
Sfrs10 expression in postnatal retinal development follows the order of terminal 
differentiation of retinal neurons.  Ganglion cells are the first cells to differentiate, followed 
by amacrine and horizontal cells at P4.  The costaining of syntaxin and Sfrs10 in the 
ONBL of P4 retina suggests that they are mostly likely differentiating amacrine and 
horizontal cells. This observation is in agreement with the previous report where it was 
shown that syntaxin marks both differentiating amacrine and horizontal cells in the 
postnatal developing retina [187].  At P8, bipolar cells, amacrine cells, and cone 
photoreceptors differentiate followed by rod photoreceptors by P21.  This suggests that 
Sfrs10-mediated AS is involved in genes that regulate the terminal differentiation of the 
retinal cells.  Further, Sfrs10 expression specifically in red/green cone photoreceptors 
suggests that Sfrs10-mediated AS is specifically required by this subset of cone 
photoreceptors during development and for their maintenance.  This observation would 
make Sfrs10 one of the first alternative splicing factors to mark red/green cone 
photoreceptors at P8.  Additionally, it would be a valuable nuclear marker of cone 
photoreceptors at this stage in retinal development as well as in retinal diseases.  
Sfrs10 is not detected in the zebrafish retina  
Sfrs10 is a widely studied alternative splicing factor that is 100% conserved at the 
AA levels in most mammals.  At the nucleotide level, Sfrs10 is one of the seven RNA-
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splicing associated genes that contain “exonic” class of “ultraconserved elements” [186]. 
This class of RNA-binding proteins is shown to auto-regulate their levels by the inclusion 
of a stop codon containing exon which is highly conserved in the vertebrate genome. This 
auto regulation is thought to be critical for the maintenance of cellular homeostasis of 
various classes of RNA-binding proteins. As Sfrs10 is one of the very few highly 
conserved genes, we investigated the expression of Sfrs10 in the retina of widely studied 
model organisms including, mouse, rat, chicken and zebrafish.  Immunoblot analysis 
showed expression in mouse, rat and chicken, which suggests that its transcription is 
conserved along with its AA sequence. As predicted, no immunoreactivity was observed 
in the lane containing zebrafish retinal extract (Fig 3.6B).  The antibody employed here 
was directed toward the N-terminus of Sfrs10, which is not conserved in zebrafish (black 
box, Fig 3.6A). Thus, the absence of the immunoreactivity could be failure of the antibody 
to recognize Sfrs10 and that it might still be expressed in the zebrafish retina.   
Sfrs10 is upregulated only in response to stress in human retinae 
Interestingly, SFRS10 is 100% conserved at the AA level between mouse and 
human, yet it is not expressed normally in the human retina.  This was surprising, but in 
agreement with its role as a stress response gene that would be normally suppressed.  
At the level of transcription regulation, CpG islands are shown to be associated with 
promoters of house-keeping genes and active genes by a comprehensive analysis of 
CpG islands in the European Molecular biology laboratory (EMBL) database [180, 188]. 
In all, the constitutive expression of Sfrs10 in mouse and rat retinae (Fig 3.7A, B) along 
with the presence of CpG islands (Fig 3.11A, B) suggests that it might regulate the AS of 
constitutively expressed genes in these organisms.  In contrast, SFRS10 is not expressed 
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in the normal human retinae (Fig 3.8A, B, C), and its promoter lacks CpG islands (Fig 
3.11C), which suggests that SFRS10 might not be required for general maintenance.  In 
contrast, it was upregulated in AMD retinae (Fig 3.10A, B, C), which is consistent with its 
role as a stress response gene.  Interestingly, sample #7, for which there was no 
diagnosis of AMD, showed upregulation of SFRS10 suggesting that it was experiencing 
stress (Fig 3.10D).  Since SFRS10 upregulation is often linked to hypoxic stress, one can 
extrapolate that retinal sample #7 was most likely undergoing hypoxic stress. In addition, 
the redistribution of red/green opsin staining throughout the membrane of photoreceptor 
(Fig 3.10D) indicates retinal degeneration [178].   
In all, the upregulation of SFRS10 in AMD retinae suggests that it might be required 
for AS of a subset of genes involved in hypoxic stress response. For instance, a gene 
might normally be expressed but under stress conditions, it might undergo AS shift and 
the isoform responding to stress is regulated by SFRS10. Some of the known targets of 
Sfrs10 like Creb1, Pank2 are known to play a key role in metabolism [122, 189]. It could 
be that there is an increased demand for the isoform regulated by Sfrs10 under hypoxic 
stress. It is to be noted that both the aforementioned targets have isoforms in the retina. 
Future investigation involves testing of the splice pattern shifts in these targets under 
hypoxic stress.    
Sfrs10 does not co-localize with SC35 domain and is not part of stress-granules in 
human AMD retinae  
  Most SR proteins have been shown to be a part of the SC35 “nuclear speckle” 
under normal conditions. Presence of Sfrs10+ speckles independent of SC35 domain in 
AMD retinae (Fig 3.13A-B”) suggests that Sfrs10 and SC35 might not interact in the retina 
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under hypoxic stress. It could be that SC35 regulates the splicing of genes that are 
normally required by the cell whereas Sfrs10 independently regulates a specific subset 
of genes that are required only under stress conditions. This partitioning of the SR 
proteins might provide efficient response to stresses such as hypoxia.   
 Non-overlapping Sfrs10 speckles with HSF1 stress granules in AMD retina (Fig 
3.13C-D”) suggest that Sfrs10 does not interact with HSF1. It could also be that HSF1 
regulates the transcription of genes that are required early in the stress response while 
Sfrs10 regulates the AS of the subset of genes that might be required later in the stress 
response. Overall, our data suggest that Sfrs10 might not be required for normal 
maintenance or functioning of neurons in human retina but is predominantly active under 
hypoxic stress, which is thought to be the underlying cause of AMD.   
3.7 Materials and Methods 
Animal Procedures  
All procedures with mice were performed in accordance with the animal protocol 
approved by Institutional Animal Care and Use Committee at the University of 
Connecticut. The CD1 or the ICR mice from Charles River Laboratory, MA, were 
employed for all experiments. Chicken eyes were also obtained from Charles River 
Laboratory, Storrs, CT. The rat strain used was Wistar and was purchased from Charles 
River Laboratory. Zebrafish were obtained from Dr. Sylvain De Guise’s laboratory at the 
University of Connecticut, Storrs, CT. 
Human samples 
Slides with human retinal sections were obtained from Abcam, MA 
(http://www.abcam.com/) and from the National Disease Research Interchange (NDRI) 
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(http://ndriresource.org/).  In both cases, the authors were not involved in the 
procurement of the samples.  Preprocessed de-identified retinal sections with the 
associated diagnosis were obtained for IHC analysis.  Therefore, in this case the 
authors were issued a waiver from the University of Connecticut Institutional Review 
Board for human subject research. Briefly, the case history for all the samples was 
provided by NDRI. Also, to classify the AMD samples from the normal, pathological 
diagnosis was performed by Dr. Federico Gonzalez-Fernandez, MD, PhD, who 
collaborates with NDRI for the ophthalmologic pathology project. The parameters used 
in the diagnosis of AMD include accumulation of soft drusen beneath the retinal 
pigmented epithelium, disciform scar formation indicated by the fragmentation of 
Bruch’s membrane and geographic atrophy. 
In regards to the one sample (sample #7) obtained from the University of Connecticut 
Health Center (UCHC), consent from the next of kin, where applicable was obtained 
prior to post-mortem retinal tissue procurement.  This protocol was approved by the 
University of Connecticut institutional review board for human subject research.  The 
sample was de-identified before it was further processed in Dr. Kanadia’s laboratory for 
IHC analysis and was conducted in compliance with the Health Insurance Portability 
and Accountability Act. 
Reverse transcriptase-polymerase chain reaction (RT-PCR) 
Retinae from different developmental time points in CD1 mice (E12, E14, E16, E18, P0, 
P4, P10, and P14) were harvested and total RNA prepared in Trizol following the 
manufacturer’s protocol (Invitrogen). For cDNA synthesis, 1μg of total RNA from retinae 
harvested at various time points was used [190].  
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Table 3.2: List of Primers used in Sfrs10 RT-PCR analysis  
Primer 
name   Primer Sequence (5' - 3') 
F1 AGCTTGACAGCTTCAGGAAAGGCC 
R1 ATCCCAGCTCTATGGCAGGTTTCAG 
Gapdh Fwd ACAGTCAAGGCCGAGAATGGGAA 
Gapdh Rev TCAGATGCCTGCTTCACCACCTTCT 
 
PCR to detect Sfrs10 isoforms was performed for 30 cycles (95°C for 30 seconds; 58°C 
for 30 seconds; 72°C for 1.5 minutes) with primers listed in Table 3.2. Gapdh was used 
as the control. PCR used to detect Gapdh was performed with the same temperature 
profile as described above. All PCR products were resolved on a 2.5% agarose gel.  
RLM-RACE 
Retinae from different developmental time points in CD1 mice (E15.5, E17.5, P0, P5, and 
P14) were harvested and total RNA was prepared as described above. 5′ RNA ligase-
mediated rapid amplification of cDNA ends (5′ RLM-RACE) (First Choice RLM-RACE kit 
from Invitrogen) was employed to determine the transcription initiation site(s) of 
Sfrs10 mRNA. This method amplifies cDNA only from full-length, capped mRNA, 
therefore allowing identification of the actual 5′ ends of mRNAs. Total RNA from different 
time points were first treated with Calf Intestine Alkaline Phosphatase (CIP) to remove 
the 5′ phosphate from degraded mRNA, rRNA, and tRNA. Samples were then treated 
with Tobacco Acid Pyrophosphatase (TAP) to remove the cap structure of intact mRNAs, 
leaving a 5′ phosphate group on this mRNA subset only, followed by ligation of an RNA 
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adapter to the decapped mRNAs. Reverse transcription and subsequent PCR 
amplification using adapter-specific outer and inner primers (provided in the kit) and gene-
specific reverse primer were performed to allow the 5′ ends of mRNA transcripts to be 
mapped. The gene specific reverse primer of Sfrs10 is 5′-
CCAAACACGCCAAGACAACAGTTG-3′. Instead of cloning, the PCR products were 
purified and then subjected to restriction digestion with EcoNI to check if the same product 
is obtained throughout development. Uncut and cut products were resolved on 2% 
agarose gels. 
3’RACE 
Retinae from different developmental time points in CD1 mice (E15.5, E17.5, P0, P5, and 
P14) were harvested and total RNA was prepared as described above. Reverse 
transcription was performed using Moloney Murine Leukemia Virus Reverse 
Transcriptase (M-MLV RT) with the addition of 3’RACE adapter to the RNA mix. cDNAs 
obtained were used for PCR amplification with gene-specific forward primer and adapter-
specific outer and inner primers. The sequence of gene-specific primer is 5’- 
CTTTCTAAATATCAATGCTTAACCAGAACCATTC-3’. Next, the PCR products were 
purified and then subjected to restriction digestion with BsrI to check if the same product 
is obtained throughout development. Uncut and cut products were resolved on 2% 
agarose gels. 
Immunohistochemistry (IHC) 
All of the experiments were performed on 10-16 μm cryosections obtained from different 
time points in CD1 mice except for the 6 month retina which was obtained from C57/BL6 
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mice. The cryosections were first hydrated in phosphate-buffered saline (PBS, pH 7.4) 
and washed three times (5 minutes each at room temperature (RT)), followed by 
incubation with PBTS buffer (1X PBS with 0.1% triton-X 100, 0.2% BSA and 0.02% SDS) 
for an hour at RT. Primary antibody (AB#1-rabbit anti-Sfrs10, 1:750, Fitzgerald inc., 
Product #70R-1420; AB#2-rabbit anti-Sfrs10, 1:500, Sigma-Aldrich, Product # AV40528; 
AB#3 – rabbit anti-Sfrs10, 1:500, Cemines, Product # AB/SF100; mouse anti-syntaxin -1 
(HPC-1), 1:300, Santacruz biotechnologies Inc., Product # sc12736; mouse anti-islet1, 
1:300, Developmental Studies Hybridoma Bank, Product# 40.2D6; mouse anti-Pkc-α, 
1:300, Calbiochem, Product # OP74; mouse anti-glutamine synthase, 1:300, Chemicon 
International, Product # MAB302; mouse anti-SC35, 1:300, Abcam, Product # ab11826; 
rat anti-HSF1, 1:100, Abcam, Product # ab61382) was incubated in PBTS buffer 
overnight at 4ºC. Sections were washed with PBTS buffer containing 4’, 6-diamidino-
2phenylindole (DAPI) (Roche diagnostics) 10 times (15 minutes each at RT). Following 
the washes, secondary antibody (anti-rabbit antibody conjugated with Alexa488, 1:750, 
Product # 21206, anti-mouse conjugated with Alexa 568, 1:750, Product # A10037, 
Invitrogen) was incubated in PBTS buffer overnight at 4ºC. Sections were washed with 
PBTS buffer 7 times (15 minutes each at RT), rinsed with PBS and covered with Prolong 
gold anti-fade reagent (Invitrogen) and coverslip glass.   
Serial IHC  
Here the aforementioned IHC protocol was employed with one modification. Upon 
completion of the nuclear antigen detection by the first antibody, (primary – rabbit anti- 
Sfrs10, 1:750 and secondary – Alexa488, 1:750), a 10’/RT incubation with 4% 
paraformaldehyde was conducted. Subsequently, the cytoplasmic antigen detection by 
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the second antibody (primary – rabbit anti - red/green opsin, 1:300, Millipore, Product # 
AB5405 and secondary – Alexa568, Invitrogen, 1:750, Product # 11011) was performed. 
Immunoblot  
Retinal tissue extracts from mouse, rat, chicken and zebrafish were prepared in RIPA 
(50mM Tris (pH 8.0), 150mM Sodium chloride, 1% Igepal, 0.5% SDS) buffer containing 
1X protease inhibitor cocktail (cOmplete mini, EDTA-free, Roche Diagnostics). Following 
the protein estimation of the extracts, 50μg of protein was resolved on 4-20% Tris-glycine 
gradient gel (Invitrogen). The gel was transferred to a positively charged nylon membrane 
(Invitrogen), which was then subjected to immunoblot analysis as described previously 
[191]. Rabbit anti-Sfrs10 (1:1000; Fitzgerald Inc., Product # 70R-1420) was used to detect 
Sfrs10 in the extract. Mouse anti-Gapdh (1:500; Sigma Aldrich, Product # G8795) was 
used as the loading control. 
Bioinformatics tools and databases 
Alignment analysis was carried out using ClustalW tool 
(http://www.ebi.ac.uk/Tools/msa/clustalw2/). Promoter regions were characterized using 
tools such as CpGPlot (http://emboss.bioinformatics.nl/cgi-bin/emboss/cpgplot) and CpG 
Island searcher (http://cpgislands.usc.edu/).  
Image Acquisition and 3D reconstruction  
Confocal fluorescence microscopy was performed using Leica SP2. Images were 
subsequently processed using IMARIS (Bitplane Inc., CA) and Adobe Photoshop CS4 
(Adobe Systems Inc., CA).  
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Figures: 
Figure 3.1 
 
Fig 3.1. Expression analysis of Sfrs10 during mouse retinal development. A: 
Schematic representation of Sfrs10 gene showing exons (orange arrows, E1-E9), intron 
(black line) and the primers (green arrows, F1 &R1) used for RT-PCR analysis. B: Gel 
image showing two RT-PCR products of Sfrs10, top band (+ exon 2a), bottom band (-
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exon 2a). B’: Gel image showing Gapdh expression. C: 5’RACE analysis across retinal 
development. Shown here is the position of the primers and the restriction site for EcoNI.  
D: 3’RACE analysis across retinal development. Shown here is the position of the primers 
and the restriction site for BsrI.  E: Schematic representation of the gene after the RACE 
analysis [144]. 
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Figure 3.2 
 
Fig 3.2. SFRS10 expression across postnatal retinal development. A, B, D, E, F: 
Immunohistochemistry across postnatal retinal development with rabbit anti-Sfrs10 
(green). Nuclei are marked with DAPI (blue). Scale bar: 30μm. GCL, Ganglion cell layer; 
INL, Inner Nuclear layer; ONL, Outer nuclear layer; ONBL, Outer neuroblastic layer. C: 
Immunohistochemistry for Sfrs10 (green) co-stained for Syntaxin (red) which marks 
differentiating amacrine cells. Nuclei are marked with DAPI (blue) [144]. 
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Figure 3.3 
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Fig 3.3. Specific enrichment of SFRS10 in red/green cone photoreceptors. A: 
Schematic of Sfrs10 protein with RRM (RNA recognition motif) flanked by two RS (Serine-
Arginine dipeptide rich) domains. Above and below the schematic are boxes representing 
the epitope positions for antibody (AB) #1 (blue box, amino acids 1-51), AB#2 (purple 
box, amino acids 2-51) and AB#3 (yellow box, amino acids 84-97). B- D”: Serial IHC with 
rabbit anti-Sfrs10 AB#1 (green) and rabbit anti-red/green opsin (red) and the merged 
image at P8 (B-B”), P10 (C-C”) and P14 (D-D”). E- E”: Serial IHC with rabbit anti-Sfrs10, 
AB#2 (green) and rabbit anti-red/green opsin (red) and the merged image (E”). F - F”: 
Serial Immunohistochemistry with rabbit anti-Sfrs10, AB#3 (green) and rabbit anti-
red/green opsin (red) and the merged image (F”). Scale bars 30 μm. G, H: Immunoblot 
analysis for Sfrs10 (AB#1 (G), AB#2 (H)) on retinal protein extracts from P0 mouse [144].  
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Figure 3.4 
 
Fig 3.4. Differential expression of SFRS10 in rod photoreceptors versus cone 
photoreceptors. A: IHC on P22 retinal section for SFRS10 (green), laminB2 (red). 
Nuclei are marked with DAPI (blue). Shown here is the outer nuclear layer. Scale bar 
5μm A’: Magnified image of the boxed region in (B) showing perinuclear localization of 
SFRS10 in laminB2 positive cells. Scale bar 3 μm. A”: Schematic representation of 
SFRS10 localization observed in A [144]. 
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Figure 3.5 
 
Fig 3.5. Sfrs10 is 100% conserved in mammals. A: Schematic of Sfrs10 protein with 
RRM (RNA recognition motif) flanked by two RS (Serine-Arginine dipeptide rich) domains. 
B - B’’: Amino acid alignment of RS1 domain (B), RRM domain (B’), RS2 domain (B”) of 
Sfrs10 protein from different species [145]. 
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Figure 3.6 
 
Fig 3.6. Expression of Sfrs10 is conserved in mouse, rat and chicken retina. A: 
Alignment of Sfrs10 amino acid (1-100) sequences from mouse, rat, chicken and 
zebrafish. The black box marks the region used as antigen to raise Sfrs10 antibodies. B: 
Immunoblot analysis for Sfrs10 (green) on retinal protein extracts from mouse, rat, 
chicken and zebrafish. The last lane has extract from HEK-293t cells that were expressing 
exogenous Sfrs10. Gapdh (red) serves as the loading control [145]. 
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Figure 3.7 
 
Fig 3.7. Sfrs10 expression is pan-retinal in mouse, rat and chicken. A-C”: IHC with 
rabbit anti-Sfrs10 (green) on retinal sections of adult mouse (A), adult rat (B) and adult 
chicken (C). DAPI (blue) marks all nuclei (A’, B’, C’). Scale Bar represents 50µm [145]. 
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Figure 3.8 
 
Fig 3.8. SFRS10 is not expressed in normal human retinae. A-C: IHC with rabbit anti-
Sfrs10 (green) on sections obtained from individuals with normal retinae.  DAPI (blue) 
marks all nuclei. Scale Bar represents 50µm [145]. 
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Figure 3.9 
 
 
Fig 3.9. Red/green opsin is dispersed throughout the photoreceptor membrane in 
AMD. A-D: IHC with rabbit anti-red/green opsin (red) on sections obtained from 
individuals with normal (A) and AMD (B-D) retinae. DAPI (blue) marks all nuclei [145].   
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Figure 3.10 
 
Fig 3.10. SFRS10 is upregulated in degenerating retina. A–C: IHC with rabbit anti-
Sfrs10 (green) on sections obtained from individuals with AMD retinae. DAPI (blue) marks 
all nuclei. D: Serial IHC with rabbit anti-Sfrs10 (green) and rabbit anti-red/green opsin 
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(red) on parafoveal section obtained from sample #7. DAPI (blue) marks all nuclei. Inset 
shows the expression of SFRS10 in the red and green cone photoreceptors indicated by 
solid white arrow and rod photoreceptors indicated by open white arrow. Scale Bar 
represents 50µm [145]. 
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Figure 3.11 
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Fig 3.11. CpGPLOT analysis of Sfrs10 promoter region in mouse, rat and human 
Sfrs10. A-C: CPGPLOT generated by CpGPlot tool used for CpG island prediction. A, 
B – Mouse and rat Sfrs10 promoter region showed CpG islands; C – No CpG islands 
were seen in human Sfrs10 promoter region [145]. 
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Figure 3.12 
 
Fig 3.12. Comparative analysis of mSfrs10 and hSfrs10 promoter region. A-A”: 
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Comparison of Sfrs10 promoter in mouse vs. rat (A), mouse vs. human (A’), and rat vs. 
human (A’’) [145].  
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Figure 3.13 
 
 
 
Fig 3.13. SFRS10 forms independent stress-related speckles. A - A”: IHC on 
human retinal section with anti-Sfrs10 (green), anti-SC35 (red). Nuclei are marked with 
DAPI (blue). B - B”: Magnified image of the boxed region in A - A” showing non-
overlapping Sfrs10+ speckles and SC35+ speckles. C - C”: IHC with anti-Sfrs10 
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(green), anti-HSF1 (red). Nuclei are marked with DAPI (blue). D - D”: Magnified image 
of the boxed region of C - C” showing non-overlapping Sfrs10+ speckles and HSF+ 
stress granules [145]. 
 
 
 
 
 
 
  
74 
 
Chapter 4: Role of the cell cycle regulator, Citron Kinase in rat retinal 
development 
This chapter addresses the role of AS in development through a cell cycle regulating 
gene, Citron kinase in retinal progenitor cells in the developing rat retinae. Since this gene 
knockout has a severe phenotype, we were able to characterize the phenotype and 
dissect the cell types affected due to the absence of this gene. We also characterized a 
novel isoforms of this gene, which could be implicated in various roles played by this 
gene. 
4.1 Cell cycle and its regulation: 
The cell cycle is a key process by which the single-celled zygote matures 
into a multicellular organism. It includes a series of events which leads to the division of 
a cell into daughter cells. It includes three main phases namely Interphase – preparatory 
phase where cell grows and accumulates nutrients needed for cell division, mitotic phase 
– cell contents are split between two daughter cells and cytokinesis – final stage of 
division which leads to two separate daughter cells. There are checkpoints at each phase 
to ensure proper cell division.  
Interphase is further divided into first growth phase (G1), synthesis phase (S) and 
second growth phase (G2). The first phase of interphase is the First Growth phase, G1, 
during which time the cell grows in size and replicates all of its organelles in preparation 
for division. In addition, mRNA and protein are synthesized, which will be used during the 
S phase [192]. The importance of the G1 phase is that this is when the cell decides 
whether it will commit to division or whether it will leave cell cycle [193]. This second 
phase is called the S or synthesis phase. As the two daughter DNA strands are produced 
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during replication, they recruit histones and to form sister chromatids. Eventually, these 
identical strands of DNA become attached at a central point by a protein named cohesin 
[192]. Cohesin is a member of the structural maintenance of chromosomes (SMC) family 
of proteins, which affect chromosome architectures. At the end of S phase, DNA check 
for successful replication is done using a set of checkpoint controls. If cells have 
successfully replicated their chromosomes, they pass to the third stage of interphase, G2. 
During G2, a second stage of growth occurs in the cell. This stage has an important 
checkpoint known as the G2/M checkpoint that must be passed for the cell to be able to 
enter mitosis [192, 194].  
Mitosis begins with prophase, during which chromosome condensation occurs 
through condensin recruitment. In addition, cohesin, which until this point encircles the 
entire chromosome is removed from the ends of the chromosome and concentrates at 
the center. This allows for the individual “arms” of the chromosomes to become visible. 
This is also the stage during which the mitotic spindle forms and when in eukaryotes, the 
centrioles migrate to opposite poles of the cells and begin to radiate their microtubules. 
Prometaphase begins with the dissolution of the nuclear envelope into membrane 
vesicles that will evenly distribute to the daughter cells and is vital for spindle attachment. 
Additionally, kinetochores form around the centromere. It is a dynamic phase with 
constant polymerization and de-polymerization of microtubules that are attached to the 
kinetochores resulting in chromosomes moving in each direction by microtubules from 
both poles of cell [194]. At the end of prometaphase, each chromosome has microtubules 
attached from each pole of the spindle to the kinetochores of the centromere, which is 
described as “chromosome biorientation”. Metaphase is an immobile phase where 
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chromosomes line up at the equator of the cell known as the metaphase plate. Anaphase 
is marked by the separation of sister chromatids due to activation of the anaphase 
promoting complex (APC/C) [194]. Once all the kinetochores are attached, APC/C 
becomes active and complexes with Cdc20, which then targets securin for degradation, 
freeing a cysteine protease separase [194]. Separase hydrolyzes the cohesin holding the 
two sister chromatids together, thereby facilitating chromatid separation. Telophase is the 
last stage of mitosis during which the nuclear envelope reforms, and the chromosomes 
de-condense [194].  
Cytokinesis can begin as early as anaphase, which brings the cell cycle to a 
completion. This is the time when the cytoplasm of the two daughter cells divides equally 
[194]. It begins with the formation of a cleavage furrow assembly once the site of 
separation is chosen. The furrow contains actin, myosin, and other cytoskeletal proteins 
that are organized into a contractile ring known as the actomyosin ring [195]. Thereafter, 
the ring contracts, generating a membrane barrier between the contents of each daughter 
cells in addition to constricting the components of the spindle midzone into a structure 
called the midbody [195]. This is followed by the process, called abscission, where the 
furrow seals itself, finally generating two completely separate cells [195]. The end-product 
of mitosis is two identical daughter cells, each with a complete set of 46 chromosomes 
[194]. 
Regulation of cell cycle is crucial to cell survival as dis-regulation could lead to 
aberrant cell division and to the eventual formation of tumors [194, 196]. On the other 
hand, mutations in genes required for completion of stages of cell cycle could result in 
aberrant cells which would then undergo apoptosis. Therefore, a balance between cell 
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division and cell death has to be maintained during development for the proper growth of 
an organism.  
4.2 Citron Kinase 
Rho GTPases are a family of GTPases found in all eukaryotic cells. When in their 
active GTP-bound state, these GTPases perform regulatory functions through specific 
interactions with target/effector proteins that include serine/threonine kinases, tyrosine 
kinases, lipid kinases, lipases, scaffold proteins, and oxidases. Through their interactions 
with effectors, these GTPases control some of the most fundamental eukaryotic 
processes: cell movement, polarity, morphogenesis, and cell division. In cell division, Rho 
GTPases influence the activity of CDK molecules during G1, microfilament and 
microtubule organization during M phase and play a vital role in the contractile ring 
formation at the cleavage furrow during the cytokinesis [197].  
4.2.1 Discovery of Citron Kinase 
Citron Kinase was discovered in 1998 by Di Cunto et al during the screening of 
new kinases that were specifically expressed in mouse primary keratinocytes [198]. It was 
originally called KK-1 and 5’ rapid amplification of cDNA ends (RACE) -PCR of KK-1 
transcripts did not show any significant extension of the coding sequence. However, 
sequencing results from the 3’ RACE-PCR showed that the part of the coding sequence 
was identical to that of Citron [198]. There were two major isoforms of Citron Kinase 
identified where the first isoform was called ‘Citron Kinase (CitK)’, which is a full-length 
protein sequence that coded for the following domains: kinase domain, coiled-coil domain 
with a leucine zipper, Rho/Rac binding domain, zinc finger region, pleckstrin homology 
domain (PH), and a proline-rich, SH3 binding domain [198]. The second shorter isoform 
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of Citron Kinase had all domain coding regions except for the kinase domain and was 
called Citron N (Neuron/Non-Kinase) (CitN). Maudaule et al. showed that the latter 
isoform is expressed specifically in the nervous system [199]. It was shown that CitN is 
associated with the Golgi apparatus of hippocampal neurons in culture. While the 
overexpression of CitN has been shown to accumulate filamentous actin and protect the 
Golgi apparatus from rupture, its knockdown has been shown to result in a dis-organized 
golgi apparatus [200]. On the other hand, CitK has been shown to play a crucial role 
during cytokinesis, specifically during the contractile process at the cleavage furrow that 
eventually led to the separation of the two daughter cells [197, 199]. Later, it was shown 
that CitK exhibits its role in cytokinesis through the di-phosphorylation of the regulatory 
light chain of Myosin II, which is important for creating contractile forces at the cleavage 
furrow and for assembly of stress fiber [199].  
4.2.2 Expression of CitK in the developing brain 
 To understand the expression patterns of CitK and CitN in the developing mouse, 
RNA in situ hybridization experiments were performed on both embryos and postnatal 
brains using two probes, one that was specific for the kinase domain that would only 
hybridize with the CitK transcript, and the other that was specific to the coiled-coil region, 
which was present on both CitK and CitN mRNA transcripts [201]. Analysis revealed that 
signal for both probes was highly robust as early as embryonic day (E) 10.5 to E16.5, with 
the highest expression in the developing CNS including retina with further localization to 
the proliferating areas of the neural tube [201].  
Protein analysis of CitK and CitN during various developmental time-points using 
specific antibodies revealed that only CitK was present during embryonic time-points prior 
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to E16.5. While, CitN expression dominated after E16.5 into the postnatal developmental 
time-points. Thus, it was shown that in the developing CNS, CitK was specifically 
expressed by proliferating cells namely progenitor cells, whereas CitN was expressed by 
post-mitotic, differentiated neurons [201]. The presence of a second transcription start 
site for CitN was shown when CitN protein levels were not decreased in a null mutant for 
CitK. 
4.2.3 Flathead mutant 
 A spontaneous autosomal recessive mutation was identified in 1998 by Cogswell et al., 
in an inbred colony of Wistar rats and was termed ‘flathead’ (fh/fh) since the mutants 
showed diminished brain growth beginning early in the embryonic development [202]. 
Perinatally, these mutants could be identified due to their flattened skulls. Flathead 
mutation is a frame-shift mutation caused by the deletion of G-C base pair in exon 1 of 
the kinase domain in the CitK gene on chromosome 12 [203]. This results in a premature 
stop codon, and the transcript is subjected to non-sense mediated decay pathway, and 
therefore no protein product would be produced. Physiologically, the fh/fh rats displayed 
tremors, ataxia, seizures, and abnormal growth in the retina, cerebellum and 
hippocampus during postnatal development [202]. Nissl staining of coronal section of P21 
wildtype and fh/fh rats revealed that the fh/fh brain was approximately one-half the size 
of the wildtype [Figure 4B]. In addition, immunofluorescence analysis revealed 
binucleated neurons present in the thalamus, midbrain, hindbrain, spinal cord and 
cerebellum [203]. Pulse-chase experiments with BrdU injections at E15 and harvest at 
P12 showed individual cells containing two BrdU+ nuclei within the same cell suggesting 
that the progenitor cells did not undergo cytokinesis in the fh/fh mutant [203]. Thus, the 
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defect in cytokinesis in these mutants resulted in increased cell death within the 
proliferative zones of the brain, thereby wiping out the progenitor pool which would then 
result in fewer neurons being born and thus a decreased brain size in the rat [203]. 
4.3 Rationale 
Cell cycle is one of the key processes in a developing tissue. The regulation of 
cell cycle is very crucial for the normal development of an organism. Mutation or mis-
splicing of any of the genes involved in the cell cycle can greatly affect the development 
sometimes leading to the death of that organism. To understand the role of alternative 
splicing in cell cycle regulation and how it informs normal retinal development, we 
employed Citron Kinase gene. It has been shown to play a key role in cytokinesis and is 
known to contain many isoforms. CitK mutant rat model called ‘flathead’ was used to 
study the role of CitK in progenitor cells of the developing rat retina. 
Following sections contain the contents of the publication, Karunakaran et al., [204] titled 
“Loss of Citron kinase affects a subset of progenitor cells that alters late but not 
early neurogenesis in the developing rat retina” 
4.4 Background 
   During retinal development, the balance between self-renewal of RPCs vs 
neurogenesis allows for simultaneous RPC amplification and neurogenesis [205, 206]. 
This produces a functional adult retina with six neuronal subtypes including rod 
photoreceptors, cone photoreceptors, bipolar cells, horizontal cells, amacrine cells and 
retinal ganglion cells and one glial cell type, Muller glia [3, 5]. Early RPCs are multipotent 
cells that are known to shift in their competence to produce different neurons over time 
[14, 207, 208]. Recently, it was shown that there are RPCs that have temporal bias in 
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producing a subset of neurons [209]. Together, this suggests a dynamic regulation of 
RPC cell division that interprets intrinsic and extrinsic cues to regulate neurogenesis. Cell 
division in the retina occurs such that the S-phase of the cell cycle occurs at the basal 
end of the outer neuroblastic layer (ONBL) followed by the inter-kinetic movement of the 
nucleus towards the apical end where the M-phase of the cell cycle occurs [210, 211]. 
Furthermore, the plane of cell division at the apical end has been reported to regulate 
whether an RPC undergoes symmetric vs. asymmetric cell division [212]. This process is 
what regulates RPC amplification vs. neurogenesis. It is here that the regulators of 
cytokinesis can influence symmetric vs. asymmetric cell division and in turn regulate 
retinal development. One such gene that regulates cytokinesis is citron kinase. Here, I 
have analyzed the role of Citron Kinase and how its spliced isoforms inform cell cycle 
division of retinal progenitor cells and in turn retinal development. 
4.5 Results 
4.5.1 Citron kinase is enriched during embryonic retinal development 
  CitK has 47 exons with exons 1 through 12 encoding the kinase domain. Upstream of 
exon 12, there is an alternative transcription start site that is utilized to produce a 
truncated protein called Citron N, lacking the kinase domain [201]. PCR amplification of 
the region coding for the kinase domain with primers F1-R3 and F3-R8 (shown as green 
arrows in Fig 4.1A) showed a trend with robust expression starting at embryonic day (E)12 
followed by a steady decline leading to absence by postnatal (P)8 (Fig.1B.i, ii). However, 
primer pairs (F12-R17) showed that the alternative transcription start site upstream of 
exon 12 was being utilized at P10 and P14 (Fig 4.1B.iv). This was further confirmed by 
F16-R30 and F29-R41 primer pairs that showed a robust PCR product at P14 and lower 
82 
 
levels at P8 and P10 (Fig 4.1B.v, vi). Interestingly, this was not the case for F35-R46 
primer pairs where the levels were not similar (Fig 4.1B.vii). The identity of the upper band 
observed in E12 with F35-R46 primers was not interrogated (Fig 4.1B.vii). Moreover, PCR 
with the primer pair F8-R12 (positions shown in Fig 4.1A) showed two bands at 594bp 
and 410bp (Fig 4.1B.iii). Sequence analysis of both these isoforms revealed that the 
isoform at 594 bp was the canonical isoform including all exons in between.  The lower 
MW isoform at 410 bp lacked exon 9 (schematic representation below Fig 4.1B.iii). For 
the primers (F12-R17) amplifying the region between exon 12 and exon 17, there were 
two bands at 843bp and 552 bp (Fig 4.1B.iv). Again, sequence analysis of both these 
isoforms revealed that the isoform at 552 bp was the canonical isoform including all 
exons, while the higher MW isoform at 843 bp was produced by (schematic 
representation below Fig 4.1B.iv)   the usage of the cryptic splice donor at 42306705 NT 
position (NCBI ref - AC_000080.1) (AGT/GTAG) in intron 13. Since our analysis 
interrogated short stretches of CitK mRNA, we could not determine the specific 
combinations in which the two alternative splicing events were utilized. For this, we 
designed a new set of primers (Fig 4.1C, Schematic representation) in cryptic donor 
region in exon 13 and junction of exon 8 and 9. RT-PCR analysis with F8-RC13 showed 
that there were two bands obtained at E12 and E14. The higher MW band at 895 bp 
corresponds to isoform containing a part of retained intron 13 along with exon 9 included 
while the lower MW isoform at 711 bp excludes exon 9 (Fig 4.1C, left). From E16 onwards, 
only the higher MW isoform was observed. Analysis was not carried out beyond P0, as 
CitK expression shuts down postnatally. To find whether exon 9 is expressed with the 
isoform containing canonical exon 13, RT-PCR analysis with F8/9 - R14 was performed. 
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Analysis showed that there were two bands obtained across development with a robust 
expression observed at E12. The higher MW band at 869 bp corresponds to isoform 
containing exon 9 with a part of intron 13 retained and the lower MW at 782 bp 
corresponds to the isoform with exon 9 and canonical exon 13 (Fig 4.1C, right).  
Next, we interrogated the expression of CitK protein by section IHC in E12 and E16 
retinae.  This analysis showed CitK to be localized in discrete puncta at the apical tip, 
where RPCs undergo M-phase of the cell cycle (Fig 4.1D, 4.1E, Insets). This observation 
is in agreement with the report by Di Cunto et al., who reported expression of CitK in the 
developing retina by whole mount in situ hybridization at E11.5 when there are only RPCs, 
which suggests expression of CitK in RPCs [201]. Moreover, in the developing brain, CitK 
expression was found at the cytokinesis furrow in progenitor cells [203]. Thus, expression 
of CitK was considered to be in RPCs.  Absence of signal in the KO-retina confirmed 
specificity of the CitK antibody (Fig 4.1D’, E’). Finally, to confirm whether the punctuate 
staining of CitK corresponds to RPCs, E12 sections were costained with anti-PH3 
antibody (Fig 4.1F’), which marks M-phase progenitor cells, which showed overlap in 
signal for PH3 and CitK (Fig. 4.1F-F”, Inset).  
4.5.2 Number of progenitor cells in the KO retina is comparable to that in the WT 
retina at E12 and E13 
 Given the robust expression of CitK in early RPCs, we wanted to interrogate its 
role in retinal development. For this, we pulsed pregnant female rats at E12 with EdU one 
hour prior to harvest. E12 WT and KO retinal sections were then subjected to IHC with 
anti-Ki67, PH3 along with EdU detection (Fig 4.2A - F). Here, we quantified EdU+ (in S-
phase) RPCs as a percentage of total Ki67+ RPCs, which showed no difference in S-
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phase RPCs in CitK KO compared to WT (Fig 4.2G). Similarly, PH3+ (M-phase) RPCs 
as a percentage of total Ki67+ RPCs did not show any difference between KO and WT 
(Fig 4.2H).   
 Next, we wanted to interrogate the effect of loss of CitK on RPCs over time. So, 
we performed EdU pulse-chase experiment. For this, we pulsed pregnant females at E12 
followed by harvest at E13. Again, WT and KO retinal sections were subjected to Ki67, 
PH3 along with EdU detection (Fig 4.3A - F). EdU+ RPCs (S-phase) as a percentage of 
total Ki67+ RPCs did not change in KO compared to WT (Fig 4.3I). This was also true for 
PH3+ (M-phase) RPCs (Fig 4.3J). Since RPCs did not show an observable phenotype in 
CitK KO retina, we wanted to interrogate if neurogenesis was affected. Since retinal 
ganglion cells (RGCs) were the only cell type produced at this point, we employed Islet1 
antibody to mark the RGCs. Specifically, we looked for Islet1+ cells that were also EdU 
+, so as to interrogate RGCs produced after the EdU pulse (Fig 4.3G- H”). Again, we did 
not see significant difference in RGC production in KO compared to WT (Fig 4.3K). 
4.5.3 Cell death of a subset of progenitor cell population is observed in the KO 
retina by E14  
Next, we pulsed E12 pregnant females with EdU followed by embryo harvest at 
E14. Retinal sections from KO and WT embryos were subjected to IHC with Ki67, PH3 
along with EdU detection (Fig 4.4A -F). Quantification of EdU+ (S-phase) RPCs as a 
percentage of total Ki67+ RPCs showed statistically significant decrease in RPCs in the 
CitK KO compared to WT (Fig 4.4I). This suggested that there was a loss of RPCs in the 
CitK KO retina, which suggests that either the RPCs died or there was an increase in 
RGC production at the expense of these RPCs. To distinguish between these two 
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possibilities, we performed IHC with Islet1 along with EdU detection (Fig 4.4G – H”). 
Quantification was restricted to the ganglion cell layer (GCL) to take in to account only 
the differentiated ganglion cells and not include newly born Islet1+ RGCs or amacrine 
cells (ACs) in the outer neuroblastic layer (ONBL). Quantification of Islet1+ cells that were 
also EdU+ as a percentage of total Islet1+ cells in the GCL did not show a statistically 
significant difference in KO compared to WT (Fig 4.4J). This led us to interrogate the 
possibility that RPCs were undergoing cell death in CitK KO retinae. Indeed, TUNEL 
analysis showed increased cell death in CitK KO compared to WT (Fig 4.5A, A’, B).  
Similar analysis was extended to E16 retinae that were harvested from embryos where 
the mother had been pulsed with EdU at E12. Here, a significant decrease in the size of 
the ONBL and a concomitant increase in TUNEL+ cells in KO retina was observed (Fig. 
4.5C, C’ D). To confirm that the TUNEL+ cells were RPCs, sections that were subjected 
to TUNEL assay were stained for Ki67. Here, we observed many TUNEL+ cells were 
Ki67+ as well (Fig. 4.5E – F”’). The overlap was confirmed using section tool in IMARIS 
7.3 software, where the cross hairs mark the cell under interrogation with the panel on 
the right showing the longitudinal axis whereas one at the bottom showing the horizontal 
axis. In both cases, overlap was observed for TUNEL and Ki67 positivity (Fig. 4.5E’, F’ – 
F”’). However, there were some cells that were TUNEL+ but Ki67- in the ONBL. These 
cells had increased intensity of TUNEL signal which correlates with the extent of cell death 
and lack of Ki67 positivity might be due to protein degradation. 
 4.5.4 Absence of Islet1+ bipolar cell production in the KO retina  
 The increase in cell death of RPCs after E14 led us to extend our analysis to the 
postnatal development. At P0, the KO retinal tissue was visibly smaller than the WT retina.  
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IHC analysis with different markers such as anti-PH3, anti-islet1, anti-Ki67 and anti-Pax6 
antibodies showed that GCL remained uncompromised (Fig 4.6A - D’). However, the 
ONBL was half the size of the WT counterpart and showed signs of rosette formation. 
However, PH3 and Ki67+ RPCs, were observed in the P0 CitK KO retina (Fig.4.6A’, C’). 
Similarly Islet1+ and Pax6+ RGCs and ACs were observed in the KO retina (Fig. 4.6B’, 
D’). Interestingly, at P2, Islet1+ RGCs and ACs were observed in the WT and KO retinae 
(Fig. 4.6F, F’). However, Islet1+ bipolar cells (BPCs) [213] were not observed in the KO 
retinae (Fig. 4.6F’). Overall, the KO retinae showed rosette formation but some Ki67+ 
RPCs were still observed (Fig. 4.6G’). At P4, the KO retina was structurally compromised 
with large rosettes in the ONBL. Again, Islet1 marked a subset of BPCs in the WT retina 
but these cells were not observed in the KO retina (Fig.4.7A, B).  To distinguish between 
BPCs and ACs in the ONBL, Pax6 was used to mark amacrine cells (Fig. 4.7A’, A”, B’, 
B”). Thus, cells positive for both Islet1 and Pax6 revealed amacrine cells in the ONBL, 
while those positive for Islet1 alone marked BPCs (Fig. 4.7A, A”, boxed region). To 
interrogate whether KO retina failed to produce BPCs, we pulsed P0 pups with EdU 
followed by retinal harvest at P4 and IHC with Islet1 and EdU (Fig.4.7C – D””). This 
analysis showed Islet1+ EdU+ BPCs were indeed produced in the WT retina (Fig.4.7C”, 
inset) but were not observed in the KO retina. However, EdU+ cells were observed in the 
ONBL of the KO retina (Fig.4.7D”).  
4.5.5 CitK KO retina undergoes severe degeneration by P14 
IHC analysis at P7 with rhodopsin showed that in the KO retina, there were 
rhodopsin+ cells except it lacked lamination or canonical morphological characteristics 
(Fig. 4.8A’). At P14, the KO retina had deteriorated such that the ONL and INL collapsed 
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to a thin layer of cells that showed positivity for markers such as red/green opsin and 
rhodopsin (Fig. 4.8C – D’).  However, the RGC layer was still present and positive for 
Islet1 and Pax6 (Fig. 4.8E – F’).  
4.6 Discussion 
Role of alternative splicing in Citron kinase expression 
Here we discovered an alternatively spliced isoform of CitK that is developmentally 
regulated such that exon 9 is excluded at E12 and E14. The amino acids encoded by 
exon 9 are 370-431 amino acids and are part of the kinase domain. Thus, the isoform 
lacking exon 9 would most likely lack the kinase function. In addition, we discovered 
another alternatively spliced isoform where cryptic donor in intron 13 such that it adds 29 
amino acids. These amino acids are added to the structural maintenance of chromosome 
(SMC) domain, which could alter the nuclear function of CitK, which has been reported in 
drosophila where its homolog is called sticky, which is required for heterochromatin-
mediated gene silencing through HP1 localization and H3-K9 methylation [214].  
RPC death does not begin until E14 
At E12, RT-PCR analysis showed highest levels of expression of CitK, but its loss 
did not affect RPCs at E12 or E13. This suggests that RPCs at E12 and E13 retina may 
have a compensatory mechanism that allows RPCs to undergo cytokinesis in the 
absence of CitK. By E14, we begin to see reduction in RPCs which is coincident with 
TUNEL+ cells suggesting CitK requirement for RPCs.  Interestingly, RGC production was 
not aberrant in CitK KO retinae, which is in agreement with the observation that RPCs at 
E12 and E13 remain uncompromised. Indeed, it is at E12, when RGC production begins 
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and the resistance of E12 RPCs to loss of CitK allows for normal RGC production. The 
observation of cell death beginning at E14 raises the issue as to why it happens at E14 
and not earlier (Fig. 4.9). One possibility is that there exists a compensatory gene(s) 
(factor(s) X) that allowed RPCs to survive at E12 and E13 and these genes were 
downregulated by E14 (Fig. 4.9). There are other Rho-dependent kinases such as Rho-
associated protein kinase (ROCK) and Cdc42 that have been shown to play a regulatory 
role in the contractility of the cleavage furrow during cytokinesis [197-199, 215]. Aurora, 
another member of serine/threonine kinase family and Aurora and Ipl1-like midbody-
associated protein (AIM-1) have also been shown to play a critical role in cell division 
especially at the midbody furrow [216, 217]. Nir1, a mammalian homolog of retinal 
degeneration B in drosophila, has been shown to have a very similar function to that of 
CitK [218]. Therefore, it is possible that one or all of these genes could compensate for 
loss of CitK function. 
Late embryonic and postnatal neurogenesis is affected in the KO retina 
The depletion of RPCs that began at E14 reached their peak at E16 resulting in a 
severely compromised retina at birth. Notably, pulse-chase experiments with EdU 
showed that RPCs that were in S-phase at E12 (time of EdU pulse) had survived cell 
cycle and had re-entered cell cycle at E16 as shown by EdU+ cells that were Ki67+. 
These cells survived because they most likely did not express CitK or if they did express 
CitK, they also had the aforementioned compensatory factor. This agrees with the 
observation in the brain where it was shown only ~50% of neurogenic cytokineses were 
affected [219]. Thus it is possible that RPCs can be grouped into two categories of 
neurogenic cytokinesis. One that is dependent on CitK and susceptible to cell death in 
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the KO retina and the other that is independent of CitK which results in RPCs that remain 
at P0 (Fig. 4.9). Moreover, the RPCs in the P0 KO retina fail to produce bipolar cells as 
shown by the pulse chase experiments where RPCs that took up EdU at P0 (time of 
pulse) did not show EdU+ Islet1+ BPCs at P4. It is also possible that RPCs in the KO 
retina failed to undergo cell division as a secondary effect of the severely compromised 
retina. This possibility is unlikely given that there are distinct EdU+ nuclei in the ONBL of 
P4 retina which suggests that the progeny of the progenitor cells that took up EdU were 
still alive (Fig.4.7B1”). In all, our data showed that loss of CitK did not affect early 
embryonic RPCs resulting in normal neurogenesis while altering late embryonic RPCs 
affecting subsequent neurogenesis. 
Here we present a model where a subset of RPCs require CitK function and these 
subsets of progenitor cells go on to produce Islet1+ BPCs (Fig. 4.9, Top). In the absence 
of CitK, expression of factor(s) X allows RPCs to survive uptil E14, when the levels of 
these factor(s) drops making CitK function crucial for RPC survival. This in turn results in 
the death of these RPCs such that there are none left at birth to produce the Islet1+ BPCs 
in the CitK KO retina (Fig. 4.9, bottom).  
4.7 Materials and methods 
Animal Procedures  
All procedures with rats were performed in accordance with the animal protocol approved 
by Institutional Animal Care and Use Committee at the University of Connecticut and in 
compliance with the regulations of ‘The Association for Research in Vision and 
Ophthalmology’ for the use of animals in research. Wistar rats from Charles River 
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Laboratory, MA, were employed for RT-PCR analysis. All CitK mutants 
(Citkfh/fh, flathead rats), heterozygous and wildtype littermates were generated from a 
breeding colony maintained at the University of Connecticut. 
Reverse transcriptase-polymerase chain reaction (RT-PCR)  
Retinae from different developmental time points in Wistar rats (Embryonic day (E) 12, 
E14, E16, E18, postnatal day (P)0, P4, P10, and P14) were harvested and total RNA 
prepared in Trizol following the manufacturer’s protocol (Invitrogen). For cDNA synthesis, 
1μg of total RNA from retinae harvested at various time points was used [190]. PCR to 
examine the expression of Citron Kinase gene was performed with the primers across the 
gene mentioned in table 1. RT-PCR thermocycler conditions were for 33 cycles (95°C for 
30 seconds; 58°C for 30 seconds; 72°C for 50 seconds). Gapdh was used as control. 
Primers used to amplify Gapdh are mentioned in table 1. RT-PCR thermocycler 
conditions were for 30 cycles (95°C for 30 seconds; 58°C for 30 seconds; 72°C for 50 
seconds). All PCR products were resolved on a 2.5% agarose gel. The products were 
then excised and cloned into pGEMT vector (Promega, catalog # A1360) and sequenced 
with T7 primer to confirm their identities. 
Table 4.1: List of primers used in the CitK RT-PCR analysis 
Primer 
name (# 
represents 
exon)  Primer Sequence (5' - 3') 
F1 CGGTAGCGGAGAGATGTTGAAGTTCAAGT 
R3 TAACCACCTGCACTTCGGCGAAGT 
F3 ACTTCGCCGAAGTGCAGGTGGTTA 
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R8 GCAACAGAGACCCTCGAACTTCAGTCTCT 
F8 AGAGACTGAAGTTCGAGGGTCTCTGTTGC 
F8/9 AATAACATCCGGAACTCTCCTCCCC 
R12 GCTCTCTGATGTCGTGGAGAAGCTGAAGA 
F12 TCTTCAGCTTCTCCACGACATCAGAGAGC 
RC13 AGGTCCTTAGCACTCGCTAAGCCA 
R14 CTGGAACATTCTCCCACTTCAGGCT 
R17 TCCTTCAGTCTGTTCTCTCTACGCTCCATG 
F16 TGCAGAACATCCGGCAGGCAAA 
R30 AGGGCGAGCTTCAGCTCATTGTACTG 
F29 CACGAGAAGGTGAAAATGGAAGGCA 
R41 CCGATGAGGATACTGTAATTGGTGAAGTGG 
F35 GGTGGAAGAATTTGAGCTGTGCCTTC 
R46 TCTGTCCGGCCCTCTCTGTCTCGGTA 
GAPDH 
Fwd ACAGTCAAGGCCGAGAATGGGAA 
GAPDH 
Rev TCAGATGCCTGCTTCACCACCTTCT 
 
EdU pulse experiments 
Pregnant heterozygous females at E12 were first weighed and injected with 1ml of 25mM 
EdU in PBS/100mg of body weight and embryos were either harvested one hour after at 
E12 or at E13, E14 or E16. P0 pups were first weighed and injected with 0.4ml of 25mM 
EdU in PBS/100mg of body weight and retinae were harvested at P4. 
Immuno histochemistry (IHC) 
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All of the experiments were performed on 10-16 μm cryosections obtained from different 
time points in CitK KO, heterozygous and WT littermates. For embryonic analysis, 
cryosections were subjected to antigen retrieval as described by the manufacturer (Vector 
laboratories, Catalog # H-3300) followed by IHC. The sections were then hydrated in 
phosphate-buffered saline (PBS, pH 7.4) and washed three times (5 minutes each at 
room temperature (RT)), followed by incubation with PBTS buffer 
(blocking/permeabilization buffer) (1X PBS with 0.1% triton-X 100, 0.2% BSA and 0.02% 
SDS) for an hour at RT. Primary antibody (mouse anti-islet1, 1:300, Developmental 
Studies Hybridoma Bank, Product # 40.2D6; mouse anti-Ki67, BD Biosciences, Product 
# 556003;  rabbit anti–Phospho Histone H3 (PH3), 1:300, Bethyl laboratories, inc., 
Product # IHC-00061; rabbit anti-Pax6, 1:300, Covance, Product # PRB-278P; mouse 
anti-rhodopsin, clone 4D2, 1:300, Millipore, Product # MABN15; rabbit anti-red/green 
opsin, 1:300, Millipore, Product # AB5405) was incubated in PBTS buffer overnight at 
4ºC. Sections were washed with PBTS buffer containing 4’, 6-diamidino-2phenylindole 
(DAPI) (Roche diagnostics) 10 times (15 minutes each at RT). Following the washes, 
secondary antibody (anti-rabbit antibody conjugated with Alexa488, 1:750, Product # 
21206, anti-mouse conjugated with Alexa 568, 1:750, Product # A10037, Invitrogen) was 
incubated in PBTS buffer overnight at 4ºC. Sections were washed with PBTS buffer 7 
times (15 minutes each at RT), rinsed with PBS and mounted in Prolong gold anti-fade 
reagent (Invitrogen) and coverslip glass.   
For the detection with mouse anti-CRIK/CitK antibody (1:50, BD Biosciences, Product # 
611376), IHC protocol as described above was employed except that the blocking buffer 
consisted of 1X PBS with 0.5% triton-X, 5% normal goat serum (NGS) containing DAPI 
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followed by the incubation of the primary antibody in permeabilization buffer (1X PBS with 
0.25% triton-X and 2.5% NGS) overnight at 4ºC. Sections were washed 3 times with the 
permeabilization buffer followed by the incubation with secondary antibody in 
permeabilization buffer for 2hours at RT. Sections were washed with permeabilization 
buffer 5 times (10 minutes each at RT), rinsed with PBS and covered with Prolong gold 
anti-fade reagent (Invitrogen) and coverslip glass.   
For EdU detection, Click-iT EdU Alexa fluor 647 imaging kit (Molecular probes, catalog # 
C10340) was used. The steps were followed as per instructions in the user manual.  
TUNEL assay 
In situ Cell death detection kit, TMR red (Roche diagnostics, catalog # 12156792910) and 
TUNEL Apo-green detection kit (Biotool, Catalog # B31112) was used to assay the cell 
death in the embryonic retinal tissue at E14 and E16 as per instructions in the user 
manual. For determining whether the dying cells were retinal progenitor cells, E16 retinal 
sections were first stained with mouse anti-Ki67 and IHC was followed as described 
earlier. The sections were then fixed and TUNEL assay was carried out.   
Image Acquisition and 3D reconstruction  
Confocal fluorescence microscopy was performed using Leica SP2. Images were 
subsequently processed using IMARIS 7.3 (Bitplane Inc., CA) and Adobe Photoshop CS4 
(Adobe Systems Inc., CA). For counting, spot tool in IMARIS software was employed. For 
confirming the overlap between Ki67 and TUNEL signal, section tool was employed. The 
placement of the cross hairs shows the signal in the longitudinal (shown on right) and 
horizontal axis (shown at the bottom) at the given position. 
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Statistical analysis 
Data were analyzed in Microsoft Excel 2007. Statistical significance was determined 
using the Student’s t test (p ≤ 0.05). Data are presented as mean ± SEM. 
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Figures 
Figure 4.1 
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Fig 4.1. Expression analysis of Citron Kinase during rat retinal development. A: 
Schematic representation of CitK mRNA showing exons (orange boxes) and the primers 
(green arrows) used for RT-PCR analysis. B: Gel images showing the expression of CitK 
at retinal timepoints indicated on top along with the forward and reverse primers used.  
Primers in (i) exons 1 and 3;  (ii) exons 3 and 8; (iii) exons 8 and 12; (iv) exons 12 and 17 
, with schematic representation of isoforms detected in (iii) and (iv); (v) exons 16 and 30; 
(vi) exons 29 and 41; (vii) exons 35 and 46 ; (viii) Gapdh. (vi) & (vii) Gel images at the 
bottom show a low exposure image. C:  Schematic representation of combination of 
isoforms identified in CitK and the primers used for RT-PCR analysis (green arrows, F8-
RC13 and F8/9 – R14). (Left) Gel image showing the expression of isoform containing 
cryptic donor in exon 13 along with or without exon 9 included across embryonic day 
(E)12, E14, E16, E18 and postnatal (P)0. (Right) Gel image showing the expression of 
isoform containing exon 9 with or without cryptic donor in exon 13 across E12, E14, E16, 
E18 and P0. D-E’: IHC with mouse-CitK antibody (green) on E12 WT (D) and KO (D’) 
retinae and E16 WT (E) and KO (E’) retinae. Insets show the localization of CitK (arrow 
heads). F-F”: IHC  with mouse anti- CitK antibody (green) along with rabbit anti-PH3 
antibody (red) on E12 retinal sections.  DAPI (blue) marks all the nuclei. ONBL – Outer 
neuroblastic layer; GCL – Ganglion cell layer [204]. 
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Figure 4.2 
 
Figure 4.2. Number of Progenitor cells in WT and KO retinae are comparable at E12. 
IHC on retinal sections obtained from embryonic day (E)12 embryos where the mother 
was pulsed with EdU one hour prior to harvest. A, D: Retinal progenitor cells  (RPCs) 
positive for Ki67 (green) and PH3 (red) in WT (A) and KO (D). B, E: RPCs positive for 
EdU (magenta) in WT (B) and KO (E). DAPI (blue) marks all nuclei. C, F: Merged image 
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showing RPCs positive for Ki67 (green) and EdU (magenta) in WT (C) and KO (F). DAPI 
(blue) marks all nuclei.  Inset shows the higher magnification image of the boxed region 
in the apical end of the ONBL where the solid arrow points to a RPC that is EdU+ and 
Ki67+. G: Quantification of S-phase RPCs (EdU+ cells) as a percentage of all RPCs 
(Ki67+ cells) in WT (blue, n=6) and KO (red, n=9). H: Quantification of M-phase RPCs 
(PH3+ cells) as a percentage of all RPCs (Ki67+ cells) in WT (blue, n=6) and KO (red, 
n=9). ONBL – Outer neuroblastic layer; GCL – Ganglion cell layer [204]. 
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Figure 4.3 
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Fig 4.3: Number of RPCs and retinal ganglion cells in WT and KO retinae are 
comparable at E13. IHC on retinal sections obtained from embryonic (E)13 embryos 
where the mother was pulsed with EdU at E12. A, D: Retinal progenitor cells  (RPCs) 
positive for Ki67 (green) and PH3 (red) in WT (A) and KO (D). B, E: RPCs positive for 
EdU (magenta) in WT (B) and KO (E). C, F: Merged image showing RPCs positive for 
Ki67 (green) and EdU (magenta) in WT (C) and KO (F). DAPI (blue) marks all nuclei.  
Inset shows the higher magnification image of the boxed region in the apical end of the 
ONBL where the solid arrow points to a RPC that is EdU+ and Ki67+. G-H”: Retinal 
sections showing EdU+ cells (magenta) in WT (G) and KO (H) along with IHC for Islet1 
(green) in WT (G’) and KO (H’). Shown in G” and H” are the merged images of G & G’ 
and H & H’, respectively. Inset shows the higher magnification image of the boxed region 
in the GCL where the solid arrow points to a RGC that is EdU+ and Islet1+.  DAPI (blue) 
marks all nuclei.  I: Quantification of S-phase RPCs (EdU+ cells) as a percentage of all 
RPCs (Ki67+ cells) in WT (blue, n=7) and KO (red, n=10). J: Quantification of M-phase 
RPCs (PH3+ cells) as a percentage of all RPCs (Ki67+ cells) in WT (blue, n=7) and KO 
(red, n=10). K. Quantification of retinal ganglion cells (RGCs) born at/after E12 by 
determining Islet1+ and EdU+ cells as a percentage of all Islet1+ cells within the GCL in 
WT (blue, n=3) and KO (red, n=7). ONBL – Outer neuroblastic layer; GCL – Ganglion cell 
layer [204]. 
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Figure 4.4 
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Fig 4.4: Number of RGCs in WT and KO retinae are comparable at E14 but the 
number of RPCs in S-phase are fewer in the KO retina. IHC on retinal sections 
obtained from embryonic (E)14 embryos where the mother was pulsed with EdU at E12. 
A, D: Retinal progenitor cells in (RPCs) positive for Ki67 (green) and PH3 (red) in WT 
(A) and KO (D). B, E: RPCs positive for EdU (magenta) in WT (B) and KO (E). C, F: 
Merged image showing RPCs positive for Ki67 (green) and EdU (magenta) in WT (C) 
and KO (F). DAPI (blue) marks all nuclei.  Inset shows the higher magnification image of 
the boxed region in the apical end of the ONBL where the solid arrow points to a RPC 
that is EdU+ and Ki67+. G-H”: Retinal sections showing EdU+ cells (magenta) in WT 
(G) and KO (H) along with IHC for Islet1 (green) in WT (G’) and KO (H’). Shown in G” 
and H” are the merged images of G & G’ and H & H’, respectively. Inset shows the 
higher magnification image of the boxed region in the GCL where the solid arrow points 
to a RGC that is EdU+ and Islet1+.  DAPI (blue) marks all nuclei.  I: Quantification of S-
phase RPCs (EdU+ cells) as a percentage of all RPCs (Ki67+ cells) in WT (blue, n=3) 
and KO (red, n=9). Student’s t-test, p=0.01. J: Quantification of retinal ganglion cells 
(RGCs) born after E12 by determining Islet1+ and EdU+ cells as a percentage of all 
Islet1+ cells within the GCL in WT (blue, n=6) and KO (red, n=7). ONBL – Outer 
neuroblastic layer; GCL – Ganglion cell layer [204].   
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Figure 4.5 
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Fig 4.5. Reduction in RPCs without change in RGCs between WT and KO retinae 
at E16. A, A’: TUNEL assay (red) on embryonic (E14) WT (A) and KO (A’) retinae. 
DAPI (blue) marks all the nuclei. B: Quantification showing cell death (TUNEL+ in A & 
A’) in E14 WT (blue, n=6) and KO (red, n=8) retinal sections. Student’s t-test, p=0.005.  
C, C’: TUNEL assay (red) on E16 WT (C) and KO (C’) retinae. DAPI (blue) marks all the 
nuclei. D: Quantification showing cell death (TUNEL+ in C & C’) in E16 WT (blue, n=3) 
and KO (red, n=6) retinal sections. Student’s t-test, p=0.05.  E-F”’: Identity of TUNEL+ 
cells by IHC for Ki67 (red) and TUNEL (green) in E16 WT (E) and KO (F) retinal 
sections. The boxed region in E is shown as a high magnification image in E’ with 
section function in IMARIS showing the overlap of cells positive for both Ki67 and 
TUNEL (Details in materials and methods). Boxed regions in F are shown as high 
magnification images in F’-F”’ with section function in IMARIS showing the overlap of 
cells positive for both Ki67 and TUNEL.ONBL – Outer neuroblastic layer; GCL – 
Ganglion cell layer [204]. 
 
 
  
105 
 
Figure 4.6 
 
Fig 4.6. Reduction in the ONBL in the CitK KO retina along with absence of 
bipolar cells at P2. A - D’: IHC on postnatal (P0) retinal section showing PH3 (green) 
in WT (A) and KO (A’); Islet1 (green) in WT (B) and KO (B’); Ki67 (green) in WT (C) and 
KO (C’); Pax6 (green) in WT (D) and KO (D’). E - H’: IHC on P2 retinal section showing 
PH3 (red) in WT (E) and KO (E’); Islet1 (green) in WT (F) and KO (F’); Ki67 (green) in 
WT (G) and KO (G’); Pax6 (green) in WT (H) and KO (H’). DAPI (blue) marks all the 
nuclei. ONBL – Outer neuroblastic layer; GCL – Ganglion cell layer [204]. 
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Figure 4.7 
 
Fig 4.7. Bipolar cells are not produced in the KO retina at P4. A – B”: IHC on postnatal 
(P4) retinal sections for -Islet1 (green) in WT (A) and KO (B) and for Pax6 (red) in WT (A’) 
and KO (B’). Merged images of A & A’ and B & B’ are shown in A” and B”, respectively. 
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In A and A’, the dashed box marks the Islet1+ & Pax6 –ve BPCs. The arrow heads point 
to cells with expression of both Pax6 and Islet1.C – D”’: IHC on sections of P4 retinae 
harvested from rats pulsed with EdU at P0. Expression of Islet1 (green) in WT (C) and 
KO (D) and EdU detection in WT (C’) and KO (D’). Merged images of C & C’ and D & D’ 
are shown in C” and D”, respectively. Inset in C” shows a higher magnification image of 
the boxed region highlighting bipolar cells born at/after P0. DAPI marks all the nuclei. 
ONBL – Outer neuroblastic layer; GCL – Ganglion cell layer [204]. 
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Figure 4.8 
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Fig 4.8. KO retina is severely compromised by P14. A – B’: IHC on postnatal (P7) 
retinal sections showing rhodopsin (green) and Pax6 (red) in WT (A) and KO (A’); Islet1 
(green) in WT (B) and KO (B’). C – F’: IHC on P14 retinal sections showing red/green 
opsin (red) in WT (C) and KO (C’); rhodopsin (green) in WT (D) and KO (D’); Pax6 (red) 
in WT (E) and KO (E’); Islet1 (green) in WT (F) and KO (F’). DAPI marks all the nuclei. 
ONL – Outer nuclear layer; INL – Inner nuclear layer; GCL – Ganglion cell layer [204]. 
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Figure 4.9 
 
Fig 4.9. Model of the effect of loss of Citron Kinase on RPCs.  Shown here is a 
developmental time line starting with E12 and P4. Top panel reflects the scenario in WT 
retinae and the bottom reflects the scenario in KO retinae. The orange triangle shows 
the expression levels of CitK as it decreases over time. The brown triangle shows the 
expression kinetics of a potential compensatory factor (Factor X), which decreases by 
E14. The circles represent RPCs, where open circles represent CitK -ve RPCs while 
solid circles (orange) represent CitK+ RPCs. The loss of CitK does not affect RPCs at 
E12 but is required for the survival of RPCs beginning at E14 shown as reduction in the 
number of solid circles in the KO scenario. This reduction in CitK+ RPCs results in 
drastic loss by P0 such that Islet1+ Bipolar cells are not produced in the KO retinae 
[204]. 
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Chapter 5: Global analyses to understand the regulation of 
transcriptome by alternative splicing 
This chapter discusses the global approach to understand the role of AS in retinal 
development. To this end, we employed RNAseq and custom microarray to address the 
question. We also devised a custom bioinformatics pipeline to extract biological meaning 
from the large dataset obtained from RNAseq. This method was compared to other 
methods routinely employed by other biologists and we showed that the former method 
has more inference values. Therefore, this strategy was extended to another RNAseq 
data obtained from various developmental time points from wild type and a triple 
microRNA cluster knockout retinae.  
5.1 Technologies employed to understand alternative splicing at the global level 
Alternative splicing (AS) has been shown to be a key regulatory step in the gene 
expression and is of the mechanisms to generate cellular and functional complexity in 
higher eukaryotes. Gene-targeted approaches highlighted the importance of AS in 
various tissues but those analyses could only go so far. Therefore, en-masse approach 
of transcriptome analysis was taken to understand the global picture of various regulatory 
networks that governed the expression of genes on the whole in a tissue -specific manner. 
Global analyses of gene expression mostly relied on Microarray profiling and expressed 
sequence tagged – cDNA sequence (EST approach), which have shown that about two-
thirds of human genes contain one or more alternatively spliced exon. Due to the limitation 
in the depth coverage and sensitivity at the time offered by microarray and conventional 
sequencing technologies, the extent of AS events in humans was not known. Whole-
genome tiling arrays were also employed to capture the transcriptome complexity but this 
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technology could not capture splice-junction information. Other method such as event-
specific arrays have been used but they have been hampered by the specificity, high 
costs and difficulty in the data analyses. The other technology, EST approach provided 
partial sequences of individual cDNA clones but is sensitive to cloning biases.   Other 
technologies that were employed include serial analysis of gene expression (SAGE) [220] 
and parallel signature sequencing, which also could not provide specific splicing event 
information. In 2007, the potential of RNA sequencing (RNA seq) was first demonstrated 
by the polony multiplex analysis of gene expression (PMAGE), which allowed for the 
detection of as low as 0.3 RNA copies per cells [221]. RNAseq offers increased depth 
coverage and sensitivity. Thus, Illumina based RNAseq technology has become the new 
way of thinking for most biologists that are interested to understand the transcriptome at 
single-nucleotide resolution. 
5.1.1 Microarray 
Microarray is a multiplex array on a solid substrate, which is used a high-
throughput screening technique to measure the expression levels of large number of 
genes simultaneously. The concept was first introduced by Tse Change in 1983, when 
he illustrated “antibody microarrays” [222]. While DNA microarray technology is the most 
widely used type of microarray, other types of microarray including protein, peptide, 
cellular, glycoarray are routinely performed.  The two platforms that are currently available 
for DNA microarrays include glass microarrays, which involves spotting on a glass slide 
and high-density oligonucleotide arrays, also called “chip”, which involves insitu 
oligonucleotide synthesis. 
5.1.1.1 Principle   
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The principle behind DNA microarrays include three main steps:  
1. Array preparation – using chip or glass slide via surface engineering, DNA fragments 
are usually synthesized and then covalently linked to the solid surface such as silicon 
chip or glass via surface engineering. The spot size is usually less than 200µ in diameter. 
Each spot contains a few picomoles of a specific sequence called probes.   
2. Sample preparation – Isolation of DNA or mRNA and cDNA preparation, known as 
targets. 
 3. Hybridization and acquisition - These immobilized probes are used to hybridize to 
the target. The probe-target hybridization is detected quantitatively either using a 
fluorophore or chemiluminescence labeled targets. The signal strength measure gives 
the relative measure of gene expression in the sample. 
Post data-acquisition, data is analyzed using appropriate software followed by 
quantification and interpretation of data. 
5.1.1.2 Advantages and Disadvantages 
Some of the advantages of microarray include: 
 Simultaneous detection of multiple probes 
 Initial and faster screening in disease diagnosis 
 Gene level and protein level detection makes the gene to protein to disease 
correlation easier. 
 Cost-effective – glass type DNA microarrays are affordable. 
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 No additional equipment is required – hybridization step does not require any other 
equipment. 
 Increased detection sensitivity – glass microarrays have longer target sequences 
about 2kb, which makes it more sensitive in probe- target hybridization.  
While there are advantages to this method and is widely used, it has a few disadvantages 
including 
 labor involved in synthesis, purification, storage of probes 
 probe bias where some probes might have a stronger covalent linking to its targets 
while some might have variations at the single nucleotide level, which in turn might 
affect the hybridization  
 cross hybridization, where homology in closely related gene family members might 
cause the target to hybridize to a different probe. 
 Upregulation or downregulation might not necessarily be reflected by the probe – 
target hybridization. 
 Difficulty in detecting alternative splicing event – although splicing arrays are 
employed, unambiguous identification of novel isoforms are harder with small 
fragments of probes. 
5.1.1.3 Applications  
Microarray is used for different kinds of analysis such as expression analysis of 
genes in normal versus diseased condition, mutation analysis to find single nucleotide 
polymorphisms (SNPs), genomic analysis to find new genes, disease prognosis, 
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especially, in cancer to find the markers that are up regulated compared to the normal 
conditions, drug discovery to identify the protein products of the diseased gene, which in 
turn is used in the synthesis of drugs to target these products and toxicology to find the 
effects of toxins at the cellular level and changes caused by in the genetic profile due to 
their exposure.  
Recent advancements in the field of deep sequencing, especially in RNA 
sequencing technology, has over ridden microarray technology to a greater extent. The 
latter method provides the depth and nuanced information that is not available in the 
former technology. Also, the bias introduced due to the probe binding in microarray is 
avoided in RNAseq technology. Additionally, RNAseq can be used to build the whole 
genome for a new model organism, which is not possible by microarray. 
5.1.2 Deep sequencing and RNA sequencing 
The advent of high-throughput sequencing based methods has changed the way 
in which transcriptomes are studied. RNA sequencing (RNAseq) is widely used in the 
analysis of transcriptome to accurately measure gene expression levels, isoform 
expression levels and to find novel isoforms. RNA sequencing (RNA-Seq) involves direct 
sequencing of complementary DNAs (cDNAs) using high-throughput DNA sequencing 
technologies followed by the mapping of the sequencing reads to the genome. It provides 
a more comprehensive understanding of the complexity of eukaryotic transcriptomes in 
that it allows for the identification of novel exons, exon-intron boundaries, transcription 
start sites [223], and new splicing variants. It also allows for the precise estimation of 
isoform expression [224-233]. RNA seq’s ability to construct a novel full length isoform 
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sequences as well give their expression levels make this technology to be widely used in 
the study of en-masse transcription regulation.   
One of the earliest technology to obtain a comprehensive profile of the 
transcriptome, including lowly expressed transcripts, polony multiplex analysis of gene 
expression (PMAGE) was developed by George M. Church [221]. It has been shown to 
provide accuracy in the mRNA expression assessment since individual cDNA molecules 
are subjected to sequencing without any prior library amplification or sub-cloning. The 
principle of PMAGE is that individual cDNA template molecules are clonally amplified onto 
each polony bead in millions of parallel, compartmentalized droplets formed in a water-
in-oil emulsion. Polony sequence-by-ligation (SBL) provides an accurate, cost-effective 
and multiplexed platform for high throughput DNA sequencing. SBl works on the premise 
of the high fidelity of DNA ligase, which iteratively label each bead with a fluorophore 
encoding the identity of a base within the template. Microscopy-based detection of 
fluorescence ligation allows for the assessment of about 5 million cDNA molecules per 
run and digital quantification allows for the analysis of broad range of mRNA expression. 
 Another form next-generation sequencing was that 454 pyrosequencing, which 
works on the principle of pyrosequencing. This technology was developed by 454 Life 
Sciences. It is quite similar to PMAGE, in that DNA is amplified in an emulsion. This 
method uses luciferase to generate light for detection of individual nucleotides added to 
the nascent DNA, data from which is used to generate nucleotide read-out of the 
sequences. This provides longer reads compared to Illumina but does not have depth 
coverage. While there are many different platforms for sequencing, the most commonly 
used platform is that Illumina. 
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5.1.2.1 Illumina (Solexa) sequencing 
Illumina sequencing, was jointly founded by Shankar Balasubramanian and David 
Klenerman in 1988 [234]. This sequencing is based on the reversible dye-terminator 
technology. The principle of this method involves formation of DNA clusters, which is the 
clonal amplification of DNA. This method gnerates shorter reads but the depth coverage 
is much greater compared to other methods. 
Sample preparation: Samples are prepared to using a two-step process: (1) 
Tagmentation and (2) Cycle-amplification. Tagmentation is the process where DNA is first 
fragmented and by transposomes, and specific adaptor sequences are ligated to the 3’ 
and 5’ ends of the resulting fragments.  Subsequently, additional motifs replace the 
adaptor sequences in the process called reduced cycle amplification.  These motifs 
include sequencing primer binding sites, indexes, and oligo sequences for hybridization 
in the flow cell [235]. 
Cluster generation: This step employs a cluster station. It comprises of a flow cell, which 
can hold up to eight samples (each can go on a lane in that flow cell). Next, the denatured 
DNA template is loaded to the flow cell, which anneals to the oligo that are already bound 
to the flow cell. Once bound, a second strand is synthesized using these oligos, creating 
a double-stranded template, which is covalently attached to the flow cell surface. This 
process is repeated after denaturing and washing away original DNA template. The 
strand that is left over, then bends over to hybridize with the lawn oligo. This is called 
bridge amplification, which is continued for many cycles to create an exponential 
amplification of these strands [236].  
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Sequencing: For sequencing, the reverse strands are cleaved and washed away. 3’ ends 
of the forward strands are also blocked. Read-1 primer is added, which binds to the 
respective binding site on the read-1 strand. Fluorescently-labeled dNTPs, with a 
temporarily blocked 3’hydroxyl groups are added. With the incorporation of each 
nulcleotide, fluorescence is emitted following a light source application, wavelength of 
which will indicate which nucleotide has been added to the read. Following this, the 
temporary inactivation is removed at the 3’ hydroxyl group allowing for binding of another 
nucleotide and the process is repeated. After the read length is reached, it is denatured 
and washed away. Then, an index-1 primer is added to the flow cell and the first index 
read is generated the same way the read-1 was generated. Incase of paired end reads, 
once forward strand is sequenced, the reverse strands are sequenced by uncapping the 
3’ ends using index-2 reads. Once it is generated, the excess is washed away. 
Polymerase generates a complementary strand and the double-strand generated is 
denatured. This time, forward strands are cleaved and washed away and 3’ ends of the 
reverse strand are blocked to inhibit hybridization. Then, read-2 primer is added following 
the addition of fluorescently labelled dNTPs and the above-mentioned process is 
repeated for this strand [231, 237]. 
 Reads generated from pooled samples are sorted based on the unique indexing 
sequences with which they were labeled during sample preparation.  Using paired-end 
reads increase the alignment depth, thereby reducing ambiguity within the alignment.   
Data analysis: During the analysis of the large dataset, the reads obtained are mapped 
to the reference genome. Once the alignment is done, subsequently the data can be 
interrogated for novel isoforms, splicing events, single nucleotide polymorphisms, 
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insertion-deletion identification, microRNA and long non-coding RNA identification etc 
[231]. 
5.2 Customized bioinformatics pipeline and microarray to understand the 
biological processes underpinning normal and aberrant retinal development 
5.2.1 Rationale: 
One of the long standing goals in the retinal field has been to get a complete 
repertoire of transcriptome underpinning various biological processes and to understand 
how the transcriptome shifts either during developmental progression or in a pathological 
condition. To this end, we employed RNA sequencing technology on a fractionated 
developing mouse retina and devised a custom bioinformatics strategy to extract the 
biological meaning from the large data-set. The fractionation facilitated the interrogation 
of the cytoplasmic transcriptome separately from that of the nucleus, thereby allowing us 
to check if the nuclear transcriptome was preparing for the next molecular event while 
transcribing genes for the current step, while cytoplasmic transcriptome would mainly 
reflect that which will be translated into proteins. Also, to understand the degree of 
alternative splicing usage by genes expressed in the developing retina, we estimated 
expression levels of the constituent isoforms of genes to leverage the gene expression. 
Also, in parallel, we devised a customized unique splice junction microarray, which 
contained the unique splice junctions for isoforms of genes expressed in RNAseq data. 
The pipeline was extended to Nrl wildtype and knockout mouse retinae (Courtesy: Dr. 
Anand Swaroop, National Eye Institute) and compared to another methodology, which is 
generally used by other biologists, to find the best way of analyzing large datasets. 
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5.2.2 Background 
The retina has been the most accessible part of the developing central nervous system 
with a wealth of information on detailed birth order of its cell types and on many genes 
involved in executing specific programs such as cell cycle regulation, cell fate 
determination, and neuronal differentiation. However, a comprehensive gene regulatory 
network is still not achieved as gene-centric approach can only go so far. To address this 
issue, transcriptome capture to identify co-transcriptionally regulated genes across retinal 
development has previously been attempted and was of great value [238]. However, 
these efforts were hampered by the lack of depth of the captured transcriptome and lack 
of fractionation to gain higher resolution. Another concern was that at any given time the 
retina consists of different cell types with varied transcriptomes, which renders finding 
meaning from co-transcriptionally regulated genes difficult. We wanted to investigate 
whether higher depth of the captured transcriptome through RNA-Seq with minimal cross-
compartment (nucleus-cytoplasm) normalization could resolve this issue.  
 Here we report analysis of RNA-Seq data from cytoplasmic and nuclear 
transcriptome of the developing retina. We show that combinatorial use of RNA-Seq with 
our custom bioinformatics strategy revealed the precise order of gene activation and 
transitions in processes during retinal development. Transition in gene expression was 
validated and resolved at the isoform level through our custom microarray. Importantly, 
we show proof of principle by extending our methodology to analyze RNA-Seq data from 
P21-Nrl-WT and KO retinae. Our approach which focuses on understanding the temporal 
progression in gene expression during normal/aberrant development can be extended to 
development and disease progression of other tissues.   
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5.2.3 Results 
5.2.3.1 RNA-Seq of fractionated retina 
RNA for deep sequencing was obtained from retinae from E16 as it is the midpoint in 
embryonic development and P0 as it is a major transition in development. RNA-Seq was 
performed on rRNA depleted RNA captured from the cytoplasmic extract (CE) of E16 and 
P0 along with nuclear extract (NE) of P0. The rationale was that by comparing the CE 
across development, we would capture mRNA that were most likely translated into 
proteins, which in turn would reveal transitions in biological processes during the retinal 
development. Also, comparing the cytoplasmic transcriptome minimizes the 
contamination of unspliced transcripts contributed by the nuclear fraction, which might 
spike the FPKM units of isoforms and in turn the gene expression. On the other hand, 
comparison of P0CE to P0NE would reveal transcriptome dynamics within a time point. 
The two-way comparison (time and fraction) would capture change in transcription 
kinetics with three distinct sets of transcripts: transcripts in both fractions; transcripts 
exclusively in the CE; and transcripts exclusively in the NE. Overall, the transcriptome 
captured by RNA deep sequencing was obtained as 99.28, 117.38, and 127.46 million 
paired-end reads from E16CE, P0CE, and P0NE, respectively. An important decision for 
RNA-Seq analysis is setting the threshold for gene expression, which in the field ranges 
from 0.3–1.0 FPKM [239]. This range suggests that the threshold for any dataset must be 
vetted through empirical evidence. Thus, we interrogated a range of FPKM values to set 
the threshold for gene expression in the retina. We found that 1 FPKM was the 
appropriate value, as genes with known retinal expression were above this threshold, 
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hence considered expressed. In contrast, skeletal muscle-specific genes were below 1 
FPKM, and were considered not expressed in the retina (Table 5.1). 
Table 5.1: Skeletal muscle-specific genes expression. The table shows FPKM 
values of skeletal muscle-specific genes in E16CE, P0CE and P0NE samples.  
Skeletal-muscle 
genes 
E16CE 
FPKM 
P0CE 
FPKM 
P0NE 
FPKM 
Tnnt3 0.10 0.11 0.00 
Tnnt1 0.94 0.50 0.50 
Tnni3k 0.00 0.02 0.10 
Tnni2 0.30 0.21 0.20 
Tnni1 0.10 0.90 0.44 
Tnnc2 0.00 0.00 0.10 
Tnnc1 0.63 0.95 0.91 
Tnn 0.00 0.00 0.10 
 
 
 While the low-level expression (<1 FPKM) of skeletal muscle-specific genes might have 
a yet-to-be-identified biological function in the retina, we reasoned that in the absence of 
any literature support it would be safe to consider them as not expressed, to ensure high 
specificity of our analysis, at the cost of possible slight loss in sensitivity. Once the 
threshold was set, the reads were then subjected to our custom bioinformatics pipeline 
as described in materials and methods. The output of mapping and gene expression 
quantification was reported in Fragment per Kilobase per million mapped reads (FPKM) 
units. 
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5.2.3.2 Validation of RNA-Seq data 
A detailed explanation of how to run the scripts in the customized bioinformatics pipeline 
and how to perform the downstream analysis are given in Appendix 1.  We used genes 
with established expression kinetics to objectively assess the sensitivity of RNA 
sequencing [240]. For example, Fgf15, Sfrp2, Atoh7 and Irx4 are known to have higher 
expression levels at E16 than at P0, which was reflected in E16CE compared to P0CE 
data (Fig.  5.2A) [238, 241-245]. Likewise, expression of Fabp7, Gngt2, Nr2e3, Nrl, and 
Rho was as predicted in that it was higher in P0CE compared to E16CE (Fig.  2B) [238, 
246-252]. Finally, Pax6 showed little variation between E16CE and P0CE (Fig.  5.2B), 
which was also as expected [253, 254]. The transcriptional kinetics of some of these 
genes was independently validated by qPCR analysis across retinal development (E14, 
E16, E18, P0, P2, P4, P10, P25), thereby confirming the robustness of both RNA-Seq 
data and the bioinformatics approach used to assign expression and binning [255].  
 We also used the same paradigm of genes with established expression kinetics to 
determine the level of cross-contamination between P0CE and P0NE RNA. To determine 
the level of nuclear RNA contaminating the cytoplasmic extract, we checked the 
expression of genes whose transcripts are predominantly nuclear, such as Xist, Malat1, 
Tsix and Neat1 [255-258]. Indeed, for all four genes, the FPKM values were significantly 
higher in the NE compared to the CE (Fig.  5.2C). Determining the level of cytoplasmic 
RNA contamination in the nuclear extract presented a unique challenge as the majority 
of the RNA in the CE would be expected to be in the NE. For this, we examined expression 
of replication-dependent histone genes, as they are intronless and are known to be 
efficiently exported to the cytoplasm [259]. Indeed, histone genes have higher FPKM in 
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the CE than the NE (Fig.  5.2D). Furthermore, replication-dependent histone genes also 
serve to account for genomic DNA contamination. These genes lack introns and do not 
require splicing, so histone genomic DNA would be read as histone mRNA and inflate 
FPKM values in the NE, which was not the case (Fig.  5.2D), thus confirming minimal 
genomic contamination. Finally, genomic DNA contamination would result in FPKM value 
>0 for all genes; however, we observed 0 FPKM in the NE for a large number (804) of 
genes. In all, these controls suggest that there was minimal genomic DNA contamination 
in our fractionated NE RNA-Seq data. 
5.2.3.3 RNA-seq revealed high-resolution transcription kinetics 
We wanted to test the fidelity of our approach in capturing in vivo kinetics and the 
identification of co-transcriptionally regulated genes. Inherent to our binning strategy is 
identification of co-transcriptionally regulated genes. Therefore, the aforementioned 
binning strategy (Fig. 5.1) was employed for the E16CE vs. P0CE comparison and the 
P0CE vs. P0NE comparison to extract the transcription kinetics. For example, genes in 
the E16CE_Only bin had FPKM below threshold in P0CE. This suggests that transcription 
of these genes was initiated at/before E16 and was downregulated after E16 or just before 
P0. Genes in the P0CE_Only bin were transcribed after E16, but before P0. Genes in the 
OR_E16CE bin suggest that their transcription was initiated at/before E16 and 
downregulated after E16, but before P0 such that their FPKM was not below threshold in 
P0CE. Overall, 12,041 gene were expressed (Additional file 1: Figure S2) of which 10,369 
were non-differentially represented (Non_DR) between E16CE and P0CE (Additional file 
2: Table S1.1, S1.2, Additional file 1: Figure S2). Further analysis of alternative splicing 
status showed that genes in Non_DR bin were alternatively spliced at a higher level (42%) 
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compared to those undergoing transcriptional change (37%, Additional file 1: Figure S2). 
Likewise, the binning strategy was employed with the P0CE-P0NE comparison, which 
showed an increase in the number of expressed genes, which was mostly accounted for 
by the 2007 genes in the P0NE_Only bin (Additional file 1: Figure S2). Investigation of 
the alternative splicing status showed that genes over represented in P0NE (OR_P0NE) 
employed the highest degree of alternative splicing (68%) compared to other bins 
including OR_P0CE (36%) and Non-DR (52%) (Additional file 1: Figure S2). Next we 
combined E16CE-P0CE transcription kinetics with those observed in P0CE-P0NE 
transcription kinetics. Briefly, we took genes in a bin from the E16CE-P0CE comparison 
and interrogated their distribution in the different bins in the P0CE-P0NE analysis, which 
yielded high-resolution transcription kinetics. The term “high-resolution transcription 
kinetics” encapsulates both temporal and detection sensitivity. For example, amongst the 
genes in the not expressed (No_Ex, 22,331) and E16CE_Only (632) bins, 1628 and 379 
were detected above threshold in the P0NE_Only bin, respectively (Fig.  5.2E and 5.2J). 
Similarly, 86 genes from the 384 genes in the OR_E16CE bin and 1710 genes from the 
10,369 genes in the Non_DR bin were upregulated in the P0NE compared to the P0CE 
(Fig.  5.2F and G). In contrast, 35 genes of the 255 genes in the OR_P0CE bin were 
downregulated in P0NE compared to P0CE, while FPKM for 13 genes was below 
threshold (Fig.  5.2H). Likewise, 11 genes of 401 genes found in P0CE_Only in the 
E16CE-P0CE comparison were downregulated in P0NE compared to CE and 94 genes 
had FPKM below threshold (Fig.  5.2I). Overall, there were 2007 genes with transcripts 
exclusively in P0NE, of which 1084 were protein coding genes, 582 were Gm clones, 214 
were Riken clones, and the rest were non-coding RNA genes (Table 5.2). 
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Table 5.2: Distribution of 2007 transcripts in P0NE_Only sample 
Type of RNA # 
genes 
Protein coding genes 1084 
Gm clones 582 
Riken clones 214 
Miscellaneous/Anti-
sense/non-coding/rRNA 
35 
Pseudogenes 33 
snoRNA 21 
microRNA 27 
lincRNA 5 
snRNA 6 
 
5.2.3.4 Transcriptionally coupled genes revealed molecular programs in the 
developing retina 
Our objective here was to employ RNA-Seq to find transcriptionally coupled genes so that 
we could leverage them to discover molecular programs being employed during retinal 
development. For this, genes were subjected to DAVID analysis (Fig. 5.3A-I). 
Interestingly, our first submission of genes (632; Fig.  5.2E) in the E16CE_Only bin to 
DAVID did not enrich for any statistically significant (Benjamini <0.05) functions (Fig.  
5.3B). But, other bins with fewer or more genes than in E16CE_only, yielded many 
functions (Fig.  5.6, Additional file 3: Table S2.1). For example, genes in the OR_P0CE 
bin enriched for 7 functions of which the top hit was “visual perception” (Fig.  5.3B, 
Additional file 3: Table S2.1), showing that this function was initiated just before birth. This 
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showed that transcriptionally coupled genes could inform biological processes that were 
executed at that developmental timepoint. 
One caveat to our binning strategy was that while it grouped genes based on transcription 
kinetics, it separated genes participating in a common biological process (identified by 
DAVID) into different bins. This in turn would prevent extraction of the expression kinetics 
of genes known to participate in executing a biological process of interest. To address 
this issue, we devised a subtractive iterative approach using GeneMANIA (Fig.  5.3C-II) 
to identify genes participating in a common biological process from the different bins. For 
example, 17 genes in OR_P0CE genes (E16CE-P0CE) that enriched for visual 
perception by DAVID were used as bait in GeneMANIA, followed by the aforementioned 
subtractive iterations (Fig.  5.3C; 1x-3x) to generate a final list of 36 genes (Fig.  5.3C, 
Right). Subsequently, each gene was assigned to its respective bin in both E16CE-P0CE 
and P0CE-P0NE comparisons (Fig.  5.3D-III). Redistribution of the genes into their 
respective bins is shown in Fig.  5.3E. For visual perception, the transcription of Rdh5, 
which converts all-trans retinal to 11-cis retinal [260] was initiated at/before E16, shut 
down just before birth and was initiated again at birth as we find it in P0NE_Only bin in 
P0CE-P0NE (Fig.  5.3E). In contrast, Crb1, Cngb3, Pcdh15 and Rgs9, which play a role 
in photo transduction [261, 262] and structural support/maintenance of photoreceptors 
[263, 264], were transcribed at/before E16 and upregulated at P0 as they were over-
represented in P0NE in P0CE-P0NE (Fig.  5.3E). Rp1, which is a photoreceptor-specific 
microtubule-associated protein [265], was the only gene that was transcribed at P0 
(P0CE_Only in E16CE-P0CE) that continued to be upregulated as it was over-
represented in P0NE in P0CE-P0NE (Fig.  5.3E). Transcription of Guca1a was initiated 
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between E16 and P0 (P0CE_Only in E16CE-P0CE), except it was turned off before P0 
(P0CE_Only in P0CE-P0NE) (Fig.  5.3E). Through this method we were able to 
deconstruct the precise activation of genes involved in many aspects of vision 
acquisition/phototransduction during embryonic development.  
The same analysis was performed on all the bins in P0CE-P0NE comparison. 
Specifically, genes in the OR_P0NE bin showed enrichment for 120 GOterms of which 
one of them was “synapse” (Additional file 3: Table S2.2). This functional enrichment 
agrees with studies showing that synaptogenesis occurs postnatally in the rodent retina 
[266]. Further analysis of genes underlying the GOterm “synapse” showed transcription 
initiation of the AMPA receptor subunit genes including, Gria1, Gria2 and Gria4 before/at 
E16 (Non_DR in E16CE-P0CE) (Additional file 1: Figure S3).  Similarly Grik2, which 
encodes for a subunit of the ionotropic kainate receptor, was also initiated before/at E16 
(Additional file 1: Figure S3). Gad2, which is necessary for the production of the inhibitory 
neurotransmitter GABA, was transcribed before E16, while Gad1 transcription was 
initiated after E16 prior to birth (Additional file 1: Figure S3). Overall, genes involved in 
formation of the presynaptic activity were activated mostly during embryonic development 
(Additional file 1: Figure S3). In contrast, genes involved in postsynaptic activity had 
overlapping transcriptional activation with a subset of genes (Grid2, Grid1, Grik5, Grin3a, 
Ryr2 and Shank2) that were specifically activated in P0NE (Additional file 1: Figure S3).  
Finally, employing the same analysis for genes in P0NE_Only, which reflected de novo 
transcription, enriched for 14 GOterms, where voltage-gated calcium ion channel activity 
was one of the top hits (Additional file 3: Table S2.2). Again, this enrichment did agree 
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with previous studies where it has been shown that calcium channel activity is crucial for 
the construction of functional synapses that occurs postnatally [266].   
5.2.3.5 Extending the analysis to other time points through the custom microarray 
To confirm our RNA-Seq findings and extend our analysis across retinal development, 
we leveraged our RNA-Seq data to design a custom microarray.  The array was designed 
to en masse validate isoform kinetics by assaying for unique exon-exon junctions of a 
subset of genes across retinal development. The junctions were selected based on the 
following criteria:  1) gene must have more than one isoform expressed in the RNA-Seq 
data; and 2) An exon-exon junction must be unique such that it is not found more than 
once in all of the isoforms for that gene in the Ensembl database.  In all, the microarray 
had 28,575 probes for 5581 genes and was employed to interrogate expression of these 
isoforms in the cytoplasmic transcriptomes of E12, E16, E18, P0, P4, P10 and P25 
retinae. Data obtained were subjected to K-means clustering with the Genesis software, 
which was set to generate 10 clusters (Additional file 4: Table S3). Based on the overall 
patterns across time, the clusters were organized into three groups: embryonic, 
embryonic + postnatal and postnatal clusters (Fig. 5.4A-C), subsequently referred to as 
clusters 1, 2, and 3, respectively.   
 Next, we applied DAVID analysis to each cluster and found that embryonic clusters 
(Clusters 1 and 2) enriched for functions such as cell cycle regulation and cell projection 
organization (Fig. 5.4D). For the embryonic + postnatal clusters (Clusters 3 - 9), the 
functional GOterms that were enriched were those required for cell cycle regulation and 
terminal differentiation of neurons, such as vesicle-mediated transport, synapse 
formation, negative regulation of apoptosis, and axon guidance (Fig. 5.4E). Finally, the 
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sole postnatal cluster (Cluster 10) was the only one that enriched for functions such as 
visual perception, photoreceptor cell differentiation and sensory perception of light (Fig. 
5.4F). In all, the isoform-specific microarray confirmed RNA-Seq findings and further 
revealed the complexity of alternative splicing employed by the developing retina.   
 Thus, binning of the RNA-Seq data was crucial for the identification of co-
transcriptionally regulated genes, which in turn gave us the temporal transitions in 
biological programs enriched by the transcriptionally coupled genes (Fig. 5.6).   
5.2.3.6 Comparison with other analysis methods 
Our analysis pipeline is characterized by two main features, namely the temporal nature 
of the analysis and the binning strategy that allow us to do the functional analysis on 
genes with very specific expression kinetics. The current norm for next generation 
sequencing based functional analysis in the literature is done based on simple differential 
expression (DE) analysis, where the whole list of DE genes is fed into DAVID, or a similar 
functional annotation analysis platform.. The list of DE genes can sometime be too large, 
exceeding the input size limit of the functional analysis tool. To overcome this problem, a 
sub-list is sometimes selected based on prior knowledge of the gene functions [267]. Most 
analysis are also done in a static manner, where samples represent two conditions at the 
same time point [268]. In this section, we study the effect of binning and the temporal 
analysis on the result, by varying the analysis strategy. We first apply our analysis strategy 
to RNA-Seq data from P21-Nrl-WT and P21-Nrl-KO (Courtesy Dr. Anand Swaroop; NEI) 
[268].Then we apply three variants of the analysis pipeline, listed in Table 5.3, to the same 
data, and we compare the results.  
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Table 5.3: The table shows our analysis strategy, highlighted in grey and the 
three other analysis variants we compared with.  
Temporal analysis coupled 
with binning strategy 
Static analysis coupled with 
binning strategy 
Temporal analysis coupled 
with simple DE analysis 
Static analysis coupled with 
simple DE analysis 
 
5.2.3.7 Temporal analysis combined with static analysis of Nrl WT and KO RNA-
Seq is more informative 
 The loss of Nrl results in cell-fate switch from rod to cone photoreceptors [269]. This 
made Nrl-KO an ideal system to test our hypothesis that temporal comparison would yield 
more information than the static analysis. First we performed static comparison between 
P21-Nrl-WT and P21-Nrl-KO data (Additional file 1: Figure S4, Additional file 5: Table 
S4.1), similar to the one previously reported [269]. The objective of transcriptomics 
analysis of wild-type and knockout tissue is to find genes undergoing change to reveal 
the resulting biological change in the absence of that gene. Surprisingly, DAVID analysis 
of genes undergoing dynamic changes in gene expression in static comparison of P21-
Nrl-WT and KO enriched for a couple of generic functions that did not could not give any 
meaning in terms of the knockout phenotype (Additional file 3: Table S2.5). 
 Our RNA-Seq analysis of data from E16CE to P0CE and P0CE to P0NE 
comparisons showed that comparison across time (∆/time) was crucial in revealing 
biologically relevant meaning from co-transcriptionally regulated genes. Therefore, we 
introduced the variable of time by comparing P21-Nrl-WT and P21-Nrl-KO data separately 
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to our P0 data (P0CE + P0NE) (Additional file 1: Figure S4, Additional file 5: Table S4.2, 
S4.3). The rationale was that ∆/time would reveal unique sets of gene in P0 vs. P21-Nrl-
KO comparison, which in turn would reveal changes in the biological processes. In both 
comparisons, there were several bins with co-transcriptionally regulated genes 
(Additional file 1: Figure S4), which is not surprising, considering the major developmental 
shift from newly born developing retinae at P0 to fully functional P21 retinae. Also, DAVID 
analysis yielded significant GOterms for all the bins in the temporal analysis (Additional 
file 3: Table S2.3, S2.4). Moreover, there were many common functions in P21_Only bin 
(P21WT_Only and P21KO_Only) in both analyses. The most relevant issue was to 
ascertain the overlap in the identity of genes for the same process in the P21_Only bin in 
both sets of comparisons. For example, one of the common function in P21_Only bin was 
“visual perception”.  Interrogating the genes underlying the GO term “visual perception” 
in these bins, there were 21 genes common to both P0-P21WT and P0-P21KO analysis. 
However, 3 genes (Gnat1, Gucy2f, Rpgr) were only found in the P0-P21WT comparison, 
and one gene (Glra1) was specific to the P0-P21-KO comparison (Fig. 5.5, Left). The 
three genes unique to WT comparison are known to operate specifically in rod 
photoreceptors, which were of course absent in the Nrl-KO retina [270-272]. On the other 
hand, Glra1 is an important gene for cone-bipolar cells, which might be undergoing 
adaptive changes in the Nrl-KO retina [273]. The GO terms enriched by genes in 
P21_Only bin in the P0 vs. P21-Nrl-KO comparison were also informative. One of the 
functions enriched in DAVID was “regulation of blood pressure” (Fig. 5.5, right). Analysis 
of function of the genes underlying this enrichment revealed that most of them were 
engaged in vasodilation, suggesting that the Nrl-KO retina was undergoing vasculature 
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restructuring/dilation as a secondary effect of the cell-fate switch. Moreover, a recent 
report showed that the Nrl-KO retina develops dilated retinal blood vessels and leakage 
at P60 [274]. This showed that our gene expression/binning strategy captured the 
molecular signature at P21 for a phenotype that manifests histologically at P60. 
5.2.3.8 Binning vs. DE based analysis of Nrl WT and KO data 
Here we have introduced a new strategy for RNAseq data analysis. To understand the 
advantages afforded by this approach we compared our binning method to the more 
commonly used DE method. First we analysed the static comparison between Nrl-WT vs. 
Nrl-KO data by the binning method and the DE-based method. Here we found that the 
DE-based method showed large number (1116) of genes with differential expression 
(Additional file 6: Table S5.1). Similar data was obtained by the binning method except 
that the DE genes were now in bins labelled OR and Only, which reduced the large list of 
DE genes into manageable quanta. Moreover, the inherent value of the bins is inferred 
transcriptional kinetics. However, the binning method has a cost, which is reflected in the 
few statistically significant biological functions enriched by DAVID analysis. In contrast, 
the DE-based method generates a large list, which requires the investigator to decide the 
fold-change that might be relevant for his/her study. The one advantage of the DE method 
is that it produces a wide range of functional enrichments (12 GOterms) for  DE gene-list 
for DAVID analysis(Additional file 7: Table S6.3).     
 Next, we analyzed temporal comparison between P0 vs. P21 Nrl-WT and P0 
vs.P21 Nrl-KO by both the binning method and the DE-based method (Additional file 6: 
Table S5.2, S5.3). Here the binning method revealed gene transcription kinetics across 
time, which inherently is valuable for deciphering developmental changes in normal and 
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aberrant situations. The DE-based method produced a large DE gene-list, but it did not 
yield any change in gene transcription over time (Additional file 7: Table S6.1, S6.2). Thus, 
it would require further deconstruction of the list, which is not necessary by the binning 
strategy. Also, DAVID analysis of the binned data provided enrichment of biological 
functions tethered to the specific gene expression profile. This is of great value as it is 
one of the central goals of performing RNAseq to capture transcriptome change over time 
(Additional file 3: Table S2.3, S2.4). In all, the two approaches of RNAseq analysis have 
merits that can be leveraged to effectively analyze RNAseq data.  
5.2.4 Discussion  
Amongst the co-transcriptionally regulated genes identified by our binning strategy, genes 
that remained transcriptionally unaltered employed a higher degree of alternative splicing 
than those undergoing dynamic regulation. This suggests that during development the 
major transcription initiations and terminations might lay down the foundation, while the 
proteome diversity generated through alternative splicing might be engaged in resolving 
the finer details, such as neuronal subtype specification and terminal differentiation. 
Another advantage of the binning strategy was that the large transcriptome data was 
quantized, allowing us to interrogate the dataset for genes with established expression 
kinetics. The purpose of this was to challenge the binned data generated based on the 1 
FPKM threshold for known gene expression patterns (Fig. 5.2A&B).  
 Once the dataset was validated, the status of genes in various bins in the E16CE-
P0CE comparison in the P0CE-P0NE comparison was interrogated, which revealed 
dynamic transitions in the transcription kinetics in the same developmental stage. For 
example, the 632 genes in E16CE_only bin in the E16CE-P0CE comparison bifurcate 
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into No_Ex and P0NE-Only bins in the P0CE-P0NE comparison (Fig. 5.2E). This 
suggests that while some genes will remain off, some are re-initiated and predicts that 
these transcripts will appear in the CE of the next developmental stage. This was 
confirmed by our quantitative PCR analysis for Nr2e3, Nrl and Rho across postnatal 
retinal development [255]. The presence of transcripts for 1084 protein coding genes in 
the P0NE_Only bin suggested that we had captured de novo transcription of genes that 
might be required for the next developmental program. For example, Ces5a is a ~36 kb 
gene that has FPKM below threshold in E16CE and P0CE, but has FPKM of 161 in P0NE. 
This value is much higher than FPKM of genes such as Nr2e3 (35.4 FPKM), Nrl (6.1 
FPKM) and Gngt2 (22 FPKM) (Table 5.4).  
Table 5.4: An example of a “P0NE_Only” gene, Ces5a, whose FPKM unit in P0NE 
is comparable to those of other genes with known established expression 
kinetics (Nrl, Nr2e3, Gngt2) 
Genes E16CE FPKM P0CE FPKM P0NE FPKM 
Ces5a 0.073539 0.420057 161.0296 
Nrl 0.558403 15.88869 6.104338 
Nr2e3 0.008781 28.08 35.45415 
Gngt2 10.06518 91.92727 22.08052 
 
This indicates that expression of Ces5a is more than physiologically equivalent, yet it is 
not observed in P0CE where it could be translated. One possibility is that there is an 
active regulation of its export, although this warrants further investigation.  
 The intrinsic value of identifying co-transcriptionally regulated genes is the 
expectation that they might reveal the biological processes being executed by the 
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developing retina. Our bioinformatics pipeline can deconstruct the order of activation of 
specific genes engaged in executing a specific biological process so that one can begin 
to generate gene regulatory networks underlying retinal development. A key feature of 
our pipeline is the use of GeneMANIA to find potential partners of the core set of genes 
from a specific bin that enrich for a function in our DAVID analysis (Fig. 5.3C). A priori, 
one would predict a progressive increase in the number of genes with sequential 
application of the GeneMANIA part of the pipeline (Fig. 5.3C). However, we observed that 
there was reduction in the number of genes (Fig. 5.3C, Right). This suggests that 
leveraging RNA-Seq data to remove genes that were not expressed in the retina enriched 
for those genes relevant to retinal development and function at the timepoint under 
investigation.  
 Next we applied our analysis pipeline to find co-transcriptionally regulated genes 
in the P0 and P21-Nrl-WT comparison and the P0 and P21-Nrl-KO comparison 
(Additional File 1: Figure S4, Additional file 5: Table S4). One of the salient features of 
this analysis was that temporal analysis was more informative than static comparison. 
One explanation is that temporal analysis created bins that were developmentally 
regulated, which through DAVID analysis revealed changes in biological processes. For 
example, there is no cell cycle occurring at P21 so the majority of the cell cycle genes 
should be inactivated. Indeed, we observe cell cycle in the P0_Only bin in both P0 vs 
P21-Nrl-WT and P0 vs. P21-Nrl-KO analysis (Additional file 3: Table S2.3, S2.4).  These 
genes in static analysis would show up as not expressed. Similarly, genes in P21_Only 
bin enriched for functions such as ion channel activity, ion transport, visual perception, 
synapse, voltage-gated ion channel activity, neurotransmission and others (Additional file 
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3: Table S2.3, S2.4). This was as expected as the retina is fully functional at P21 
compared to P0.  The advantage of our strategy is that it allowed us to understand the 
progression in gene expression kinetics in normal development and leverage that to 
understand how this progression deviates in the knockout retina. When P21_Only bin 
(either P21WT_Only or P21KO_Only) was analyzed through DAVID, we found many 
functions that were common to both sets of comparison, except examination of the 
number of genes underlying these functions revealed that there were subtle differences 
between the two bins (P21WT_only and P21KO_Only) (Additional file 3: Table S2.3, 
S2.4). This suggested that while many of the functions remain unaltered in the KO, there 
are subtle changes in the manner in which they might be executed. For example, “visual 
perception” showed up in the P0 vs. P21-Nrl-WT and P0 vs. P21-Nrl-KO comparisons in 
the P21_Only bins (Fig. 5.5). There were 24 genes underlying enrichment of this function 
in the WT comparison (Fig. 5.5), while there were 22 genes in KO comparison (Fig. 5.5). 
Upon comparing the gene identities from both sets, subtle differences emerged that 
allowed us to find the biological meaning from change in a single gene such as the rod 
photoreceptor-specific gene, Gnat1, that was absent in the Nrl-KO retina, which lack rod 
photoreceptors [270]. Finding Gnat1 through temporal analysis raises the question 
whether it would have been found in static analysis. While Gnat1 was present in the 
P21WT_Only bin in static analysis, the rest of the genes that would normally be part of 
the GO term “visual perception” were in the Non_DR bin. Thus, without a priori knowledge 
one would not find this specific gene out of the entire list of genes in the P21WT_Only.  
Temporal analysis combined with our gene expression and binning strategy followed by 
our custom bioinformatics pipeline was able to find these subtle changes, which in case 
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of static analysis was not possible (Additional file 1: Figure S4). While one could find these 
subtle changes in the static analysis by looking at specific genes, but that requires a priori 
knowledge. The advantage of doing whole transcriptome analysis is that one could find 
patterns computationally, which can be leveraged to obtain new insights without the need 
for a priori knowledge. For example, GOterms such as potassium channel complex, 
sodium channel activity, synaptic vesicle, calcium ion transport and regulation of blood 
pressure regulation (Additional file 3: Table S2.4) were enriched by genes in the 
P21_Only bin in P0 vs. P21-Nrl-KO comparison, but were absent in the WT comparison. 
This finding suggests that there are specific anomalies in the Nrl-KO retina. Given that in 
the Nrl-KO retina, the majority of the rod photoreceptors have converted to cone 
photoreceptors, changes in ion transport and synaptogenesis are to be expected [17, 
275]. However, regulation of blood pressure seemed out of place for the Nrl-KO retina. 
Indeed, closer examination of the genes underlying this function revealed the need to 
examine vasodilation in the Nrl-KO retina. Notably, previous reports showed that the Nrl-
KO retina develops dilated retinal blood vessels and leakage at P60 [274]. Thus, this 
confirming the prediction made through shifts in the molecular signatures identified by our 
temporal analysis. Importantly, our analysis predicted an outcome based on gene 
expression pattern changes occurring between P0 to P21 that manifests at P60. 
5.2.5 Materials and Methods 
Animal Procedures 
All experiments used CD1 mice from Charles River Laboratory, MA. All mice procedures 
were compliant with the protocols approved by the University of Connecticut’s Institutional 
Animal Care and Use Committee (IACUC).   
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RNA fractionation 
Retinae were dissected from E16 embryos and P0 pups followed by fractionation protocol 
as described previously [255].  Once the fractions were obtained, Trizol (Invitrogen, CA, 
cat # 15596-026) was used as per the manufacturer’s instruction. 
Library preparation for deep sequencing 
After the total RNA was prepared from the two fractions, ribosomal RNA (rRNA) was 
removed using Ribozero Ribosomal RNA removal kit (Epicenter, WI, cat # RZH1046) by 
following the manufacturer’s instruction. The removal of rRNA was confirmed by gel 
electrophoresis and was used for RNA-Seq library preparation.  RNA-Seq library was 
prepared using Script-seq mRNA seq library preparation kit (Cambio, UK, cat # 
SS10906). The library was deep sequenced in multiple runs using Illumina Hi-Seq 2000 
platform at the University of Connecticut Health Center Deep sequencing core facility. 
P21 WT and Nrl-KO RNA-Seq data was shared with us by Dr. Anand Swaroop; National 
Eye Institute  [268].  
RNA-Seq analysis 
CD1 reference creation 
The transcriptome captured by deep sequencing was obtained as short paired-end reads. 
We analyzed the RNA-Seq data from each sample through riboPicker [276], an algorithm 
to identify reads derived from rRNA, which showed minimal (0.02 – 0.34%) rRNA 
transcripts (Table 5.5).  
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Table 5.5: Read mapping statistics and rRNA levels in the E16CE, P0CE, and 
P0NE samples 
Sample Percentage of transcriptome 
mapped read pairs 
Percentage of 
rRNA reads 
# mapped bases 
in Gb 
E16CE 61.26% 0.34% 7.54 
P0CE 52.85% 0.19% 7.69 
P0NE 25.42% 0.03% 4.02 
 
Next, reads were mapped to the mouse genome and the transcriptome to create a 
reference. The mouse genome sequence (mm10, NCBI build 38) was downloaded from 
UCSC database [277, 278] together with the GTF for the Ensembl transcript library 
(release 68) (http://genome.ucsc.edu).  The paired-end reads from E16 cytoplasmic 
extract (CE), P0CE and P0 nuclear extract (NE) were mapped separately to the mm10 
genome and the transcript sequences extracted according to the Ensembl transcript 
library coordinates. Mapping was done using bowtie [279] and allowed for three 
mismatches in seed-length of 30 bases. For each sample, the two sets of read alignments 
(genome and transcriptome) were merged together using the HardMerge tool from the 
NGSTools suite [280]. HardMerge keeps alignments of read that align uniquely to the 
transcriptome, uniquely to the genome only or uniquely to each reference, where both 
alignments agree. Other alignments are discarded. This initial mapping was used to 
perform mismatch analysis with another tool in the NGSTools suite (Additional file 1: 
Figure S1). Accordingly, the first 6 and last 32 bases from each read were trimmed. The 
trimmed reads (62 bp) were remapped using the aforementioned mapping parameters to 
the genome and transcriptome, and were once again merged using the HardMerge rules. 
Since the RNA-Seq was performed on retinal RNA extracted from CD1 strain mice, the 
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resulting alignments from all three samples were pooled together and used to call Single 
Nucleotide Variations (SNVs) using SNVQ [280]. The CD1 reference genome was 
created by modifying the mm10 reference to reflect the inferred SNVs. Transcript 
sequences were extracted from the modified genome.   
Gene Expression Analysis 
E16CE, P0CE and P0NE reads were mapped against the created CD1 transcriptome 
reference. The P21 WT and KO single end reads were mapped against the C57BL6 
reference transcriptome (version 68). Mapping was done using bowtie and allowed for 
one mismatches in seed-length of 30 bases. Gene expression were estimated using, 
IsoEM, a novel expectation-maximization algorithm that estimates isoform frequency from 
single and paired RNA-Seq reads. IsoEM exploits read disambiguation information 
provided by the distribution of insert sizes generated during sequencing library 
preparation, and takes advantage of base quality scores, strand, and read pairing 
information.  Isoform expression is reported as Fragment per Kilobase per million mapped 
reads (FPKM) units and gene expression is the sum of FPKM of its constituent isoforms 
[281]. For gene differential expression, two methods were run, GFOLD [282] and Fisher’s 
exact test with house-keeping gene normalization as suggested by Bullard et al. [283]. 
Gapdh was used as the housekeeping gene for this analysis. Genes were called 
differentially expressed if they showed ≥2 fold expression in one sample by both methods. 
GFOLD was run on the CD1 transcriptome aligned reads, with default parameters and a 
p-value of 0.01. Fisher’s exact test was run on estimated number of reads mapped per 
kilobase of gene length (calculated from IsoEM estimated FPKM values). Similar to 
GFOLD, a p-value of 0.01 was used for Fisher’s exact test. 
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Binning strategy 
Samples were analyzed in pairs, and genes were classified based on their expression 
levels (expressed vs. not expressed), differential gene expression calls, and the number 
of expressed isoforms for the gene. 1 FPKM was set as threshold for expression. Genes 
were then classified into one of the following bins (Fig.  1) based on yes/no calls. Firstly, 
genes with expression level less than 1 FPKM are placed in the not expressed (not_Ex) 
bin (Fig.  1i). Rest of the genes, which were expressed were further categorized into the 
following bins (Fig.  1ii). Genes expressed exclusively in one sample were placed in one 
of the ONLY bins (Fig.  1iii). Differential expression calls were made to genes expressed 
in both samples (Fig.  1iv). If a gene passed GFOLD and Fisher’s test, then it was placed 
in the over represented (OR) bin. Genes, which did not pass both or either of these tests, 
were placed in the non-differentially represented (non_DR) bin. Bins of expressed genes 
were subcategorized based on the alternative splicing status of the genes. This 
categorization included single and multiple isoform bins (SI, MI). There were genes with 
multiple isoforms that were individually below threshold, but the sum of FPKM values of 
these isoforms is above threshold. These were placed in the multiple isoforms below 
threshold (MIBT) bin. Similarly, genes expressed with multiple isoforms where only one 
isoform was above threshold were placed in the multiple isoforms one above threshold 
(MOAT) bin. 
Functional annotation analysis 
Genes belonging to each bin were analyzed for enrichment of individual GOterms to find 
whether co-transcriptionally regulated genes had overlapping functions using the 
Database for Annotation, Visualization and Integrated Discovery, DAVID (Fig.  3A-I) [284, 
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285]. Default parameters (≤0.05 Benjamini score) were used for all analyses. The gene 
lists enriching for GOterms were run through GeneMANIA to identify potential partners 
[286]. First, we took the gene list underlying a biological process identified by DAVID and 
used it as bait in another online tool called GeneMANIA (Fig.  3C-II), which identified 
potential partners for genes from the primary list. The potential partners identified by 
GeneMANIA are based on all published literature and databases, which could introduce 
a partner that is relevant in another tissue, but might not be expressed in the retina. To 
eliminate such genes, we selected only those genes that were expressed in our RNA-
Seq data. Subsequently, this short list of genes was added to the primary list to generate 
a secondary list, which was used again as bait in GeneMANIA. This process was repeated 
until convergence, which was reached after three iterations (Fig.  3C-II). 
Microarray design 
We designed a custom microarray with Affymetrix to en masse interrogate the 
presence/absence of unique exon/exon junctions in isoforms expressed in the RNA-Seq 
data.  After mapping the RNA-Seq reads from the three samples (E16-CE, P0-CE and 
P0-NE) to the Ensembl 68 transcripts and running IsoEM to estimate the FPKM values 
for each of the three samples, genes expressed in any of the three samples were 
selected. Exon-exon junctions that are unique among expressed transcripts in genes that 
have more than one expressed transcript were selected (Junctions with flanking 
sequences of length ≤ 12 bases were eliminated). As a result, we included probes for 
28,574 unique junctions from 11,923 transcripts on the custom Affymetrix microarray chip. 
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Custom Affymetrix data analysis 
Cytoplasmic RNA (1µg) was prepared from retinae harvested from E12, E16, E18 
embryos and P0, P4, P10 and P25 and processed at Yale Center for Genome Analysis. 
Expression levels of probe targets were computed from the raw intensity values using the 
Robust Multichip Average (RMA) algorithm [287, 288], which was performed with the affy 
R package [289]. Subsequently, the data were processed through Gene Expression 
Similarity Investigation Suite (Genesis) (v1.7.6) for k-means clustering [290]. Here, we 
ran 500 iterations to generate a total of 10 clusters that fell into three categories based 
on expression kinetics. These trends were defined as embryonic, postnatal, and 
embryonic + postnatal.  The gene lists belonging to each cluster were separately analyzed 
for functional enrichment using DAVID. 
5.3 Extension of the pipeline to understand the effect of triple microRNA knockout 
in mouse retinal development 
5.3.1 Rationale 
We devised a custom bioinformatics pipeline which we leveraged to extract 
biological processes underpinning retinal development and extended the analysis to a 
wildtype and knockout paradigm. Once we established, the workability of our pipeline, we 
wanted to extend it to study the temporal progression of wildtype and knockout and use 
the information to extract the pathway affected in the knockout during the course of the 
aberrant development. Here, we used RNAseq data obtained from a normal and triple 
microRNA (miR 183/96/182) knockout retinae (Courtesy: Dr. Lijin Dong, National Eye 
institute) to identify molecular signatures that are changing in the knockout compared to 
the wildtype developing retina. This data was leveraged to the expression of one of the 
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key targets of the microRNA cluster named Mak. Quantitative PCR results from Dr. Dong 
has shown that this gene is shown to be upregulated in the knockout compared to the 
wildtype and this result was used to leverage the output of our pipeline. 
5.3.2 Background 
microRNAs are class of small non coding RNAs, which are about 22 nucleotides 
in length. These evolutionarily conserved class of RNA play an important role in post 
transcriptional regulation by binding to the 3’UTR of mRNA target via RNA interference 
mechanism. Since their discovery in C. elegans, about 2000 microRNAs have been 
identified and have been shown to play a key role in various cellular processes such as 
cell proliferation, regeneration, hematopoiesis, neuronal differentiation etc. Also, they 
are known to regulate cellular pathways as multiple microRNAs can target one mRNA 
and one microRNA can have multiple mRNA targets. microRNAs have diverse temporal 
and tissue-specific expression patterns across different species. Previous studies on 
various microRNAs in primary cell culture have shown that they play a vital role in the 
regulation of angiogenesis of choriocapillaries, oxidative damage prevention and proper 
maintenance of cultured RPEs. They are also strongly linked to the ER stress, 
implicating their role in various diseases such as AMD. Approximately 78 microRNAs 
have been shown to be expressed only in the retina, implying the importance of 
microRNAs in the regulation of gene expression in the retina [291, 292]. In Drosophila, 
microRNAs have been suggested to play a role in photoreceptor differentiation, while in 
murines, they have been linked to lens differentiation [292]. In mice, inactivation of 
Dicer, which is required for microRNA maturation, has been shown to cause 
progressive degeneration of retina [293].  
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More than 30% of animal microRNAs are organized into clusters (miRBase), 
which are group of microRNA precursors with an inter-microRNA distance of less than 
10kb on the same genomic strand [294]. One of the highly conserved cluster of miRNAs 
is miR-183/96/182, which is located on an intergenic region of human chromosome 7q. 
In mouse, the sequences coding for these miRNA are located within 4 kb of each other 
on chromosome 6qA3 and transcribed in the same orientation.  They have been shown 
to give very similar expression patterns in zebrafish whole-mount experiments [295].  
miR-96/182/183 cluster play an important role in both development and disease and are 
considered as a specific cluster for sensory organ development, particularly in retina 
[296] and in hair cells of the inner ear [297]; their expression has also been documented 
in several cancers including breast, ovarian, endometrial, bladder, prostate, lung, 
hepatocellular and thyroid [298-300]. Inhibition of the miRNA cluster has been shown to 
induce p53/apoptosis signaling pathway [301]. The temporal and spatial expression of 
miR-96/-182/-183 cluster has been shown to correlate with functional maturation of the 
inner ear [297]. Expression analysis of miR-96/182/183 across retinal development 
have been shown to be minimal at embryonic time points with a steady increase 
postnatally and reaching the peak in the adult retina [302].  Insitu hybridization of retina 
has shown miR-183/96/182 cluster to be highly expressed in photoreceptors and 
interneurons of the inner nuclear layer (INL) and was shown to be down-regulated 
during dark adaptation and up-regulated in light-adapted retina [303]. In various disease 
models including the three photoreceptor-linked mouse models of RP (Opsin/, 307 and 
rds), a human retinitis pigmentosa model, expression of the miR-183/96/182 cluster was 
shown to be dramatically decreased [303], suggesting a correlation between decreased 
147 
 
expression and retinal disease. Inhibition of miR-83/96/182 cluster have also been 
shown to cause severe retinal degeneration in sponge (for the cluster) transgenic mice 
[296, 303]. Despite their implication in retinal degeneration, role of miR 96/182/183 in 
normal retinal development is not well understood. 
The vertebrate retina is a part of the central nervous system and contains six 
neurons including, rod photoreceptors, cone photoreceptors, amacrine cells (AC), 
bipolar cells (BP), horizontal cells (HC), and ganglion cells (GC) and one glial cell 
namely Müller glia.  The rod and cone photoreceptors are highly specialized neurons, 
divided into morphologically and functionally distinct compartments: a synaptic terminal, 
an outer segment, an inner segment, and a cilium connecting the outer and inner 
segments [304]. Outer segments (OS) are formed initially from the primary cilia and 
contain an axoneme, which begins at the basal bodies, and passes through a transition 
zone also called the connecting cilia and into the outer segment. The miR182/96/183 
cluster has been shown to play a vital role in the maintenance of cone photoreceptor 
outer segments [296]. Global analysis of the cluster knockout has shown to enrich for 
genes involved in synaptogenesis, synaptic transmission and phototransduction [296] 
but the systematic analysis to find the primary, secondary and tertiary effects of the 
cluster knockout in the retinal development has not been done. 
5.3.3 Results and discussion 
5.3.3.1 Transcriptomics summary of the static comparison 
RNA sequencing (RNAseq) data from three developmental time points, including 
postnatal (P) 5, P11, P27 wild type (WT) and triple microRNA knockout (KO) retinae were 
analyzed. Static comparison was performed where the wild type and knockout at a given 
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time point were compared to each other (Fig 5.7A). The binning data showed that 14,544 
genes were expressed in P5WT and P5KO comparison, 14,598 genes were expressed 
in P11WT –P11KO comparison and 13,778 genes were expressed in P27- P27KO 
comparison (Fig 5.7B-D). In P5WT-KO comparison, of the expressed genes, 13,643 
genes were non-differentially represented (Non_DR), while 12 genes were over 
represented in P5KO (OR_P5KO) and 1 only one gene was over-represented in P5WT 
(OR_P5WT) (Fig 5.7B). 319 and 569 genes were present in the P5WT_only and 
P5KO_only bins, respectively. In P11WT-KO comparion, of the expressed genes, 13,643 
genes were non-differentially represented (Non_DR), while 9 genes were over 
represented in P11WT (OR_P11WT) and 1 only one gene was over-represented in 
P11KO (OR_P11KO). 331 and 614 genes were present in the P11WT_only and 
P11KO_only bins, respectively (Fig 5.7C). In P27WT-KO comparison, of the expressed 
genes, 13,133 genes were non-differentially represented (Non_DR), while 3 genes were 
over represented in P27KO (OR_P27KO) and 8 genes was over-represented in P27WT 
(OR_P27WT). 277 and 357 genes were present in the P27WT_only and P27KO_only 
bins, respectively (Fig 5.7D).  
Alternative splicing status: When the alternative splicing (AS) status of each bin was 
interrogated in P5WT-KO comparison, 59 % of genes in Non_DR bin employs AS, while 
38% of genes in P5WT_Only bin and 47% of genes in P5KO_Only bin employ AS. Similar 
trend is seen in other two static comparisons as well (Fig 5.7B). In P11WT-KO analysis, 
59 % of genes in Non_DR bin employs AS, while 36% of genes in P11WT_Only bin and 
42% of genes in P11KO_Only bin employ AS (Fig. 5.7C). In P27WT-KO analysis, 58 % 
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of genes in Non_DR bin employs AS, while 35% of genes in P27WT_Only bin and 41% 
of genes in P27KO_Only bin employ AS (Fig. 5.7D). 
Thus, genes in Non_DR showed greater degree of AS, which is pattern that has 
consistently been shown in the other analyses of retinal developmental time points as 
well. It further emphasizes the importance of regulation of AS at the isoform level, when 
the at the gene level, the expression is not changed very much. 
5.3.3.2 Transcriptomics summary of the temporal comparison 
 Temporal comparison was performed where the developmental time points 
were compared as the course of development progressed separately in WT and KO. In 
this strategy, P0 wild type data, which was used to compare the P21 Nrl WT and KO data, 
was used to compare with P5WT and P5KO to understand the changes that could have 
manifested in the P5KO retina. Also, P5 was compared to P11 and P11 was then 
compared to P27 (Fig 5.8A).  
The binning data of P0WT – P5WT comparison showed that 15,055 genes were 
expressed in P5WT and P5KO comparison (Fig 5.8B). Out of 15,055 genes, 10,814 
genes were present in Non_DR bin, 307 genes in OR_P0WT bin, while 1081 and 2854 
genes were present in P0WT_Only and P5WT_Only bins, respectively (Fig 5.8B). In 
P0WT-P5KO comparison, the number of genes in Non_DR bin were 10,886 out of 15,118 
genes that were expressed (Fig 5.8C). There were 316, 1000, and 2916 genes in 
OR_P0WT, P0WT_Only and P5KO_Only bins, respectively (Fig 5.8C). There was a slight 
increase in the number of expressed genes in the P0WT-P5KO comparison, which was 
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reflected in P5KO_only bin and Non_DR bins. But, there was no gene over represented 
in P5WT or KO compared to P0WT.  
In P5WT-P11WT comparison, 14,546 genes were expressed, out of which 13,402 
genes were present in Non_DR bin (Fig 5.8D). 7 and 10 genes were present in OR_P5WT 
and OR_P11WT bins, while 571 and 556 genes were present in P5WT_only and 
P11WT_only bins (Fig 5.8D). In the KO comparison between P5 and P11, 14,849 genes 
were expressed, out of which 13,526 genes were present in Non_DR bin (Fig 5.8E). 6 
and 4 genes were present in OR_P5KO and OR_P11KO bins, while 731 and 582 genes 
were present in P5KO_only and P11KO_only bins (Fig 5.8E). 
In P11WT-P27WT comparison, 14,586 genes were expressed, out of which 
12,804 genes were present in Non_DR bin (Fig 5.8F). 9 and 6 genes were present in 
OR_P11WT and OR_P27WT bins, while 1165 and 602 genes were present in 
P11WT_only and P27WT_only bins (Fig 5.8F). In the KO comparison between P11 and 
P27, 14,614 genes were expressed, out of which 13,144 genes were present in Non_DR 
bin (Fig 5.8G). 8 and 2 genes were present in OR_P11KO and OR_P27KO bins, while 
1113 and 347 genes were present in P11KO_only and P27KO_only bins (Fig 5.8G). 
Alternative splicing status: When the alternative splicing (AS) status of each bin was 
interrogated in P0WT-P5WT and P0WT-P5KO comparisons, genes in Non_DR bin 
showed the highest degree of AS with 64% of genes with multiple isoforms (Fig 5.8B,C). 
Similar pattern was observed in other comparisons where Non_DR bin had about 59% of 
its genes with multiple isoforms and exhibited the higher degree of AS compared to other 
bins (Fig 5.8D-G). Genes in the “Only” bins were predominantly ones with only one 
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isoform, therefore no AS event. Overall about 51 – 80% of genes in only bins in all the 
temporal comparisons had single isoforms (Fig 5.8D-G). 
5.3.3.3 DAVID analysis of static and temporal comparison 
 Once the bins were obtained, next step was to analyze the functions enriched by 
transcriptionally co-segregated genes present in each bin. DAVID analysis was 
performed on each bin belonging to every pairwise comparison in static and temporal 
analysis. Many unique GOterms emerged in the temporal analysis but not as many 
enriched in the static analysis. 
Static Comparison: In static analysis, in P5WT-KO comparison, only bin that enriched 
for functions was P5KO_Only. There were 7 functional GOterm enrichments and all 
functions were mostly associated with the synaptic transmission including 
neurotransmitter receptor activity, ion channel activity, GABA receptor activity, and 
synapse (Fig 5.9). It has been shown that in the tri microRNA knockout, beta waves by 
electro retinogram were flat, suggesting that there could be deficits in the synaptic 
transmission (unpublished data from Dr. Dong). In P11WT – KO analysis, there were two 
enrichments for P11WT_only and P11KO_Only bins, which mainly enriched for muscle-
related functions. There were a few functions relating to cellular maintenance including 
translation and cellular matrix were enriched in P27WT-KO comparison (Fig 5.9). 
Temporal comparison: DAVID analysis of temporal comparison yielded many more 
functional enrichments compared to static comparison. Interestingly, P5KO_Only bin in 
P0-P5KO comparison yielded muscle related functions and synapse related functions, 
suggesting that these molecular programs could be affected much as early as P5 (Fig 
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5.9). By leveraging the data to P0WT, the aberrance in the normal development was 
extracted.  
P5WT-P11 WT comparison had many interesting functional enrichments. Mainly, genes 
belonging to P5WT_only bin enriched for ‘cell fate commitment’, which is the case in the 
developing mouse retina round P5, when many cells including amacrine cells, cone cells, 
bipolar cells begin to differentiate. Genes in both P11WT_Only and P11KO_only bins, 
enriched for ‘GABA receptor activity’ function and interestingly, there were different 
number of genes underlying them. This function was seen in at P5 in static analysis, while 
in temporal analysis, it appears much later. In the comparison of P11WT-P27WT, there 
were a few functional enrichments relating to immune system by genes in P11WT_Only, 
which could be due to the development of glial cells and DAVID analysis could have 
related glial-associated genes with immune response (Fig 5.9). 
5.3.3.4 Covariance and coefficient correlation analysis results  
Covariance and correlation coefficient is used to describe linear relationships 
between two variables, in this case two developmental time points. Correlation and 
covariance describe how one time point behaves with respect to another. Therefore, 
when a developmental time point is compared to itself, it has the highest correlation, which 
is given as 1. This correlation could be positive or negative or neutral. Closer a time point 
in the gene expression changes to that of another time point, stronger the correlation is 
and would be closer to 1. When the genes behave in a totally opposite manner between 
two points, the correlation becomes negative. Usually, the value of sample correlation 
coefficient, r, ranges from 0 – 0.2, it is considered a very weak or negligible correlation, 
while 0.2 – 0.4 is considered weak, 0.4 – 0.7 is considered moderate, 0.7-0.9 is strong 
153 
 
and 0.9 -1 is very strong correlation. This correlation gives a sense of how a 
developmental time point behaves, in terms of overall gene pattern changes in every bin 
or by a particular function. Here, we used genes enriching for the function ‘GABA receptor 
activity’ in P11WT_Only bin to see how this time point behaves in relation to other time 
points both in the WT and in KO (Fig 5.10).  
The covariance results showed that when a time point is compared itself, the 
covariance was 1. When P0WT was compared all other time points including P5WT & 
KO, P11WT & KO, P27WT &KO, r value was in the range of 0.2 – 0.5, where it was least 
correlated with P27 (r = 0.2) and most correlated with P5 (r = 0.59) (Fig 5.10). Next, when 
P5 was compared in a similar manner, it had highest correlation to the KO counterpart (r 
= 0.96), closely followed by P11 (r=0.9), then followed by P27 (r = 0.7) and strangely least 
correlated with P0 (r = 0.59) (Fig 5.10). This trend explains the course of development, 
where a given time point is closer to the next developmental time point compared to the 
previous time point. P5KO followed a similar pattern in that it was the closest to P5WT 
(Fig 5.10). P11WT was almost equally closely related to both P5 and P11 WT and KO at 
about 0.87 – 0.9 r vale. The interesting observation was in P11KO, where it showed a 
higher correlation with P27WT (r = 0.97) compared to its own WT counterpart (r = 0.92) 
(Fig 5.10). This suggests that P11KO might have the gene expression patterns similar to 
that in P27WT, thereby indicating a developmental shift in the KO, where the patterns 
observed by P27 in normal development might happen sooner around P11 in the KO (Fig 
5.10). However, this result has to be vetted through more covariance analyses for other 
functional enrichments to see if this pattern truly emerges. 
5.3.4 Future directions 
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Currently, I am employing this strategy to find the correlation of genes enriching 
for various functions in each bin to check if the pattern of P11KO and P27WT correlation 
is consistent, which if the case, can help in the understanding of retinal development in 
the absence of this triple microRNA cluster as a whole and might suggest re-wiring of the 
networks in the P11KO to mimic the gene regulatory networks at P27 in the wild type 
retina. 
5.3.5 Materials and methods 
Binning strategy 
Binning strategy employed in this analysis is same as that described in section 5.2.5 
under ‘Binning strategy’. 
Functional annotation analysis 
DAVID analysis to extract functional enrichments was done in the same way as described 
in section 5.2.5 under ‘Functional annotation analysis’. 
Covariance and correlation coefficient analysis 
Covariance and correlation coefficiency is a function of Microsoft excel, which helps in 
determining the correlation between two variables. The sample correlation coefficient (r) 
gives the strength of correlation. 
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Figures: 
Figure 5.1 
 
Fig 5.1  Binning strategy for RNA-Seq data: Binning protocol shown here is for two 
theoretical samples, A and B. Schematic on the top shows the different steps in the 
binning protocol and the outcomes are shown as bar graphs underneath (purple boxes). 
In the bar graph FPKM units are shown on the y-axis and the gene is represented as a 
bar in green (sample A) and orange (sample B). Colored lines within the bar represent 
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the constituent isoforms (Yellow boxes). The dashed line represents the threshold (1 
FPKM) of gene expression. 
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Figure 5.2 
 
 
Fig 5.2 Validation of high-resolution transcriptome by RNA-Seq A-D. Expression of 
genes with established expression kinetics including (A) Fgf15, Sfrp2, Atoh7, Irx4, (B) 
Fabp7, Gngt2, Nr2e3, Nrl, Rho, Pax6, (C) Malat1, Xist, Tsix, Neat1, (D) Hist2h2bb, 
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Hist2h2aa2, Hist1h4k and Hist1h4f shown as bar graph with FPKM in y-axis (log scale 
for A-C) between E16CE (blue), P0CE (red), and P0NE (black). E - J. Combined 
E16CE-P0CE and P0CE-P0NE high-resolution transcription kinetics, E16CE_Only (E), 
OR_E16CE (F), Non_DR (G), OR_P0CE (H), P0CE_Only (I) and No_Ex (J). 
OR_E16CE - Over represented in E16CE; OR_P0CE – Over represented in P0CE; 
Non_DR – Non-differentially represented.  
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Figure 5.3 
 
Fig 5.3 Custom bioinformatics pipeline revealed transition in biological 
processes: A. E16CE-P0CE comparison is shown with its bins as boxes that were 
used to extract gene list for DAVID analysis and the GOterms for functions enriched by 
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these lists were curated (Detailed list of GOterms in Additional file 2: Table S1.1, S1.2). 
This process is represented by the roman number I. B. An example to show the output 
of Part I, where OR_P0CE bin was chosen from E16CE-P0CE comparison. The genes 
that enriched for a function in each bin in A were then subjected to pipeline shown in C 
(II), which starts with gene list entry to GeneMANIA followed by (arrow going up) 
identification of new partners. (Right) Output of the pipeline in C (II), where the primary 
gene list (17 genes) that enriched for “Visual Perception” function is shown in the first 
column. The three iterations of the pipeline in part II are denoted as 1X, 2X and 3X. D 
(III). Genes in the final list were assigned to their bins in E16CE-P0CE and P0CE-P0NE 
comparisons. E. Output for D (III) with rows showing distribution of genes in bins from 
E16CE–P0CE comparison and the columns reflecting genes in bins from P0CE-P0NE 
comparison.  
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Figure 5.4 
 
Fig 5.4 Custom microarray revealed isoform/gene expression coherence and 
validated RNA-Seq. A -C. Shown here is a centroid view of K-means clusters of 
isoform-specific probes across retinal development (Clusters given in Additional file 4: 
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Table S3). The y-axis shows arbitrary units (-3 to 3) of expression and the 
developmental time is shown on top and bottom. D – F. Selected GOterms enriched by 
DAVID analysis for genes in clusters A-C. 
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Figure 5.5 
 
Fig 5.5 Temporal comparison of P21-Nrl-WT and P21-Nrl-KO to P0 
Shown is an example of common and unique GOterms identified in the P21_only bin in 
both P0 vs. P21-Nrl-WT (P21WT_Only) and P0 vs. P21-Nrl-KO (P21KO_Only) 
comparisons and the genes underlying them. Left common function (visual perception); 
Right Unique to P0 vs. P21-Nrl-KO (regulation of blood pressure) (Detailed list of 
GOterms in Additional file 2: Table S1.3, S1.4).  
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Figure 5.6 
 
Fig 5.6  RNA-Seq revealed progression of biological programs across normal and 
aberrant retinal development. A. Schematized representation of kinetics of the 
molecular programs identified by RNA-Seq (E16CE-P0CE- P0NE) is represented with 
different colors and the shapes represent the gene expression kinetics. B. Extension of 
our temporal analysis strategy to P21-Nrl-WT and P21-Nrl-KO by comparing them to P0 
(P0CE +P0NE) revealed molecular programs in normal development (P21-Nrl-WT) and 
unique programs in aberrant development (P21-Nrl-KO). C. Schematic representation of 
a cell at P0, where the cytoplasm and the nucleus are temporally synchronized and the 
cell with dotted line shows that the nuclear transcriptome is shifted forward temporally 
compared to that of the cytoplasm  
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Figure 5.7 
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Fig 5.7. Transcriptomics summary of static comparison: A. Strategy employed in 
the static comparison where wild type and knock out are compared. B – D. 
Transcriptome summary of the comparison between P5WT-P5KO (B), P11WT-P11KO 
(C), P27WT-P27KO (D). The white box represents all genes examined for this study. 
The venn diagram within it represents the different bins. Alternative splicing status of 
each bin is shown as a pie chart. 
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Figure 5.8 
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Fig 5.8. Transcriptomics summary of temporal comparison: A. Strategy employed 
in the temporal comparison where developmental time points are compared to each 
other as the development progresses. B – G. Transcriptome summary of the 
comparison between P0WT-P5WT (B), P0WT-P5KO (C), P5WT-P11WT (D), P5KO-
P11KO (E), P11WT-P27WT (F) and P11KO-P27KO (G). The white box represents all 
genes examined for this study. The venn diagram within it represents the different bins. 
Alternative splicing status of each bin is shown as a pie chart. 
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Figure 5.9 
 
 
Fig 5.9. DAVID analysis output of Static and Temporal comparisons. Table shows 
the two comparisons – Static and temporal comparisons with the pairwise comparisons 
and Goterm functional enrichments of genes belonging to their respective bins.  
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Figure 5.10  
 
Fig 5.10 Covariance analysis of genes enriching for GABA A receptor activity. 
Covariance and correlation analysis of genes enriching for ‘GABA A receptor activity’ 
across different time points both in the wild type and miR182/96/183 knock out retinae. 
Cells in ‘red’ indicate the highest correlation between those time points. While cells in 
‘blue’ indicate weaker correlation. 
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Chapter 6: Conclusion and Future Directions 
In Chapter 3, it was shown that Sfrs10 was expressed in differentiating retinal 
neurons and are maintained in the adult retina.  Its expression implies the usage of RNA 
processing including AS by retinal neurons during terminal differentiation.  The extent to 
which AS is employed during neuronal differentiation and function is not well understood 
and our data on the expression of Sfrs10 suggests that it might play a crucial role.  Indeed, 
neuronal specific-knockout of Sfrs10 has shown perinatal lethality due to massive 
apoptosis in ventricular regions in the cortex. Thus, a retina specific-knockout of Sfrs10 
will be a valuable tool in helping us understand the role of Sfrs10 and its downstream 
targets in the developing retina. Additionally, using the inducible cre, Sfrs10 can be 
ablated at various stages of development to check if Sfrs10 is required for the 
maintenance of retinal neurons post-differentiation. The expression of Sfrs10 specifically 
in the red/green cone photoreceptors during the postnatal retinal development suggested 
Sfrs10-regulated alternative splicing in that subset of cone photoreceptors. Currently 
there are no clear nuclear markers for red/green cone photoreceptors. Thus, Sfrs10 can 
serve as a valuable marker for these cone cells. 
  The upregulation of SFRS10 in AMD retinae suggests that it might be required for 
AS of a subset of genes involved in hypoxic stress response. For instance, a gene might 
normally be expressed but under stress conditions, it might undergo AS shift and the 
isoform responding to stress is regulated by SFRS10. It could be that there is an 
increased demand for the isoform regulated by Sfrs10 under hypoxic stress. By identifying 
the targets of Sfrs10 in the AMD could pave way for the therapeutic intervention of the 
disease progression. It was shown that Sfrs10, indeed, plays an anti-apoptotic role by 
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regulating the alternative splicing of Bcl2 in colon cancer. It was also shown that Sfrs10 
competes with miR-204 to bind to Bcl2. Thus, the same pathway could be activated under 
hypoxic stress to exhibit a protective role. A mouse model for retinal degeneration such 
as rd1 (where rod photoreceptors die as early as P13) could be employed to check if, by 
knocking down miR-204 or by over expressing Sfrs10, rod photoreceptors survive longer 
in this disease model.  
In Chapter 4, it was shown that Citron kinase was expressed in a specific subset 
of retinal progenitor cells and its expression diminishes postnatally. Loss of CitK shows 
the absence of Islet1 specific subset of bipolar cells. This suggests that CitK might be 
present in those progenitor cells that would eventually give rise to Islet1+ bipolar cells 
postnatally. This observation corroborates the ‘competence’ model where it was shown 
that a retinal progenitor cell, once determined to become a bipolar cell, cannot make 
embryonically born neurons even when placed in the embryonic environment. By 
employing conditional knockout mice for Citron Kinase crossed with inducible Chx10-cre 
mice, we can study the role of Citron kinase in the bipolar cells postnatally and if Citron 
N has a role to play in the terminal differentiation of these cells. Another question that still 
remains unanswered is the other factor that compensates for the loss of CitK in the 
knockout till E14 after which the massive apoptosis of retinal progenitor cells begin. Since 
there are other members of the ROCK/ROK family present, it would be interesting to 
knockdown each one at a time, to see if these are playing the role of the compensatory 
factor for CitK loss. Further, the role of Citron N has not been studied in the retina and if 
we could specifically knockdown the kinase domain of CitK, the role of Citron N could be 
investigated. 
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Two novel isoforms of CitK were identified, where one lacked the exon 9 while 
another had intron 13 retention. The former isoform would result in a protein, which lacks 
the kinase domain and the latter would have an altered SMC domain, suggesting its 
influence on the nuclear activity of CitK, which has been reported in Drosophila.  Thus, 
investigating the role of these isoforms separately can provide more information on 
diverse roles of CitK in retinal progenitor cells. For this, isoform specific short hairpin RNA 
(shRNA)s have been engineered. Using RNA interference technique, these shRNAs will 
be introduced into the dividing progenitor cells using P0 invivo retinal electroporation. 
Post- electroporation, retinae can be harvested at various time points and 
immunohistochemistry analysis on these tissue will be performed. This will allow us to 
identify the isoform-specific aspects of the phenotype and could possibly highlight both 
the nuclear and cytoplasmic role of Citron Kinase, attributing each role to a specific 
isoform.   
In Chapter 5, global analyses of transcriptome changes and how alternative 
splicing informs retinal development was discussed. It was shown that genes, which did 
not change in their transcriptional levels, had the highest level of alternative splicing at 
the isoform level.  RNAseq data obtained from fractionated retinae revealed that the 
nuclear transcriptome was temporally ahead of cytoplasmic transcriptome, in that nucleus 
was preparing for the next molecular event while executing the current program. A 
customized bioinformatics pipeline was devised to extract the biological meaning from 
large datasets. This strategy was also compared to other methodologies routinely 
employed by other biologists. The application of this pipeline is diverse, in that, it could 
be used to investigate transition in molecular programs across tissue types and cell 
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states, including investigations of disease progression.  This pipeline was also employed 
to understand the progression of uterine cancer, where RNAseq data from tumor samples 
from five different regions as well as from different stages of cancer. The goal here is to 
identify the chronology in which each of the tumor developed and whether or not the 
tumors developed at later stages were formed de novo or from metastasized cells. By 
identifying tumor-specific molecular signatures and finding the underpinning biological 
programs, the relationship between each tumor with respect to that biological function 
begin to emerge, thereby allowing us to determine the similarities and differences 
between the tumors.  
Another analysis that employed this pipeline was investigating the role of a 
microRNA cluster knockout in the retinal development. Since the cluster, miR 182-92-
183, is known to play a role in photoreceptor and bipolar cell maintenance, one would 
predict that the absence would lead to pathways involved in photoreceptor 
function/maintenance going aberrant. To test whether or not, we can identify these 
molecular signatures early in the development, RNAseq data from various stages of 
retinal development is obtained from the knockout and wildtype counterpart. Additionally, 
downstream targets of this miRNA cluster is known, which would help us to leverage the 
changes we observe in the bins obtained through our analysis. Currently, this work is in 
progress, where we employed the automated upstream and downstream bioinformatics 
pipeline to extract all the pathways enriched by each bin in a pairwise comparison along 
with the whole gamut of genes involved in each of the pathway. We are also employing 
the nodal analysis where, for example, P5WT is compared to P11KO RNAseq data and 
this comparison along with P5WT-P11WT comparison. The rationale here is that by 
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comparing these two pairwise comparisons, we can detect the divergence in the normal 
pathway as it precipitates. This way, primary, secondary and tertiary effects of the miRNA 
cluster KO can be established.  
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Appendix 1: 
1. Steps to run the bioinformatics pipeline 
Analyses from RNAseq data involve mapping the reads obtained from sequencing onto 
the reference genome or transcript libraries or exon-exon junction libraries or 
combinations of these. The gene expression level is then estimated from unique reads. 
Biological meaning can be extracted by comparing the expression levels of genes 
between samples.  
The pipeline that was employed by us to extract biological information from big data 
(RNAseq) used a customized bioinformatics pipeline which organized information into 
separate bins. The genes in these bins were grouped based on their transcriptional 
kinetics across two samples. Then genes belonging to each bin were analyzed using 
DAVID to understand the functions enriched by them. Additionally, other potential 
partners to these genes involved in a pathway were also identified using another tool 
called GeneMANIA.  
Following sections describe step-wise procedure to execute the bioinformatics pipeline 
mentioned above. It begins with accessing the remote server to execute the scripts. This 
is followed by the main scripts employed in our pipeline and the tools employed in those 
scripts such as Bowtie for read mapping, IsoEM for estimating the isoform frequency of 
genes from mapped reads, and GFOLD and Fisher’s exact test for making differential 
expression calls. 
1.1. Server Access 
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To access the remote server, accounts have to be created by Dr. Ion Mandoiu of 
Computer Science and Engineering department. Once they are created, the user has to 
download two software namely, WinSCP and PuTTY. While WinSCP is the client server 
that saves all the directories, scripts and the output of the script execution, PuTTY is the 
user interface. The platform used is Linux; hence the commands are given in Linux 
language. Once these two softwares are downloaded, the user can logon to WinSCP 
using their username and the password provided by Dr. Mandoiu. Once logged in, the 
user can change his/her password by giving the command “passwd”. 
Default server given is cnv1 and so the host is cnv1.engr.uconn.edu. The default port is 
22. After the password change, the user could see their home directory as the default 
start screen in WinSCP. All directories, fastq files and scripts for running the pipeline are 
stored in “data1” directory in the “root” directory. When the user wants to switch to that 
directory, command line “cd” followed by the path to that directory should be given. To 
login in PuTTY, the user should use the same password (Note: no characters will appear 
when the user types his/her password. Once they hit enter, cnv1% will appear. The screen 
in PuTTY will always have the header, “cnv1%”. If that shows up, the user can continue 
typing their command line. For example, to change the directory to data1 from home 
directory, the user can type 
Cnv1%  cd /data1 
If the user wants to create directory under their name in data1, the command line is, 
Cnv1% mkdir Krishna 
This will create a directory named “Krishna” under data1 directory. 
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Likewise, new directories can be created. The user has to be careful in knowing where 
they currently are as creating directories elsewhere could be confusing later. To make 
sure they are in the correct location, the user can type the command “pwd”. This will show 
the current location. Then they can change directory using “cd” followed by the path of 
the location they want the new directory created.  
1.2. Common command lines 
Some of the commonly used command lines are as follows: 
1. To check the current location of the user: pwd 
2. To create new directory: mkdir <a name> 
3. To copy the contents of a directory: cp –recursive <pathname> <destination path 
name> 
4. To create short links (short cuts for directories): ln –s <path name> 
shortcutname.same extension as the original file. 
5. To unzip or zip files: gunzip or gzip followed by the path name. 
6. To check if the script is running: ps x 
7. To abort a running script: kill followed by the ID (it will show up when the user uses 
ps x command). 
8. To find a particular character in the output: grep followed by that character (it could 
be a gene name or word) 
9. To save the log file for a script: /pathname of the script >& output name.log & (This 
enables the script to run even when the user terminates the session in WinSCP). 
10.  To concatenate two data: cat filename1.extension filename2.same extension > 
newname.same extension. 
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1.3. Building index files: 
For comparing the RNAseq data, a reference file or an index file must be first built. It has 
to be done for each species. In case of mouse, separate index files were built for C57/BL6 
and CD1 strain of mice. CD1 reference was used in the E16CE, P0CE, P0NE comparison, 
while the former was used in the Nrl wildtype (WT) and knockout (KO) and microRNA WT 
and KO RNAseq data analysis. To build the index file, one needs two reference files. First 
one is the FASTA file, which contains the genome information for the species under 
investigation. It can be obtained from UCSC genome browser (https://genome.ucsc.edu/). 
For mouse, version Mus musculus 10 (mm10) was used. This reference genome is that 
of the C57/BL6 strain. The second file that is required is the gene transfer file (GTF), 
which contains information about gene structure such as gene name, start and end 
positions, frame, and strand. This file is obtained from Ensembl browser 
(www.ensembl.org), where the mouse file (version 68) was used to generate the index 
file. The downloaded file contains the isoform IDs, but not the gene IDs, which are needed 
for generating the index file.   
Script used: 
#!/bin/tcsh 
 
set genome=/import1/UCSC/mm10/mm10.fa; 
set GTF=/import1/GTF/mm10Ensembl68wGeneNames.gtf; 
set isoSequences=/import1/bowtie_index/mm10/mm10Ens68_polyA200_randOrder.fa; 
set Ens_index=/import1/bowtie_index/mm10/mm10Ens68_polyA200_randOrder.fa; 
 
 
The highlighted fields in “green” are species-specific. Here shown is that of mouse. 
These fields have to be changed when working with different species. 
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Prior to executing the above mentioned script, the “CreateGTFWithGeneIDs” script 
must be executed, which queries the Ensembl transcript IDs to a clusterFile containing 
both transcript and gene IDs, generating a new GTF file that contains the gene IDs.  When 
executing this script, the file names of the downloaded GTF, the clusterFile with geneIDs 
and transcriptIDs, and the output GTF must be provided as inputs one, two, and three, 
respectively.  The output files will be created at the location of the user when they enter 
the command to execute the script.  Therefore, the user should enter the intended 
destination directory before executing the script.  This is done by entering the change 
directory command, cd, followed by the destination path/directory. Following is the 
‘createGTFWithGeneIDs’ script: 
GTF=$1 
clusterFile=$2 
outputGTF=$3 
 
rm -f tmp.GTF sortedClusterFile.txt tmp.txt 
awk '{print substr($12,2,length($12)-3), $0}' $GTF | sort -k 1,1 > tmp.GTF 
sort -k 1,1 $clusterFile > sortedClusterFile.txt 
join sortedClusterFile.txt tmp.GTF > tmp.txt 
awk '{print $3 "\t" $4 "\t" $5 "\t" $6 "\t" $7 "\t" $8 "\t" $9 "\t" $10 "\t" $11, 
"\42" $2 "\42;", $13, $14}' tmp.txt > $outputGTF 
   
CD1 reference genome: 
Single nucleotide variations due to the strain difference between C57/BL6 and CD1 are 
first accounted for and reads are mapped to the newly created reference genome. 
1.4. Input files: 
The input files for the analysis are the FASTQ files. They are unmapped raw reads 
obtained from the RNAseq run. Nowadays, reads are obtained as paired-end reads (~ 
120 bp per end). Therefore, each sample contains two FASTQ files for each end. The 
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user then sometimes unzips the files followed by creating a short link for these files in 
their directory in the root directory. 
1.5: Read mapping: Bowtie 
Reads are mapped using the read aligner, Bowtie, which efficiently aligns short reads 
(~35bp). Burrows-Wheeler index is used by Bowtie to index the genome. The output is 
usually obtained in the sequence alignment/map (SAM) format. Bowtie forms the basis 
for other algorithms such as TopHat, Cufflinks, Crossbow and Myrna. Input for Bowtie 
include an index file and fastq files (raw reads). These fastq files can be single or paired-
end reads.  
The alignments that are reported by Bowtie are randomized to avoid “mapping bias”, 
which is defined as the spurious holes that cause the aligner not to report a particular 
class of good alignments. These alignments cannot have more than “N” mismatches, 
where N= 0 – 3 in the first “L” bases, where L ≥ 5. The first L bases are called the “seed”. 
Also, the sum of the Phred quality values may not exceed “E” (default is 40).  
Required Inputs: (Bowtie, IsoEM command lines along with these inputs are a part of 
Run-analysis.sh script) 
set genome=/import1/genome/mm10/mm10.fa; 
set knownGeneGTF=/import1/GTF/mm10Ensembl68wGeneNames.gtf; 
set index=/import1/bowtie_index/mm10/mm10Ens68_polyA200_randOrder.fa; 
set isoSamFile=mm10_Ens68_coordinates; 
set genomeSamFile=mm10_Ens68_in_genome_coordinates; 
#set geneClusters=/import1/GTF/mm10Ens68_TransID_GeneName.txt; 
set isoEM_Dir=/home/sahar/isoem-clip-polyA/bin; 
set fastqDir=/data1/krishna/nrlko/data 
Bowtie command: 
bowtie --chunkmbs 512 -k 20 -l 30 -n 3 -p 16  -e 250 --sam --sam-nohead \ 
    $index ${fastqDir}/${condition}-${replicate}.fastq  \ 
    ${condition}-${replicate}-$isoSamFile.sam 
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1.6: IsoEM 
Isoform expectation-maximization (IsoEM) algorithm is employed to infer the frequency 
of isoform occurrence for a gene from the mapped reads. The algorithm uses information 
on the standard deviation, distribution of insert sizes, which are generated during the 
sequencing library preparation. It uses base quality scores, strand and read pairing 
information. IsoEM maps the reads to the known isoforms using output from Bowtie by 
converting read alignments to genome coordinates. This in turn is combined to obtain 
isoforms for each read, which then use “line sweep” technique to detect the compatibility 
between reads and isoforms, during which reads are grouped based on their isoform 
compatibility. Next, when reads match multiple isoforms, IsoEM simultaneously estimates 
the frequencies as well as iteratively performs the following two steps until they converge: 
 E-step: Expected number of reads, n (j) is computed from isoform (j) based on 
computed weight (w) assuming that the frequency of the isoform, f (j) is correct. 
 M-step: For each isoform, f (j) is set and read coverage is normalized based on the 
E-step. 
Script used: 
set option="--directional"; 
set average=320; 
set std=60; 
isoem -a --directional -G $knownGeneGTF P0-all-sort.sam -polyA 200  
     mv ${condition}-${replicate}-$genomeSamFile.iso_estimates ${condition}-
${replicate}.iso_estimates 
     mv ${condition}${replicate}-$genomeSamFile.gene_estimates ${condition}-
${replicate}.gene_estimates 
 
 
1.7: Making the differential expression (DE) calls: 
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Once the reads are mapped and the isoform frequency is estimated in Fragment 
Per Kilobase per Million mapped reads (FPKM) units, the threshold for gene expression 
is set. In case of retina, based on the known expression kinetics of genes, the threshold 
was set to 1. Therefore, when a gene (whose FPKM is calculated based on the sum of 
its constituent isoforms) is considered expressed (FPKM ≥ 1), differential expression (DE) 
calls had to be made. To make DE calls, two independent algorithms were employed 
namely, GFOLD and Fisher’s exact test. The overall script that is executed is “analysis-
pipeline script” which is as follows: 
#!/bin/sh 
 
sample1=$1 
sample2=$2 
 
#1 
../bin/run-all-methods $sample1 $sample2 
#2 
../bin/getGFOLDIsoDEIntersection ${sample1}_${sample2} # no second parameter 
for isoform 
../bin/getGFOLDIsoDEIntersection ${sample1}_${sample2} gene 
##3 
../bin/ExpressedNotExpressedAnalysis ${sample1}_${sample2} 
# 
##4, 5, 6, and 7 
 
../bin/DivideOnlyGroupsToOneAndMultipleIsoforms ${sample1}_${sample2} 
../bin/GetDIEGenes ${sample1}_${sample2} 
 
../bin/MergeFiles ${sample1} ${sample2} ${sample1}_${sample2} 
## 7 
../bin/LabelGeneSubgroupsInAllPartitionsFiles ${sample1}_${sample2} 
#8 
../bin/GetStats 
 
#clean up 
#rm -f *List 
#rm -f *.tmp 
This script encompasses the following eight scripts: 
i. Run-all-methods 
#!/bin/bash 
 
geneGTF=/import1/GTF/mm10Ensembl68wGeneNames.gtf 
isoDE=/home/sahar/code/FishersTest/isode 
isoGTF=/import1/GTF/mm10Ensembl68.gtf 
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sample1=$1 
sample2=$2 
 
echo "in run-all-methods" 
echo $sample1 
echo $sample2 
 
# The number of mapped reads in million is taken from the bowtie log. 
Eventaully needs to be computed from the sam file for automation 
#get the number of aligned reads 
count1=`awk '{if ($3 != "*") print $1}' ${sample1}-
mm10_Ens68_in_genome_coordinates.sam | sort --parallel 6 | uniq | wc -l` 
count1InMillion=$(( count1/1000000 )) 
count2=`awk '{if ($3 != "*") print $1}' ${sample2}-
mm10_Ens68_in_genome_coordinates.sam | sort --parallel 6 | uniq | wc -l` 
count2InMillion=$(( count2/1000000 )) 
../bin/runFisher $sample1 $sample2  $count1InMillion $count2InMillion  
../bin/runGFOLD ${sample1}-mm10_Ens68_in_genome_coordinates ${sample2}-
mm10_Ens68_in_genome_coordinates $geneGTF gfold.geneout  
../bin/runGFOLD ${sample1}-mm10_Ens68_in_genome_coordinates ${sample2}-
mm10_Ens68_in_genome_coordinates $isoGTF gfold.out  
echo "end run-all-methods" 
 
This in turn contains two other scripts including (1) runGFOLD and (2) runFisher 
GFOLD: 
Generalized fold change algorithm is based on the Bayesian posterior probability 
distribution, which is used to estimate the relative difference in the gene expression. It is 
also employed for the isoform level analysis of differential expression. This method is 
preferred over methods that give raw fold change for estimating the differential expression 
of gene in terms of p-value. 
Script used: runGFOLD 
#!/bin/sh 
 
sample1=$1 
sample2=$2 
GTF=$3  
output=$4 
echo "runGfold" 
 
gfold count -ann $GTF -tag ${sample1}.sam -o ${sample1}.${output}.read_cnt 
gfold count -ann $GTF -tag ${sample2}.sam -o ${sample2}.${output}.read_cnt 
gfold diff -sc 0.01 -s1 ${sample1}.${output} -s2 ${sample2}.${output} -suf 
.read_cnt -o $output  
 
echo "end runGfold" 
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If the fold change needs to be changed, “format GFOLD” script has the parameter that 
needs to be changed. 
formatGFOLDfiles script: 
#!/bin/bash 
 
gfoldFile=$1 
FCThreshold=$2 
rm -f ${gfoldFile}.${FCThreshold}.isoDEFormat 
awk -v FCt=$FCThreshold '{FC=2^$4; if (FC < 1 && FC > 0) FC=(1/FC); if 
($5>$6) Dir=1; else Dir=2; if (FC >= FCt && $2!=0) diff="DE"; else 
diff="nonDE"; if ($1 != "#") print $1, $5, $6, $2, Dir, FC, diff}' $gfoldFile 
> ${gfoldFile}.${FCThreshold}.isoDEFormat 
 
The field in “red” needs to be changed to “2” for the script to consider the input fold change 
along with the change mentioned in the ‘getGFOLDsioDEintersection’ file. 
Fisher’s exact test:  
Fisher’s exact test is another algorithm used in the estimation of differential expression of 
genes between tow samples. This algorithm calculates the probability score (P-value) and 
it gives an exact measure of the deviation from the null hypothesis compared to G-test or 
Chi-square test, when the sample size is small.  
Script used: runFisher 
#!/bin/sh 
 
Fisher=/home/sahar/code/FishersTest/isode 
echo "in runIsoDE" 
sample1=$1 
sample2=$2 
NumberOfMappeReadsinMillion1=$3 
NumberOfMappeReadsinMillion2=$4 
pair=${sample1}_${sample2} 
echo $pair 
rm -f ${pair}*.iso_estimates 
rm -f ${pair}*.gene_estimates 
rm -f ${pair}.DE 
rm -f ${pair}_wgeneName.DE 
rm -f ${pair}.geneDE 
 
key-merge ${sample1}.iso_estimates ${sample2}.iso_estimates  > 
${pair}.iso_estimates  
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awk '{if ($2 < 1) fpkm1 = 0; else fpkm1 = $2; if ($3 < 1) fpkm2 = 0; else 
fpkm2 = $3; if (fpkm1 != 0 && fpkm2 != 0) print $1 "\t" fpkm1 "\t" fpkm2}' 
${pair}.iso_estimates > ${pair}Tab.iso_estimates 
key-merge ${sample1}.gene_estimates ${sample2}.gene_estimates > 
${pair}.gene_estimates  
awk '{if ($2 < 1) fpkm1 = 0; else fpkm1 = $2; if ($3 < 1) fpkm2 = 0; else 
fpkm2 = $3; if (fpkm1 != 0 && fpkm2 != 0) print $1 "\t" fpkm1 "\t" fpkm2}' 
${pair}.gene_estimates > ${pair}Tab.gene_estimates 
 
$Fisher ${pair}Tab.iso_estimates $NumberOfMappeReadsinMillion1 
$NumberOfMappeReadsinMillion2 2 0.01 housekeeping  ENSMUST00000147954 > 
${pair}.DE 
$Fisher ${pair}Tab.gene_estimates $NumberOfMappeReadsinMillion1 
$NumberOfMappeReadsinMillion2 2 0.01 housekeeping Gapdh > ${pair}.geneDE 
 
 
# $Fisher ${pair}Tab.iso_estimates $NumberOfMappeReadsinMillion1 
$NumberOfMappeReadsinMillion2 2 0.01 total > ${pair}.DE 
# $Fisher ${pair}Tab.gene_estimates $NumberOfMappeReadsinMillion1 
$NumberOfMappeReadsinMillion2 2 0.01 total > ${pair}.geneDE 
 
echo "end run IsoDE" 
 
The number in “red” is the specified fold change. This number can be changed based 
on the fold change for each set of data. This change has to accompany the fold change 
in formatGFOLD script for the change to take effect. The field highlighted in “green” is 
the transcript ID of mouse Gapdh gene. When different species data is analyzed, this 
field should be changed to the species-specific Gapdh isoform that is expressed in the 
data. 
 
ii. getGFOLDisoDEintersection 
 
This is the intersection of GFOLD and Fisher test results to select for genes with p-value 
0.01 and fold change ≥ 2. 
#!/bin/sh 
 
pair=$1 
subset=$2 # gene if for gene DE and nothing (do not supply parameter) if 
isoform DE 
 
echo "In getGFOLDIsoDEIntersection" 
       
 echo $pair $subset 
 ../bin/formatGFoldFiles gfold.${subset}out 1 # 1 will not eliminate 
DE calls based on fold change of GFOLD; it will be done on the intersection 
with isoDE; so it would be based on isoem FPKMs 
 rm -f ${pair}.${subset}DE.IdFpkm1Fpkm2DirDE 
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 awk '{print $1, $2, $3, $5, $7}' ${pair}.${subset}DE > 
${pair}.${subset}DE.IdFpkm1Fpkm2DirDE 
 rm -f  gfold.${subset}out.IDDirDE 
 awk '{print $1, $5, $7}' gfold.${subset}out.1.isoDEFormat > 
gfold.${subset}out.IDDirDE 
 rm -f keymerge.tmp 
 key-merge ${pair}.${subset}DE.IdFpkm1Fpkm2DirDE 
gfold.${subset}out.IDDirDE > keymerge.tmp 
 rm -f ${pair}.${subset}DE.IdFpkm1Fpkm2DirDEGFoldDirDE 
 awk '{if (NF == 7) print $0}' keymerge.tmp > 
${pair}.${subset}DE.IdFpkm1Fpkm2DirDEGFoldDirDE # eliminate lines with no 
IsoED output; isoDE with run only on genes expressed on both samples (FPKM > 
0.1) 
 
 rm -f ${pair}.${subset}IsoDEGFOLDOverExpIn1List 
 awk '{if ($4 == $6 && $5 == "DE" && $7 == "DE" && $2 > $3) print $1, 
$2, $3, "1", ($2/$3), "DE"}' ${pair}.${subset}DE.IdFpkm1Fpkm2DirDEGFoldDirDE 
> ${pair}.${subset}IsoDEGFOLDOverExpIn1List 
 rm -f ${pair}.${subset}IsoDEGFOLDOverExpIn2List 
 awk '{if ($4 == $6 && $5 == "DE" && $7 == "DE" && $3 > $2) print $1, 
$2, $3, "2", ($3/$2), "DE"}' ${pair}.${subset}DE.IdFpkm1Fpkm2DirDEGFoldDirDE 
> ${pair}.${subset}IsoDEGFOLDOverExpIn2List 
 rm -f ${pair}.${subset}IsoDEGFOLDNonDEList 
 awk '{if ($4 != $6 || $5 != "DE" || $7 != "DE") print $1, $2, $3, 
"nonDE"}' ${pair}.${subset}DE.IdFpkm1Fpkm2DirDEGFoldDirDE > 
${pair}.${subset}IsoDEGFOLDNonDEList 
 if [ "$subset" != "gene" ] 
 then 
  rm -f  ${pair}_wgeneID.${subset}IsoDEGFOLDOverExpIn1List 
  key-merge ../mm10Ens68TransID_GeneName.txt 
${pair}.${subset}IsoDEGFOLDOverExpIn1List | awk '{if (NF == 7) print $0}' > 
${pair}_wgeneID.${subset}IsoDEGFOLDOverExpIn1List 
  rm -f  ${pair}_wgeneID.${subset}IsoDEGFOLDOverExpIn2List 
  key-merge ../mm10Ens68TransID_GeneName.txt 
${pair}.${subset}IsoDEGFOLDOverExpIn2List | awk '{if (NF == 7) print $0}' > 
${pair}_wgeneID.${subset}IsoDEGFOLDOverExpIn2List 
  rm -f ${pair}_wgeneID.${subset}IsoDEGFOLDNonDEList 
  key-merge ../mm10Ens68TransID_GeneName.txt 
${pair}.${subset}IsoDEGFOLDNonDEList | awk '{if (NF == 5) print $0}' > 
${pair}_wgeneID.${subset}IsoDEGFOLDNonDEList 
      else 
 
 
              rm -f ${pair}.${subset}IsoDEGFOLD*List.GeneIDs 
              awk '{print $1}' ${pair}.${subset}IsoDEGFOLDOverExpIn1List > 
${pair}.${subset}IsoDEGFOLDOverExpIn1List.GeneIDs 
              awk '{print $1}' ${pair}.${subset}IsoDEGFOLDOverExpIn2List > 
${pair}.${subset}IsoDEGFOLDOverExpIn2List.GeneIDs 
              awk '{print $1}' ${pair}.${subset}IsoDEGFOLDNonDEList > 
${pair}.${subset}IsoDEGFOLDNonDEList.GeneIDs 
 
 fi  
 
 
echo "End getGFOLDIsoDEIntersection 
 
The field in “red” has to be changed to the desired fold change along with the changes 
in ‘formatGFOLDfiles’ and ‘runFisher’ scripts for the new fold change to be included in 
the anaylsis. This script works directionally, i.e., a gene that comes out of GFOLD as 
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“differentially expressed”, then is checked for its p-value (whether it is 0.01) in the output 
of runFisher script. Only those genes that have passed this becomes “DE genes”. If a 
gene is “DE” by GFOLD but does not pass the set p-value in Fisher, the gene does not 
pass the DE test. 
iii. ExpressedNotExpressedAnalysis 
This script uses threshold = 1 to determine whether a gene is expressed (FPKM≥1) or 
not (FPKM <1). 
iv. DivideOnlyGroupsToOneAndMultipleIsoforms 
This script further sub-divides the “Only” group of genes into single isoform or multiple 
isoform. 
v. GetDIEGenes 
vi. MergeFiles 
It merges the output of the above mentioned scripts. 
vii. LabelGeneSubgroupsInAllPartitionsFiles 
This assigns the label to each gene by merging the output of the above scripts. 
viii. GetStats 
This gives the final number of genes in each category (bin) and in the sub-category 
along with the number of mapped reads and number of not expressed genes. 
1.8: Binning:  
Once the genes are categorized based on their FPKM units and their differential 
expression, they are subjected to DAVID analysis to identify the functional enrichments 
of those genes.  
2. Downstream analysis of the binned data 
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2.1: Finding the functional enrichment through DAVID analysis. 
The Database for Annotation, Visualization and Integrated Discovery (DAVID) is 
an algorithm to provide functional enrichments for a given set of genes. Additionally, it 
provides other major biological functions related to the gene list as well as find other 
functionally similar genes in the species genome not listed in the query. Protein domain 
and motifs information along with gene-disease association are also provided by DAVID. 
It is one of the most sought big data mining tool to investigate the biological meaning from 
RNAseq data. DAVID mines the available literature and gene ontology studies to give 
functional enrichments for the genes. Usually a gene list that has an underlying common 
feature such as transcriptional kinetics could enrich for more meaningful functions 
compared to a random list of genes. For example, most up- or down- regulated set of 
genes between two samples have been shown to be involved in specific interesting 
biological processes compared to genes that are not changing between the two. The 
functions enriched by DAVID could be either validated from apriori knowledge or by 
performing wet lab experiments. Also, the size of the gene list is an important factor in 
determining the function with higher statistical significance. Therefore, a larger gene list 
can have a statistically significant enrichment. 
The advantages of DAVID includes its flexibility to use different species 
background for analyses. Besides giving the functional enrichment with statistical 
significance, DAVID also provides annotation categories, protein-protein interaction, 
protein functional domains, disease association, bio-pathways, sequence feature, 
homology, and gene tissue expression etc.  
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Following are the steps to identify the functional enrichments of genes belonging to 
different bins: 
1. Highlight “Upload” tab. 
2. Paste the gene list in the white space under “A. Paste a list”.  
3. Choose “Ensembl _Gene _ID” in the drop down box under “Step 2: Select 
Identifier”.  
4. Choose “Gene list” under “Step 3: List type”. Hit “Submit list”. 
5. Click “Submit to conversion tool” which will be next to the drop down box in 
option 1. 
6. Another tab would open up. Click on “red arrow” next to “official _gene _symbol” 
under “convert all” under “Summary of Ambiguous gene IDs”. 
7. Click “Submit converted list to DAVID as a gene list”. Give a name to the list 
instead of “new_converted_list”. 
8. Go to the neighbouring tab that was already open but now the “list” tab would 
be highlighted. 
9. Choose “Mus musculus” species and click on “Select species”. If any other 
species is selected (You can find it by looking at the current background) other 
than Mus musculus, go to “Background” tab and choose “Mus musculus” from 
it and click “Use”. 
10. Click “Functional Annotation clustering”.  
11. Repeat the step above again with selecting the species, and clicking on 
“Functional Annotation Clustering” again. 
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12. Another window would open. Click on “Download file”. Save the text file under 
the same name you gave earlier. 
2.2: Finding the potential interactors of genes involved in a pathway through 
GeneMANIA 
GeneMANIA is an algorithm that finds genes related to a set of input genes by 
functional association. GeneMANIA mines data from literature regarding genetic 
interactions, pathways, co-expression, protein domain similarity, protein-DNA, protein-
protein, genetic interactions, gene and protein expression data, phenotypic screening 
profiles, and co-localization studies. Sometimes, orthologous studies are also used to 
define a partner to a gene in a complex or a pathway. The first input set of genes are 
“bait” as they define the rest of the potential partners. 
GeneMANIA works best with the maximum input number of 50 genes and make 
gene function predictions on the basis of gene ontology annotation patterns. Network 
generated is accompanied by the data source such as PubMed or BioGRID, Pfam etc. 
Co-expression data usually is collected from Gene Expression Omnibus (GEO) from a 
publication. Physical interaction data is mainly associated with protein-protein interaction 
studies from primary literature and databases such as BioGRID and Pathwaycommons. 
In genetic interaction data, two genes are functionally associated if perturbation of one 
gene affects the other gene. Also, two genes are linked if they share a protein domain, 
which is obtained from InterPro, SMART and Pfam. Co-localization is another way of 
linking two genes when they are shown to be present in the same tissue and the same 
location or gene products present at the same cellular location. Connection between two 
genes also come from pathway data where they are shown to participate in the same 
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reaction within a pathway (data collected fromReactome, bioCyc, Pathwaycommons). 
Predicted connections are usually associated with orthology.  
Following are the steps involved in identifying the network in GeneMANIA: 
1. Input the list of genes, which is considered the “bait”. 
2. Select the species. 
3. The input list is shown in black balls while the new potential interactors as ones in 
grey balls. 
4. Save the network and the list of genes. 
The scripts for the above mentioned customized bioinformatics pipeline were written by 
Dr. Sahar AlSeesi under the guidance of Dr. Ion Mandoiu. 
 
  
210 
 
Supplementary Information for Chapter 5 
Supplementary figures – Additional file 1 
Figure S1 
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Figure S1 (Related to Materials and Methods): Read position mismatch analysis.  
A – C. Reads obtained from deep RNA sequencing for E16CE (A), P0CE (B) and P0NE 
(C) were subjected to mismatch analysis by HardMerge alignment. Shown in x-axis is 
the read position (1 – 101) and shown in y-axis is the percentage of reads with 
mismatch. 
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Figure S2 
 
Figure S2 (Related to Fig. 5.2): Transcriptome summary for E16CE-P0CE & P0CE-
P0NE comparison: A & B. Transcriptome summary of the comparison between 
E16CE-P0CE and P0CE-P0NE, respectively. The white box represents all genes 
examined for this study. The venn diagram within it represents the different bins. C. 
Alternative splicing (AS) status of “expressed in both” groups (OR_E16CE, Non_DR, 
OR_P0CE, and OR_P0NE) in E16CE-P0CE and P0CE-P0NE comparisons. 
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Figure S3 
 
Figure S3 (Related to Fig. 5.4): Downstream analysis of genes belonging to the 
OR_P0NE bin enriching for the GOterm "Synapse": A. Output of the downstream 
gene annotation analysis pipeline parts II and III for OR_P0NE category which enriched 
for synapse. B. Genes resulted from the DAVID analysis for the GOterm “synapse” 
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were further sub-divided into presynaptic or postsynaptic along with the time point of 
their transcription initiation. Up (↑) and down (↓) arrows indicate upregulation or 
downregulation of transcription at that time point. 
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Figure S4 
 
Figure S4 (Related to Fig. 5.5): Transcriptome summary for static & temporal 
comparison: A. Transcriptome summary of the comparison between P21-Nrl-WT and 
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P21-Nrl-KO (Static comparison). The white box represents all genes examined for this 
study. The venn diagram within it represents the different bins. B & C. Transcriptome 
summary of the comparison between P0 vs. P21-Nrl-WT and P0 vs. P21-Nrl-KO, 
respectively (Temporal comparison). The white box represents all genes examined for 
this study. The venn diagram within it represents the different bins.  
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Supplementary tables 
Legends: 
Additional file 2: Table S1: Output of Binning in E16CE – P0CE and P0CE –P0NE 
comparisons: Custom bioinformatic pipeline and binning of E16CE - P0CE and P0CE-
P0NE comparisons at the gene level (S1.1, S1.3) and isoform level (S1.2, S1.4) as 
discussed in the strategy in Fig. 1C.  
Additional file 3: Table S2: DAVID analysis output for temporal comparisons: 
DAVID output for genes belonging to bins in E16CE-P0CE comparison (S2.1), P0CE-
P0NE comparison (S2.2), P0 vs. P21-Nrl-WT comparison (S2.3) and P0 vs. P21-Nrl-KO 
comparison (S2.4).  
Additional file 4: Table S3: Clusters obtained in the microarray analysis: Clusters 
generated through K-means clustering in Genesis for the microarray.  
Additional file 5: Table S4: Output of Binning in P0 – P21WT and P0 – P21KO 
comparisons: Custom bioinformatics pipeline and binning of P0 (P0CE+P0NE) vs. 
P21WT-rep1, P0 vs. P21WT-rep2 and P0 vs. P21-WT-rep3 comparisons (S4.1) and P0 
(P0CE+P0NE) vs. P21KO-rep1, P0 vs. P21KO-rep2 and P0 vs. P21-KO-rep3 
comparisons (S4.2). 
Additional file 6: Table S5: DE based analysis results for static and temporal 
comparisons: DE based analyses for static (P21WT vs. P21KO) (S5.1) and temporal 
(P0 vs. P21WT and P0 vs. P21KO) comparisons (S5.2, S5.3). 
Additional file 7 – Table S6: DAVID analysis output of DE based analyses for  
218 
 
static and temporal comparisons: Results of DAVID analysis based on DE genes for 
P0 vs. P21WT (S6.1), P0 vs. P21KO (S6.2), and P21WT vs. P21KO (S6.3) 
comparisons. 
 
 
 
